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1Summary
SUMMARY
Initiation of transcription by eukaryotic RNA polymerase II is finely controlled by 
a multitude of regulatory factors. Among them, the negative cofactor 2 (NC2), 
composed of the subunits NC2α and NC2β, is able to bind directly to TBP-DNA 
complexes, preventing the assembly of the general transcription factors TFIIA 
and TFIIB. Despite extensive research on the negative and positive function of 
NC2, several questions concerning its regulation remain unexplored. In particular, 
localization and post-translational modifications are poorly understood.
This work is the first to give some insights on the regulation of this factor.
We present evidence that both subunits contain a nuclear localization signal (NLS) 
responsible for the accumulation of proteins in the nucleus. Immunofluorescence 
studies showed that NC2 dimer localizes exclusively in the nucleoplasm. However, 
the two subunits reveal characteristic and unique distribution patterns: NC2α is 
also found in the nucleoli, and NC2β in small concentrations also in the cytoplasm. 
Moreover, we show that the two subunits already dimerize in the cytoplasm and are 
transported into the nucleus as a complex. Interestingly, both NLS are essential for 
import of the dimer. 
We also report for the first time several isoforms of both subunits. In vivo labeling 
experiments showed that NC2α is specifically hyperphosphorylated during mitosis. 
This modification does not impair its ability to dimerize with the partner and bind 
to TBP-DNA complexes, nor affects the stability of the complex. Furthermore, the 
phosphorylated protein maintains the ability to mobilize TBP on the DNA. These 
results suggest that NC2 is still bound to DNA during mitosis, in line with the idea 
that this factor keeps TBP stably associated to DNA. 
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I. INTRODUCTION
1. Eukaryotic gene expression: from gene sequence to active 
protein 
The process of gene expression involves the whole series of events that, starting 
from transcription of a gene, leads to the synthesis of a functional protein. During 
the transcription process, the information is transferred from the deoxyribonucleic 
acid (DNA) to the messenger ribonucleic acid (mRNA). The enzyme responsible 
for this reaction is called RNA polymerase (RNA Polymerase II in the eukaryotes, 
Pol II), which is aided in its function by other factors, termed general transcription 
factors (GTFs).
In most of the genes the level of expression is regulated by transcription factors that 
bind directly to regulatory DNA sequences. The interaction of transcription activators 
with different kinds of coregulatory proteins promotes chromatin decompaction 
and access to DNA, facilitating recruitment of the RNA transcription machinery 
at the transcription start site. As soon as the nascent RNA is transcribed, the 5ʼ 
end of the molecule is modified by the addition of a “cap”. During transcription 
elongation, the polymerase moves from the 5ʼ to the 3ʼ end of the gene sequence 
to extend the transcript. Both coding regions (exons) and non-coding regions of 
the gene (introns) are transcribed by the Pol II in the pre-mRNA transcript. At the 
same time, the splicing machinery starts to remove the introns from the pre-mRNA, 
and the proteins involved in export of the mature mRNA bind to the molecule. 
Upon reaching the end of a gene, Pol II stops transcribing (termination), the newly 
synthesized RNA is cleaved, and a polyadenosine tail [(polyA)] is added to the 3ʼ 
end of the transcript. The newly synthesized mRNA is then transported from the 
nucleus to the cytoplasm, where the information is transferred from the mRNA 
to the protein (translation). In eukaryotes, the nuclear membrane separates the 
compartments where transcription and translation take place, and the export of 
the protein-bound mRNA is mediated by apposing pore structures associated to 
the nuclear envelope. Once in the cytoplasm, translation of mRNA takes place on 
large ribonucleprotein complexes called ribosomes. The newly synthesized protein 
undergoes folding and, eventually, post-translational modifications. 
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The traditional view of gene expression considered each of the steps in the 
pathway from gene to protein (transcription-mRNA-processing-export-translation), 
as independent and chronologically subsequent events. Yet, in recent years this 
view has changed, and now the diverse stages are considered physically and 
functionally related to one another, so that different processings are overlapping 
rather then distinct (Orphanides and Reinberg 2002). As a consequence, the gene 
expression pathway is regulated at multiple levels, since each process is controlled 
per se and also in coordination with the others. Increasing observations point to 
the notion that the passage from transcription initiation to transcription elongation is 
not only dependent on the accurate work of transcription factors and polymerase, 
but also on the capping machinery related to mRNA processing and mRNA export 
(Proudfoot et al. 2002; Meinhart and Cramer 2004).
2. Promoter structure in eukaryotic class II genes
Depending on the enzyme responsible for their transcription, eukaryotic genes 
have been divided in three classes. RNA Pol I transcribes the ribosomal RNAs 
(rRNAs), which are components of the ribosomes. Transcription of protein-coding 
genes is catalyzed by RNA Pol II, whereas RNA Pol III is involved in synthesis of 
the 5S rRNA and the transfer-RNAs (tRNAs).
2.1. The core promoter elements
The core promoter of the class II genes is defined as the minimal DNA sequence 
required for correct positioning and assembly of the pre-initiation complex (PIC), 
which is composed by the RNA Pol II and the general transcription factors (GTFs). 
Characteristic core promoter elements are the TATA box, the Initiator (Inr), the 
TFIIB recognition element (BRE), located directly upstream the TATA box and, 
in Drosophila genes, the downstream promoter element (DPE) element. Most 
promoters contain one or more of these elements, but no one is essential for 
promoter function. Promoter elements are binding sites for subunits of the PIC 
and serve to orient the transcription machinery in order to direct unidirectional 
transcription.
2.1.1. TATA-box
The TATA sequence is the binding site for the TATA binding protein (TBP). TATA 
elements in Saccaromices cerevisiae are typically located 40 to 120 bp upstream of 
the transcription start site, but in other eukaryotes, including Schizosaccharomyces 
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pombe, it is usually located at a fixed distance of 25 to 30 bp from the start site 
(Struhl 1995). Functional analysis of the mutated sequence defined the sequence 
TATAAA as the consensus TATA sequence in yeast (Chen and Struhl 1988; Singer 
et al. 1990; Wobbe and Struhl 1990). Yeast and human TBP have nearly identical 
TATA sequence requirements, emphasizing the evolutionary conservation of the 
TBP-TATA interaction. In yeast, transcription from TATA-less promoters remains 
TBP dependent, and presumably, other components of the transcription machinery 
recognize a promoter structure other than TATA to nucleate PIC assembly, like the 
Inr element or the DPE. 
2.1.2. Initiator Elements
Inr elements are DNA sequences encompassing transcription start sites. The 
position of the Inr is not defined by its distance with respect to the TATA box, 
since this distance is not constant in all organisms. Rather, TATA elements define 
the window within which initiation can occur. Mutational analyses have defined 
preferred Inr sequences (Furter-Graves and Hall 1990), but there is not a clear 
consensus sequence, yet.
2.1.3. DPE
The DPE is located at ca. 30bp downstream from the transcription start site and 
seems to act, in conjunction with the Inr element, as a TFIID binding site for the 
TAF6 and TAF9 at TATA-less promoters (Butler and Kadonaga 2002; Kadonaga 
2002). 
 2.2. Regulatory sequences
 2.2.1. Enhancer and Silencer elements
In metazoans enhancer and silencer elements are DNA sequences that function 
as binding sites for transcriptional activators and repressors, respectively. They 
function in either orientation and independently from their distance to the core 
promoter (up to many kilobasepairs), being found both upstream and downstream 
of the TATA box and also in the intron regions of genes. Upstream activation 
sequences (UAS) are the yeast analogs of the enhancers, with the difference that 
they do not function when positioned downstream of the TATA box (Guarente and 
Hoar 1984; Struhl 1984).
Once associated with the cognate enhancer elements, transcriptional activators 
facilitate the assembly of the PIC, either directly contacting the GTFs, or indirectly 
through coactivators. Vice versa, binding of repressors to the silencer elements 
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recruits remodeling complexes that promote chromatin compacting. 
2.2.2. Insulator
Insulators are complex DNA sequence elements that can help to preserve the 
independent function of genes embedded in a genome in which they are surrounded 
by regulatory signals they must ignore (Burgess-Beusse et al. 2002; Kuhn and Geyer 
2003). In some cases insulators can serve as barriers to protect a gene against 
the encroachment of adjacent inactive condensed chromatin. Some insulators also 
can act as blocking elements to protect against the activating influence of distal 
enhancers associated with other genes. In that case, insulators prevent enhancer 
action when placed between enhancer and promoter, but not otherwise. Although 
most of the insulators identified so far derive from Drosophila, they also are found 
in vertebrates (Burgess-Beusse et al. 2002). 
3. The preinitiation complex: the general transcription factors and 
the RNA Polymerase II
3.1. The general transcription factors (GTFs)
Pioneering studies performed in Roeder laboratories showed that purified 
mammalian RNA Pol II was able to initiate RNA synthesis from template DNA only 
when supplemented with a crude cell extract (Weil et al. 1979). Different fractions 
of extracts were tested for the ability to allow in vitro RNA Pol II transcription activity, 
leading to the identification of the general transcription factors (GTFs) (Matsui et 
al. 1980). Unlike the prokaryotic enzymes, eukaryotic RNA polymerases alone 
cannot recognize the promoters of their target genes, and instead rely on a series 
of accessory factors, the GTFs. 
The GTFs include TBP, TFIIB, TFIIE, TFIIF and TFIIH, and were identified 
biochemically as factors required for accurate transcription initiation by RNA Pol 
II from double stranded DNA templates in vitro (Roeder 1996; Orphanides and 
Reinberg 2002). 
Biochemical approaches investigating preinitiation complex formation demonstrated 
that PIC assembly is nucleated in vitro by binding of TBP, followed by the concerted 
recruitment of TFIIB, RNA Pol II-TFIIF, TFIIE, and TFIIH (see Fig. 1; Van Dyke et al. 
1988; Buratowski et al. 1989; Maldonado et al. 1990) 
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3.1.1. TBP 
TBP was identified as part of TFIID, a multiprotein complex of ca. 700kD in size, 
composed also of 14 TBP-associated factors (TAFs) (Albright and Tjian 2000; Tora 
2002). TBP is a universal transcription factor, required for initiation by all three 
eukaryotic RNA polymerases (Hernandez 1993), by association with a distinct set 
of factors. In metazoans, four different TBP complexes have been described: the 
transcription factors SL1 (RNA Pol I), TFIID (RNA Pol II), TFIIIB (RNA Pol III) and 
SNAPc, another RNA Pol III-TBP complex required for transcription of certain small 
nuclear RNA (snRNA) genes.
In human TBP, two different domains can be distinguished: a core domain, 
composed of two imperfect repeats highly conserved among eukaryotes, and 
an N-terminal domain, containing a glutamine rich region conserved among 
vertebrates, but not present in yeast. Crystallographic studies of the core domain 
of TBP bound to a TATA box revealed that TBP has a saddle-like structure (Burley 
and Roeder 1996). Unlike other DNA binding proteins, the concave surface of the 
TBP saddle makes contacts with the minor groove of the DNA (Lee et al. 1991; 
Starr and Hawley 1991; Kim et al. 1993a; Kim et al. 1993b). TBP saddle binds 
the 8-bp TATA element, unwinding about a third of a helical turn and bending the 
DNA 80° toward the major groove (Kim et al. 1993a; Kim et al. 1993b). Although 
the TBP molecule is symmetrically shaped, the protein surface of the two repeats 
is very divergent, forming a large asymmetric protein-DNA interface, thus creating 
a platform for binding other components of the transcription machinery. TBP does 
not bind to TATA elements with high orientation specificity (Cox et al. 1997). Other 
promoter elements in combination with TATA determine instead the orientation of 
transcription machinery assembly at a promoter (Inr, BRE, DPE).
3.1.1.1. TBP paralogues
Database searches for paralogous genes encoding for the GTFs revealed that 
TFIIB, TFIIE, TFIIF, TFIIH, and Pol II are encoded by single-copy genes (Aoyagi 
and Wassarman 2000). On the contrary, both TBP and TAFs have paralogue genes. 
Concerning TBP, at least two new gene families encoding proteins related to TBP 
have been found in metazoans. To one group belong the TBP-like factor (TLF), or 
TBP-related factor 2 (TRF2), identified in C. elegans, Drosophila and vertebrate. 
Unlike TBP, TLFs may bind to DNA sequences other than canonical TATA box 
(Dantonel et al. 1999; Rabenstein et al. 1999). In fact, vertebrate TLFs support 
transcription from a TATA-less promoter (Ohbayashi et al. 2003). D. melanogaster 
also contains a further TBP-related factor called TRF1. A second group of TBP 
paralogue genes, called TBP2s, has been recently identified, also in vertebrates 
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(Veenstra and Wolffe 2001). Binding of vertebrate TBP2 to TATA box promoters 
has not yet been documented. 
It is likely that higher organisms have developed different TBP-like factors to 
allow differential gene expression according to the developmental stage and 
the differentiation state of the cells. In line with this hypothesis, also TAFs have 
paralogous genes and the TAF-like proteins are usually expressed in a cell type 
and tissue-specific pattern.
3.1.2. TFIIB
TFIIB is recruited to the PIC after TBP. TFIIB interacts directly with the DNA, where 
it recognizes the BRE element (Imbalzano et al. 1994), with TBP and RNA Pol II, 
as well as other GTFs (Goodrich et al. 1993; Ha et al. 1993; Chen and Hampsey 
2004). Thus, TFIIB plays a role in the correct selection of the transcription start 
site (Hawkes and Roberts 1999), its recruitment is a prerequisite for binding of the 
RNA Pol II to the PIC (Buratowski et al. 1989), and it is also a target of many gene-
specific transcriptional activators (Lin et al. 1991).
3.1.3. TFIIF
TFIIF has two subunits, called RAP30 and RAP74 in human, conserved among 
eukaryotes.
TFIIF binds tightly to RNA Pol II, suppresses non-specific DNA binding of RNA Pol 
II and stabilizes the PIC (Conaway and Conaway 1993). TFIIF is also implicated 
in start site selection. For these reasons, this transcription factor is thought to be 
the eukaryotic correspondent of the bacterial σ factor. In fact, both subunits show 
limited sequence similarity to σ factor (McCracken and Greenblatt 1991; Garrett et 
al. 1992). TFIIF is also important during elongation, since it prevents pausing of RNA 
Pol II (Bengal et al. 1991). The RAP74 subunit is phosphorylated by TAF1 (Dikstein 
et al. 1996). Moreover, TFIIF itself has been shown to posses an associated ser/thr 
kinase activity, which may modulate its activity (Rossignol et al. 1999).
3.1.4. TFIIE
TFIIE enters the PIC after RNA Pol II and prior to TFIIH (Buratowski et al. 1989). 
TFIIE interacts directly with the unphosphorylated form of RNA Pol II, TFIIF (both 
subunits) and TFIIH (Flores et al. 1989). TFIIE is also a target of gene-specific 
transcription activators (Sauer et al. 1995; Zhu and Kuziora 1996). Functions 
attributed to this factor include recruitment of TFIIH to the PIC (Flores et al. 1992), 
stimulation of both the kinase and helicase activities of TFIIH (Ohkuma 1997; Lee 
and Young 2000). Structure-function analysis suggests that TFIIE could act as a 
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checkpoint for formation of the PIC via its control of TFIIH recruitment and activities 
(Ohkuma et al. 1995). Some promoters are more dependent on TFIIE than others, 
in particular TATA-containing promoters (Sakurai et al. 1997).
3.1.5. TFIIH
The last factor to bind the PIC is TFIIH. TFIIH is composed of nine polypeptides with 
four enzymatic activities, comprising DNA-dependent ATP-ase (Roy et al. 1994), two 
ATP-dependent DNA helicases (Schaeffer et al. 1993), and CTD kinase (Lu et al. 
1992). TFIIH is an essential factor in transcription, as well as in nucleotide excision 
repair (NER), and has also been implicated in mammalian cell cycle progression. 
Consistent with these multiple roles, TFIIH is also the most complex GTF. TFIIH 
exists in two forms: (1) a six subunit core complex, containing the two DNA helicase 
activities and active in nucleotide excision repair (Svejstrup et al. 1995); and (2) 
the holo-TFIIH, that results from the association of a core, containing the two DNA 
helicase activities, and a kinase domain termed CAK (CDK-activating kinase), 
containing Cdk7 (Coin and Egly 1998). The activity and substrate specificity of 
Cdk7 are regulated by phosphorylation and / or association with other polypeptides 
like Mat1 and core TFIIH (Busso et al. 2000). The ADP-dependent DNA helicase 
activity of the XPB subunit is required for formation of an open promoter complex 
(promoter melting) (Wang et al. 1992a; Holstege et al. 1996; Moreland et al. 1999), 
whereas the CTD kinase activity is implicated in the transition from transcription 
initiation to elongation (promoter clearance) (Dvir et al. 1997). Furthermore, TFIIH 
promotes transition from very early elongation complexes to stable elongation 
complexes (Dvir et al. 1997). 
The dual TFIIH role in transcription and DNA repair seems to correlate with the 
observation that transcriptionally active genes are preferentially repaired (Mellon 
and Hanawalt 1989).
3.2. RNA Polymerase II
RNA Polymerase II (Pol II) is a multiprotein complex composed of 12 subunits with 
a total size of 500 kD. Subunits of RNA Pol II, in particular the two largest ones, 
Rpb1 and Rpb2, are highly conserved among eukaryotes. These subunits can be 
classified in three categories: (i) subunits of the core domain, having homologous 
counterparts in RNA Pol I and III (Rpb1, 2, 3, 11), (ii) subunits shared between all 
three nuclear polymerases (Rpb5, 6, 8, 10 and 12), and (iii) subunits specific to Pol 
II, but not essential for transcription elongation (Rpb4, 7and 9) (Cramer et al. 2000; 
Cramer et al. 2001).
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3.2.1. CTD
A unique feature of the largest RNA Pol II subunit, Rpb1, is the presence of tandem 
repeats of a heptapeptide sequence at its carboxy-terminal domain (CTD). The 
sequence of the repeat is Tyr-Ser-Pro-Thr-Ser-Pro-Ser, with both Ser2 and Ser5 
as sites of phosphorylation. Although the presence of the CTD is a ubiquitous 
feature among eukaryotic RNA Pol II, the repeat length varies and increases with 
increasing genome complexity (26 or 27 repeats in yeast, 34 repeats in C. elegans, 
43 in D. melanogaster, 52 in human). Depending on the phosphorylation state of 
the CTD, two forms of RNA Pol II exist in vivo: IIA, which is not phosphorylated, and 
IIO, which is extensively phosphorylated. The IIA form preferentially enters the PIC 
(Lu et al. 1991), whereas IIO is present in the elongation complex (Dahmus 1996). 
Conversion of IIA to IIO occurs concomitant with, or shortly after, the transition from 
initiation to elongation (OʼBrien et al. 1994). 
3.2.2. The transcription cycle
In the pre-initiation complex, Pol II and the general transcription factors are all 
bound to the promoter, but are not in an active conformation to begin transcription 
(Fig. 1). Next, a marked conformational change occurs, in which 11-15 base pairs 
(bp) of double strand DNA surrounding the transcription start site are melted and 
the template strand is positioned within the active site cleft of Pol II to form the 
open complex (Wang et al. 1992a). Pol II is unique among cellular Pols in requiring 
the action of an ATP-dependent DNA helicase (XPB) for open complex formation. 
In many systems, multiple short RNAs (from three to ten bases), termed abortive 
products, are synthesized before Pol II productively initiates synthesis of full-length 
RNAs (Luse and Jacob 1987; Holstege et al. 1996). After synthesis of ca. 30 
bases of RNA, Pol II is thought to release its contacts with the core promoter and 
the rest of the transcription machinery (promoter clearance), and to finally enter 
the stage of transcription elongation. The transition from transcription initiation to 
transcription elongation is accompanied by phosphorylation of the CTD of Pol II. 
Different kinases are involved in CTD phosphorylation. During promoter melting, 
CTD is phosphorylated at Ser5 by two cyclin dependent kinases: Cdk7, a subunit 
of the general transcription factor TFIIH, and Cdk8 (Lee and Young 2000; Liu et 
al. 2004). Although previous work indicated that only Cdk7 positively regulates 
transcription, recent work indicates that in yeast both kinases can promote 
transcription in vivo and in vitro (Liu et al. 2004). After initiation, other kinases such 
as Cdk9/Ctk1 phosphorylate Ser2, resulting in recruitment of the RNA processing, 
polyadenylation and termination factors to the elongating RNA Pol II. The flexibility 
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of the CTD tail combined with multiple modifications by phosphorylation, makes 
Pol II a central player in regulation of transcription initiation and in coordinating 
transcription to mRNA processing events (Hirose and Manley 2000; Bentley 2002; 
Proudfoot et al. 2002; Meinhart and Cramer 2004).
After initiation of transcription, Pol II and the general transcription factors TFIIB and 
TFIIF, dissociate from the promoter, leaving the remaining general factors at the 
promoter in the Scaffold complex (Yudkovsky et al. 2000; Hahn 2004). This complex 
presumably marks genes that have been transcribed and enables the typically slow 
step of recruitment to be bypassed in subsequent rounds of transcription. In order 
to be reincorporated in a new initiation process, the phosphatase Fcp1 recycles 
Pol II to its unphosphorylated form, allowing the GTFs and Pol II to initiate another 
round of transcription (Reinberg et al. 1998; Cho et al. 2001). 
3.2.3. The holoenzyme 
Biochemical approaches investigating preinintiation complex formation in a 
reconstituted in vitro system suggested that RNA Pol II and GTFs assemble to the 
promoter in a defined and sequential order (Van Dyke et al. 1988; Buratowski et al. 
1989; Maldonado et al. 1990). This scenario was challenged by the purification of 
preassembled complex, containing GTFs other than TBP, Pol II and other regulatory 
factors (Mediator), first in yeast (Chao et al. 1996; Chang and Jaehning 1997) and 
Figure 1. The pathway of transcription initiation and reinitiation for RNA Polymerase II. For abbre-
viations, see text. From Hahn (2004).
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later also in human cells (Ossipow et al. 1995; Maldonado et al. 1996; Chang and 
Jaehning 1997). These findings suggested that Pol II and its accessory factors are 
recruited to the promoter as a preformed complex, in the form of a “holoenzyme” 
(Conaway and Conaway 1993; Ossipow et al. 1995). However, the exact composition 
of RNA Pol II holoenzymes is not known in vivo and certain holoenzyme components 
are recruited to some promoters independently of Pol II (Cosma et al. 1999; Ranish 
et al. 1999; Rani et al. 2004). Moreover, PICs are composed of different factors at 
distinct promoters (Muller and Tora 2004). Furthermore, the relative abundance of 
yeast GTFs is more compatible with a step-wise assembly model (Borggrefe et al. 
2001). Hence, whether PIC assembly in vivo occurs in a stepwise manner or by 
holoenzyme recruitment is still not completely clear.
4. Transcriptional activators and repressors
The complexity of gene regulation is mirrored by the high number of genes coding 
transcription factors (e.g. Tupler et al. 2001). Transcription factors, binding to 
promoters or enhancer-regions, can stimulate or repress gene transcription. Usually, 
they consist of two domains: (i) a DNA binding and (ii) an activation (or repression) 
one. Typical DNA binding domains in eukaryotes are the basic helix-loop-helix and 
leucine zipper, zinc finger, and homeodomain. Present in at least one copy, they 
interact with the major grooves of the correspondent cognate site in the DNA. Most 
genes are under the control of multiple transcription factors that attach to the same 
transcription-control regions. Moreover, cofactors (coactivators or corepressors) 
often coregulate transcription by interaction with transcription factors. This means 
that frequently the real effect of a transcription factor depends on which cofactor 
it binds with (Kaiser and Meisterernst 1996; Lemon and Tjian 2000; Malik and 
Roeder 2000; Courey and Jia 2001; Naar et al. 2001). 
5. Transcriptional cofactors/coregulators
Transcriptional cofactors function as adaptor molecules between sequence specific 
DNA binding activators or repressors and the transcriptional machinery (Burley and 
Roeder 1996; Kaiser and Meisterernst 1996).
Coactivators are distinct from GTFs, since they are not dispensable for basal 
transcription in vitro. They are also distinct from activator in that most do not 
directly bind DNA and none binds DNA in a sequence specific manner. Coactivators 
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interact either with components of the core transcriptional machinery (TFIIA, TAFs, 
USA (upstream stimulatory activity) factors, SRB/Mediator), or with nucleosomes, 
promoting chromatin modification (HATs), or chromatin remodeling (SWI/SNF). 
Moreover, other gene or cell type specific coactivators have been described in 
metazoan systems (Fondell et al. 1996; Kim et al. 1996). 
5.1. TAFs: TBP associated factors
 
Whereas TBP is required for promoter recognition and assembly of the other GTFs 
in the PIC (Buratowski et al. 1988), activation of transcription is observed in in vitro 
systems only when TFIID is part of the transcription machinery (Pugh and Tjian 
1990; Burley and Roeder 1996). This observation led to the discovery of the TAFs 
and to the idea that TAFs function in transcriptional activation by relaying information 
from activators to the core transcriptional machinery. Functions attributed to TAFs 
are: coactivator activity, facilitating promoter recognition, enzymatic activities. TAFs 
seem to function as coactivators in a gene-specific manner, since they are not 
generally required for activation of yeast genes (Moqtaderi et al. 1996; Walker 
et al. 1996), but rather of specific genes, including those involved in cell cycle 
progression (Apone et al. 1996; Walker et al. 1997).
The TAF1, the biggest TAF, (TAFs are named after the new nomenclature, Tora 
2002) has three enzymatic activities: phosphorylation of the RAP74 subunit of 
TFIIF (Dikstein et al. 1996), histoneacetyltransferse (HAT) and ubiquitinligase 
modification of Histone H1 (Mizzen et al. 1996; Imhof et al. 1997).
TAF2 shows specific DNA binding activities in the region immediately downstream 
of TATA box up to the initiator (Verrijzer et al. 1994), whereas TAF6 and TAF9 
bind the DPE element of Drosophila (Burke and Kadonaga 1997). Probably the 
cooperative binding of several TAFs subunits facilitates promoter recognition and 
enhances stability of TFIID-DNA complex (Albright and Tjian 2000).
Sequence analysis of TAFs reveals similarity with the histones (Burley and Roeder 
1996). In fact, many TAFs contain the characteristic histone fold domain through 
which they can make pairs similar to the histones H2A-H2A.
5.1.1. TAF paralogues
Depending on TAF composition, many different TFIID complexes have been isolated 
from human cells, with differences regarding the composition of the core TAFs, as 
TAF10-lacking hTFIID (Brou et al. 1993; Jacq et al. 1994) and TAF6δ-containing 
TAF9-lacking complex (Bell et al. 2001); or of the cell-type specific TAFs, as B cells 
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and ovary-specific hTFIID containing TAF4b (Dikstein et al. 1996; Freiman et al. 
2001) and hTFIID involved in spermatogenesis, containing TAF1L and TAF7L. 
The existence of different TFIID complexes could reflect different roles in recognition 
of distinct promoters, in mediating response to different activator/coactivators, and 
differential regulation based on the interaction with distinct transcription factors.
5.2. TFIIA
Since TFIIA is not absolutely required for PIC assembly and subsequent transcription 
in a purified in vitro transcription system, it is not considered a general transcription 
factor. Human and Drosophila TFIIA contains three subunits. In both organisms, the 
two largest subunits are coded by the same gene and derived from posttranslational 
modifications of the same precursor protein (DeJong and Roeder 1993; Yokomori 
et al. 1993). The yeast homologue has two polypeptides, encoded by the TOA1 
and TOA2 genes
TFIIA binds TBP (Buratowski et al. 1989), is located upstream of TATA, stabilizes 
TBP-TATA box interaction (Imbalzano et al. 1994) and contributes to the formation 
of an open promoter complex (Wang et al. 1992b). TFIIA also interacts with specific 
transcriptional activators, TAF4 (formerly TAFII110), the coactivators PC4 and HMG2 
and is considered to stimulate transcription through displacement of transcriptional 
repressors such as NC2, PC3/Dr2 (topoisomerase I), HMG1 and Mot1 from the 
TFIID complex (Meisterernst and Roeder 1991; Merino et al. 1993; Yokomori et al. 
1993; Auble et al. 1994; Ge and Roeder 1994a; Ge and Roeder 1994b; Shykind 
et al. 1995; Ma et al. 1996; Orphanides et al. 1996). Thus, TFIIA is dispensable for 
a correct initiation but is also involved in transcriptional activation functioning as 
either an antirepressor or a coactivator (Kang et al. 1995; Ma et al. 1996).
5.3. The Mediator
Most of the transcriptional coactivators (TAFs, TFIIA, chromatin modifiers) are not 
required for expression of all Pol II genes. The most universal cofactor transmitting 
regulatory information to the transcription machinery, in particular to the RNA Pol 
II enzyme, is a large modular complex known as Mediator (Myers and Kornberg 
2000). The main function of mediator is to mediate the interaction between the 
transcriptional activator and the transcription machinery, in particular the RNA 
Pol II. Mediator stimulates both basal transcription and activated transcription. 
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Furthermore, Mediator stimulates in vitro the CTD phosphorylation activity of TFIIH 
(Kim et al. 1994). In yeast it has been shown that Mediator plays also a role in 
transcription reinitiation (Yudkovsky et al. 2000). 
Mediator complexes have first been identified in yeast, were they have been 
purified as part of the RNA Pol II holoenzyme (Thompson et al. 1993; Kim et al. 
1994; Koleske and Young 1994). Later, mediator complexes have been found in 
all eukaryotes examined, although the Mediator subunits are the least conserved 
of all the members of the transcription machinery, consistent with the idea that 
many mediator subunits serve as regulatory factor targets (Malik and Roeder 2000; 
Myers and Kornberg 2000; Boube et al. 2002). Despite considerable variation 
in subunit composition of Mediator complexes from yeast, mouse and man, the 
overall structure of the complexes is very similar (Asturias et al. 1999; Dotson et al. 
2000), and the three characteristic domains are always recognizable: the tail, the 
middle domain and the head, the last two making contacts with Pol II (Asturias et 
al. 1999). 
5.4. USA factors (upstream stimulatory activity)
The cofactors belonging to the USA (upstream stimulatory activity) class interact 
with the PIC to repress transcription in the absence of activators or to stimulate 
transcription in the presence of activators (Meisterernst et al. 1991). 
Initially, cofactors belonging to this class were classified in positives (PC) and 
negative cofactors (NC), although now some factors seem to play a role in both 
activation and repression of transcription and also new general cofactors have 
been discovered with the time.
To the group of positive cofactors belong PC1 (later identified as a poly(ADP-
ribose) polymerase, PARP (Meisterernst et al. 1997), PC2, a component of the 
mediator complex (Kretzschmar et al. 1994; Malik et al. 2000); PC3/Dr2, which 
is the topoisomerase I and functions in both repression of basal transcription 
and stimulation of activated transcription (Kretzschmar et al. 1993; Merino et al. 
1993), PC4, PC5, PC6. To now, the activities of these factors have been identified 
and differently characterized (Kaiser and Meisterernst 1996). The nonhistone 
chromosomal protein HMG2 was also identified as a transcriptional activator. This 
architectural protein functions as a coactivator by stabilizing an activated form of 
PIC (Shykind et al. 1995). PC1, PC3, PC4, and HMG2 are all nonsequence-specific 
DNA binding proteins, suggesting that these cofactors function by affecting the 
accessibility of RNA Pol II to chromatin (Kaiser and Meisterernst 1996).
The most known positive cofactor is PC4. PC4 dramatically stimulates activated 
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transcription through direct interaction with various activator domains and with the 
DNA-TBP-TFIIA complex (Ge and Roeder 1994b).
The group of negative cofactors includes NC1 and NC2 (discussed in detail below). 
NC1 represses basal transcription binding to the TFIID-DNA complex, activity that 
is competed by binding of TFIIA to the same complex (Meisterernst et al. 1991). 
Among the general cofactors with negative effect in transcription there are also 
the HMG1 (high mobility group) and HMG2 proteins and Ada1/Mot1 (Kaiser and 
Meisterernst 1996). 
5.5. BTAF1
Human BTAF1 (formely TAFII170/TAF-172) and its yeast ortholog, Mot1p, are 
general repressors of Pol II-dependent transcription (Davis et al. 1992). BTAF1 and 
Mot1p possess an ATPase activity and dissociate TBP from TATA-DNA complexes 
using the energy of ATP hydrolysis (Chicca et al. 1998; Pereira et al. 2003) This 
activity is not restricted to specific promoters and is counteracted by TFIIA and, 
partially, also by TFIIB, although the exact mechanism is not fully understood. In 
mammalian cells the majority of TBP is not found in TFIID but in a complex with 
BTAF1, called B-TFIID (Timmers and Sharp 1991). 
Recent data have revealed BTAF1 and Mot1p as positive regulators of TBP function 
in the Pol II system. Genome wide transcriptional profiling analysis and mutational 
studies suggest that Mot1p positively and negatively affects transcription of subsets 
of yeast genes (Collart 1996; Prelich 1997; Muldrow et al. 1999; Andrau et al. 
2002; Dasgupta et al. 2002; Geisberg et al. 2002). Thus, these factors can function 
either as an activator or as a repressor of transcription. To reconcile the opposite 
effects on transcription, it has been hypothesized that BTAF1 and Mot1 delocalize 
TBP from non-promoter regions, in an ATP-dependent manner, and deliver it to 
promoter sites (Muldrow et al. 1999; Geisberg et al. 2002).
6. Chromatin structure
The compaction of DNA that occurs through packaging is necessary to fit into the 
limiting confines of the nucleus. DNA is packaged into a nucleoprotein complex 
known as chromatin.
The fundamental repeating unit of chromatin is the nucleosome, which includes 
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a histone core (made of two of each of the four histones H2A, H2B, H3, H4), one 
molecule of H1 or H1-like linker histone, and the associated DNA, usually about 200 
bp long, (Kornberg 1977; Chambon 1978). Histones proteins are highly conserved 
among eukaryotes and consist of a globular domain and a N-terminal unstructured 
tail. Unlike the four histones H3, H4, H2A, H2B, the lysine-reach histone H1 is not 
essential for the basic chromatin structure. Also non-histone proteins, like HMG- or 
SIR-proteins, bind to DNA producing a compact, higher order structure (Naar et al. 
2001).
6.1. Histone modifications and histone modifying complexes
Histones serve to pack DNA into compact chromatin structure. However, during 
specific phases, replication-, transcription-, and repair-factors need to access 
specific DNA sequences. For this purpose, chromatin organization is regulated 
by covalent modifications of the histones themselves, association of non-histone 
proteins, and ATP-dependent mobilization of nucleosomes (Strahl and Allis 2000; 
Becker and Horz 2002; Berger 2002; Geiman and Robertson 2002; Narlikar et al. 
2002). Also substitution of histones with certain histone variants and corresponding 
modifications of DNA can have an effect on chromatin structure (Hake et al. 2004). 
Histones undergo several post-translational modifications, like phosphorylation, 
acetylation and methylation. In many instances, the precise sites of modifications 
have been identified. 
A breakthrough in understanding the role of histone modification came from the 
discovery that some transcription cofactors are able to modify histones, suggesting 
a direct link between transcription and histone modifications (Bannister and 
Kouzarides 1996; Brownell et al. 1996; Ogryzko et al. 1996). 
The discovery of histone tails modifications and that these are recognized by 
different classes of remodeling proteins, led to the so-called histone-code model 
(Strahl and Allis 2000; Jenuwein and Allis 2001). This model proposes that specific 
combinations of histone tail modifications provide binding sites for effector proteins, 
which in turn translate this code into chromatin structural changes. Thus, these 
modifications may serve as a code to initiate specific cellular actions on the DNA 
template, such as mitosis, transcription, or replication. For example, acetylation is 
a mark for the regions of the genome that are competent for transcription, as it is 
the case for acetylation of H3 and H4 tails (Eberharter and Becker 2002).
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6.1.1. Acetylation and HATs/HDACs
Histone acetylation is the best understood of the histone modifications, both in 
terms of the residues affected and the consequences for transcriptional activity. 
Several lysines on the N-terminal tail of each of the core histones can be reversibly 
acetylated.
Histone acetylation neutralizes the positive charges on lysines, weakening the tight 
interaction with the DNA and neighboring nucleosomes (Allfrey et al. 1964; Luger 
and Richmond 1998; Berger 2001). Acetylation may also influence transcription by 
promoting or suppressing interactions with specific transcription factors (Garcia-
Ramirez et al. 1995; Dhalluin et al. 1999; Ornaghi et al. 1999).
The enzymes responsible for these modifications are called histone acetyltransferases 
(HATs) and they all contain a bromodomain, which binds acetylated Lys (Dhalluin 
et al. 1999).
After initial discovering that the yeast transcription factor Gcn5 has HAT activity, 
many others HATs have been described, that are now divided in three families 
(Gregory et al. 2001; Marmorstein and Roth 2001). In addition, also CBP/p300, 
TAF1, TAFIIIC, and Nut1 posses HAT activity.
Histones are not the only substrate for HATs. Several transcription factors including 
E2F (Martinez-Balbas et al. 2000) and p53 (Gu and Roeder 1997) have been shown 
to be acetylated.
Lysine acetylation is reversed by histone deacetylases (HDACs) (Marks et al. 
2003). Like HATs, HDACs are part of multiprotein complexes, which have different 
substrate specificities and corepressor interactions. 
6.1.2. Phosphorylation
Histone tails are also modified by phosphorylation on serine or threonine. 
Phosphorylation of histones H1 and H3 has been implicated in chromosome 
condensation during mitosis (Bradbury et al. 1974; Bradbury 1992; Berger 2002), 
although a revised model indicates H3-S10 phosphorylation as a signal for the 
cells to proceed from metaphase to the anaphase (Hans and Dimitrov 2001). 
6.1.3. Methylation and histone methyltransferases (HMTases)
Histone can be methylated both in the lysine and in the arginine residues. Arginines 
can be mono- or di-methylated by the protein R-methyltransferases (PRMTs), 
whereas lysines can be mono-, di- or tri-methylated by the HMTs. Besides one 
exception (Feng et al. 2002), all the Lys methyltransferases contain the so-called 
SET domain. 
Arginine methylation of histones has so far only been associated with transcriptional 
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activation (Kouzarides 2002), whereas the effect of lysine methylation can have 
opposite effects (Lachner and Jenuwein 2002).
The first HMTase discovered was the Lysine-methyltransferase SUV39H1 (Rea 
et al. 2000), followed by many others. Methylation of H3-K9 leads to conversion 
of chromatin in the transcriptionally inactive heterochromatin (Jenuwein and Allis 
2001; Lachner and Jenuwein 2002). Interestimgly, lysine methylation on the same 
histone tail (H3-K4) results in transcriptional activation (Strahl et al. 1999; Xu et al. 
2001; Santos-Rosa et al. 2002). 
Lysine methylation is a very stable histone modification and so far no demethylase 
has been found. However, since lysine methylation is associated with constitutive 
heterochromatin and transient transcription regulation, the existence of 
demethylases is plausible. Alternatively, histones could be replaced with unmodified 
histones during replication or through degradation of the histone tails (Bannister et 
al. 2002). 
6.1.4. Additional histones modifications
Ubiquitination, ADP-ribosylation, biotinylation and SUMOyation have also been 
reported to be histones modifications. 
Histones can be reversibly ubiquitinated, especially on histone H2A but also on H2B 
and H3 (Chen et al. 1998; Pham and Sauer 2000), and these ubiquitinated histones 
are associated with transcriptionally active DNA (Nickel et al. 1989). A regulatory 
role for histone ubiquitination in transcription is not yet firmly established.
ADP-ribosylation has been connected to transcription, apoptosis and genomic 
stability (Rouleau et al. 2004). Histones have also been reported to be biotinylated 
(Camporeale et al. 2004) and SUMOylated (Shiio and Eisenman 2003).
6.2. Non covalent chromatin modification: ATP-dependent Chromatin 
remodeling complexes
In addition to covalent modifications, nucleosomes are subjected to conformational 
remodeling (Becker and Horz 2002). Remodeling involves the breaking and 
reforming of histone-DNA contacts that result in the mobilization of nucleosomes 
in the chromatin template (Peterson 2002). Although the precise mechanism is 
unknown, several different remodeling complexes have been identified. All of these 
complexes contain an ATPase subunit along with additional subunits that affect 
regulation, efficiency, and specificity.
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As for HMTase, also ATPase enzymes can have a double role in transcription 
repression and activation (Stokes et al. 1996; Tong et al. 1998; Xue et al. 1998).
Chromatin remodeling complexes are divided in 3 major groups, depending on the 
ATPase activity: SWI/SNF, ISWI and the Mi-2/CHD-Group (Becker and Horz 2002; 
Peterson 2002; Tsukiyama 2002).
7. The negative cofactor 2, NC2
NC2 was initially purified from human cell extracts as an activity that inhibits 
transcription initiation by RNA Pol II (Meisterernst and Roeder 1991; Inostroza et 
al. 1992). NC2 is a heterodimer consisting of two subunits, NC2α and NC2β, also 
called DRAP1 and DR1, respectively (Goppelt et al. 1996; Mermelstein et al. 1996). 
Both NC2 subunits have a histone fold domain, necessary for their interaction (Fig. 
2). These domains are similar to those found in the histone pair H2A-H2B, which 
are closely related to those found also in the transcription factors NF-YB/NF-YC, 
in the yeast HAP3/HAP5 and in the chromatin remodeling proteins CHRAC-15/17 
(Corona et al. 2000; Poot et al. 2000). Both subunits are highly conserved in 
eukaryotes, especially in their histone fold domains (Fig. 3). 
The homologous yeast complex is called yNC2α/Bur6p and NC2β/Ydr1p. Both 
subunits are essential for yeast viability and are functionally interchangeable 
between yeast and human (Goppelt and Meisterernst 1996; Gadbois et al. 1997; 
Kim et al. 1997; Prelich 1997; Lemaire et al. 2000; Xie et al. 2000). The genes 
encoding the subunits were identified by sequence analysis of the yeast genome 
(Goppelt and Meisterernst 1996; Gadbois et al. 1997; Kim et al. 1997) and in two 
genetic selections for general repressors of transcription. First, bur6 mutations were 
identified by their ability to increase transcription from enhancerless promoters, 
suggesting that NC2 inhibits basal transcription in vivo (UAS-less SUC2 promoter) 
(Prelich and Winston 1993; Prelich 1997), both bur6 and ydr1 mutations were found 
to suppress mutation in SRB4, which encodes a subunit of the Mediator complex 
(Gadbois et al. 1997; Lee et al. 1998). Expression of high copy number of YDR1 
diminished mRNA accumulation and caused slow growth of yeast, consistent with 
its role of general transcriptional repressor. Moreover, the slow growth phenotype 
is partially suppressed by overexpression of TBP (Kim et al. 1997). 
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hNC2α
MPSKKKKYNA  RFPPARIKKI  MQTDEEIGKV  AAAVPVIISR  ALELFLESLL  50
KKACQVTQSR  NAKTMTTSHL  KQCIELEQQF  DFLKDLVASV  PDMQGDGEDN  100
HMDGDKGARR  GRKPGSGGRK  NGGMGTKSKD  KKLSGTDSEQ  EDESEDTDTD  150
GEEETSQPPP  QASHPSAHFQ  SPPTPFLPFA  STLPLPPAPP  GPSAPDEEDE  200
EDYDS           205
hNC2β
MASSSGNDDD  LTIPRAAINK  MIKETLPNVR  VANDARELVV  NCCTEFIHLI  50
SSEANEICNK  SEKKTISPEH  VIQALESLGF  GSYISEVKEV  LQECKTVALK  100
RRKASSRLEN  LGIPEEELLR  QQQELFAKAR  QQQAELAQQE  WLQMQQAAQQ  150
AQLAAASASA  SNQAGSSQDE  EDDDDI     176
Figure 2. (A) Schematic drawing of NC2α and NC2β from human (h) and S. cerevisiae (y). The 
histone fold domain, the acidic and the basic residues are indicated with different colours. The 
potential nuclear localization signals (NLS) (numbers refer to first and last residues in the sequence) 
are represented by triangles. (B) Amino acid sequence of the two NC2 subunits. hNC2α has 205 
amino acids and a predicetd molecular weight of 22.3 kD. hNC2β has 176 amino acids and weights 
19.4 kD. In blue are the NLS studied in the present work. Potential phosphorylation sites are in bold. 
Underlined residues are recognition sites for the kinase CKII, the red ones for the kinase PKA and 
the green for both the kinase PKA and PKC.
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D.mel
A.tha
H.sap
C.ele
R.nor
M.mus
S.cer
Consensus
X.sp
D.mel
A.tha
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NC2α
NC2β
Figure 3. Alignement of NC2α (upper panel) and NC2β (bottom panel) from different species. H.sap 
= Homo sapiens; M.mus = Mus musculus; R.nor = Rattus norvegicus; D.mel = Drosophila melano-
gaster; X.sp. = Xenopus spp.; S.cer = Saccaromices cerevisiae; A.tha = Arabidopsis thaliana.
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7.1. NC2 is a general transcriptional repressor
 
In vitro, NC2 associates with promoter-bound TBP, thereby preventing the 
recruitment of TFIIA and TFIIB to the promoter (Meisterernst and Roeder 1991; 
Inostroza et al. 1992; Kim et al. 1995; Goppelt et al. 1996; Mermelstein et al. 
1996). 
NC2 globally represses Pol II and Pol III mediated transcription, but not Pol I 
transcription (White et al. 1994).
The crystal structure of NC2 in a complex with TBP-DNA provided a model for the 
repression mechanism of NC2 (Fig. 4). This structure shows that the N-terminal 
ends of NC2α and NC2β, containing the histone fold domain, form an intimate 
heterodimer that binds to the under side of the TBP-DNA complex. The C-terminus 
of NC2β makes specific contacts with the convex surface of the TBP saddle and 
blocks entry of TFIIB into the transcription complex (Kamada et al. 2001). This 
is consistent with the previous observations that TBP mutations that prevent the 
TFIIA
TFIIB
Figure 4. Schematic representation of the  crystal structure of the NC2-TBP-DNA complex. In or-
ange is the DNA; TBP is in green and NC2 in blue (NC2α in light,  NC2β in dark). NC2 binding to 
TBP-DNA prevents recruitment of TFIIA and TFIIB in the promoter (after Kamada et al. 2001).
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interaction with NC2 locate near the surfaces of TBP that also mediate association 
with TFIIB (Cang et al. 1999). 
It is not yet clear how NC2 competes with TFIIA for TBP binding, since the two 
proteins have distinct interaction domains with TBP (Maldonado et al. 1999). 
Comparison of NC2/TBP/DNA and TFIIA/TBP/DNA structures suggests that TFIIA 
and NC2 could bind to TBP simultaneously, albeit with lower affinity than for either 
molecule alone (Bleichenbacher et al. 2003). However the superposition of the 
structures does not take in account that NC2-TBP-DNA structure does not contain 
the C-terminus of NC2α, which could also make additional contacts with TBP 
(Gilfillan et al., submitted; Klejman et al. 2004). NC2 efficiently displaces TFIIA 
on TBP-promoter complexes and this biochemical data is supported by genetic 
interaction studies in yeast (Xie et al. 2000). 
In support of the negative function is also the finding that in conditions of hypoxia, 
mammalian cells can induce selective transcription repression increasing NC2 
activity (Denko et al. 2003).
7.2. Interplay between negative and positive effectors
Increasing evidence suggest that NC2 is functionally related to the Pol II holoenzyme. 
Genetic studies established a functional interaction between NC2 and distinct 
subunits of the Mediator component of the yeast Pol II holoenzyme. (Gadbois et 
al. 1997; Lee et al. 1998; Kim et al. 2000; Lemaire et al. 2000). The Srb4 protein 
is an essential component of the RNA polymerase II holoenzyme. Suppressors of 
Srb4 mutation included partial loss-of-function mutations in the negative regulators 
NC2 and the Not complex (Lee et al. 1998). Moreover, defects in either subunits 
of NC2 can be rescued by loss-of-function mutations in the Sin4 subunit of the 
mediator (Gadbois et al. 1997; Kim et al. 2000; Lemaire et al. 2000). Thus, defects 
in positive regulators of transcription can compensate for loss-of-function mutations 
in negative regulators of transcription and vice versa. This observation strengthens 
the argument for an active interplay between positive and negative regulators in 
vivo.
7.3. Positive role of NC2 in transcriptional regulation
In addition to its well-characterized role as a repressor, several experiments suggest 
that NC2 might also play a positive role in transcription. In yeast, bur6 mutations 
reduce transcription from many promoters (Prelich 1997; Geisberg et al. 2001) and 
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a slow-growth NC2β mutant inhibited transcription from TATA-containing promoters 
but stimulated TATA-less-promoters of the HIS3 and HIS4 genes (Lemaire et al. 
2000). In Drosophila, NC2 stimulate in vitro transcription from promoters containing 
downstream promoters elements (DPE), whereas it represses transcription from 
TATA-containing promoters (Willy et al. 2000). Recently, Cang and Prelich provided 
the first evidence that yeast NC2 directly stimulates activated transcription in yeast 
from TATA promoters (Cang and Prelich 2002). Also, gene occupancy experiments 
in yeast correlated the presence of NC2 on promoters with gene activation (Geisberg 
et al. 2001). NC2 was also found to be associated with a hyperphosphorylated form 
of Pol II, but the meaning of this interaction is still unknown (Castano et al. 2000).
8. Post-translational protein modifications: the role of 
phosphorylation in the regulation of transcription factors 
During the past decade, there have been major advances in understanding how post-
translational modifications of transcription factors can modulate gene expression 
changes. The most common mechanism to regulate (positively and negatively) the 
activity of many eukaryotic transcription factors is certainly protein phosphorylation 
(Hunter and Karin 1992; Jackson 1992; Whitmarsh and Davis 2000; Holmberg et 
al. 2002). Although the importance of other types of covalent modifications, such as 
acetylation, ubiquitination and sumoylation, is now emerging, phosphorylation has 
several features that make it ideal for regulating transcription factor activity. First, 
phosphorylation can be very rapid. For example, changes in c-Jun phosphorylation 
upon phorbol esters stimulation occur within 15 min (Boyle et al. 1991). Second, it 
is readily reverted by phosphatases, permitting transcriptional regulation to operate 
in a highly dynamic way. Third, phosphorylation is very effective at integrating 
information from a number of signal transduction pathways. Fourth, in some cases 
a single kinase can have different effects on different transcription factors. Finally, 
phosphorylation can affect different aspects of transcription factor function and 
regulation. 
Serine, threonine, and tyrosine are the amino acids that can be phosphorylated. 
Addition of a negative charge by phosphorylation can induce allosteric conformation 
changes, as well as repulsive and attracting forces, thus affecting protein-protein or 
protein-DNA interactions (Sprang et al. 1988; Hurley et al. 1990). 
Protein phosphorylation and dephosphorylation can regulate transcription factor 
function by at least five different mechanisms (Fig. 5).
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(1) Phosphorylation can affect the stability of the transcription factor in both directions, 
protecting protein from degradation (e.g. ATF2 and p53; Appella and Anderson 
2000; Fuchs et al. 2000) as well as promoting proteolysis (e.g. MyoD and EsF-1; 
Song et al. 1998; Vandel and Kouzarides 1999; IkB inhibitory subunit of NFkB, 
Yaron et al. 1998; Spencer et al. 1999). In the second case, protein phosphorylation 
allows recognition of the transcription factor by a group of enzymes (E1, E2, and 
E3) that covalently attach ubiquitin to the target protein. The ubiquitinated proteins 
are than degraded by the 26S proteosome (Hershko and Ciechanover 1998).
(2) Phosphorylation can regulate the subcellular localization of a protein. Many 
transcription factors are constitutively nuclear, and are phosphorylated and 
dephosphorylated by protein kinases and protein phosphatases within the nucleus. 
However, a number of transcription factors shuttle between the cytoplasm and the 
nucleus, and in many cases this process is regulated by protein phosphorylation/
dephosphorylation. The nucleocytoplasmic shuttling of transcription factors is an 
active process that relies on the recognition of nuclear localization signals (NLS) 
and nuclear export signals (NESs), present in the transcription factor primary 
sequence, by proteins of the nuclear import and export machinery (Hood and Silver 
1999). Protein phosphorylation and dephosphorylation can however regulate the 
accessibility of the NLS and NESs to the nuclear import and export proteins in 
at least two ways: (i) by directly masking or unmasking the transcription factor 
signal, or (ii) by modulating the binding of the transcription factor to other regulatory 
Figure 5. Regulation of transcription factors by phosphorylation. Five different mechanisms of regu-
lation are represented. The transcription factor is depicetd in green, RNA Pol II in red, and the 
mRNA in black (after Holmberg et al. 2002).
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proteins which mask or unmask the signal sequences. 
In the first case, phosphorylation usually prevents nuclear import, while 
dephosphorylation activates it. For example, NFAT and FKHRL1, a member of the 
Forkhead family, are both retained in the cytoplasm when highly phosphorylated 
(Zhu et al. 1998; Biggs et al. 1999; Brunet et al. 1999; Brunet et al. 2001b).
 A good exemple of the second mechanism is the heterodimeric transcription 
factor nuclear factor-κB (NF-κB). NF-κB is regulated by binding to the cytoplasmic 
anchoring protein inhibitor of NF-κB (I-κB) (Ghosh et al. 1998). The binding of I-κB 
to NF-κB masks the NLS located on the p65 subunit of the NF-κB heterodimer, 
thereby preventing translocation of NF-κB to the nucleus (Ghosh et al. 1998). 
Phosphorylation of I-κB targets this subunit for degradation, allowing exposure of 
the NLS on p65 and transport to the nucleus.
(3) Phosphorylation can modulate protein-protein interactions. This can occur by (i) 
blocking of an interaction surface following phosphorylation; (ii) by a phosphorylation-
induced conformational change that unmasks or masks the binding surface; (iii) 
by phosphorylation causing the dissociation of an inhibitor molecule to unmask a 
binding surface. 
A well-known example of how protein phosphorylation can regulate the interaction 
of transcription factors with cofactors is represented by the transcription factor 
cAMP-response element binding protein (CREB). When phosphorylated at a 
certain residue, CREB binds to the coactivator protein CBP, which links CREB 
with components of the basal transcription machinery, leading to increased 
transactivation (De Cesare et al. 1999).
(4) Phosphorylation affects the DNA-binding activity. Many DNA binding domains are 
basic in character, so phosphorylation within or nearby these domains introduces a 
negative charge, which may be incompatible for efficient DNA binding. For example, 
the DNA binding activity of c-Jun is both positively and negatively regulated by 
phosphorylation in a site-specific manner (Whitmarsh and Davis 2000).
(5) Phosphorylation regulates the transcriptional activity of a factor such as HSF1, 
the mediator of stress-induced expression of heat shock genes (Knauf et al. 1996; 
Holmberg et al. 2002). In response to heat shock and other protein-damaging 
stresses, HSF1 undergoes nuclear localization, binds to heat shock elements, 
becomes phosphorylated and subsequently acquires transcriptional activity 
(Pirkkala et al. 2001).
In addition, phosphorylation can also regulate transcription by modifying chromatin 
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structure and the accessibility of promoter binding sites to transcription factors. These 
changes are mediated by multisubunit ATP-dependent remodeling complexes or 
by covalent modification of the nucleosomes (Workman and Kingston 1998).
All these regulatory processes are fully integrated, and the outcome depends on 
the types of signals operating at a particular time and place in the cell.
9. Silencing of transcription during mitosis
The typical eukaryotic cell cycle comprises 4 phases (Fig. 6). During mitosis (the 
M phase) the cell divides into two daughters cells. The M phase comprises mitosis 
and cytokinesis (Earnshaw and Pluta 1994; King et al. 1994). With mitosis, sister 
chromatids segregate into two nascent cells, such that each daughter cell inherits 
one complete set of chromosomes. In addition, each daughter cell must receive 
one centrosome and the appropriate complements of cytoplasm and organelles. 
After the M phase, the two daughters cells enter in the interphase of a new cycle. 
The interphase begins with the G1 phase, during which the biosynthetic activity of 
the cell starts again at high speed. 
The S phase is so called because the synthesis of the DNA takes place, and this 
phase ends only when chromosome duplication is accomplished. The S phase is 
followed by a second gap phase, called G2, which precedes the entry in a new cell 
division.
M
Mitosis
G2
Gap 2
Interphase
S
Synthesis
G1
Gap 1
G0
Resting
Figure 6. Schematic representation of the cell cycle phases.
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The regulation of the M phase progression relies predominantly on two mechanisms: 
protein phosphorylation and proteolysis. These are intimately intertwined, in that 
the proteolytic machinery is controlled by phosphorylation, whereas several mitotic 
kinases are downregulated by degradation.
The most prominent mitotic kinase is the founding member of the Cdk family of cell-
cycle regulators, the cyclin-dependent kinase1, Cdk1, also called cdc2 (Coleman 
and Dunphy 1994; Elledge and Harper 1994; King et al. 1994). The activity of 
the Cdks is modulated through phosphorylation of their catalytic subunits, and by 
their association with positive (cyclins) and negative regulatory proteins (Elledge 
and Harper 1994). Distinct cyclins perform different tasks in specific phases of the 
cell cycle. The cyclin associated to the cdc2 kinase is the cyclin B. The complex 
formed by the kinase and the cyclin, cdc2/cyclinB, is also called MPF, for mitosis 
promoting factor (Labbe et al. 1988; Gautier et al. 1990). Activation of MPF results 
in the activation of different kinases and the inhibition of the phosphatases PP1 and 
PP2A (Nigg 1993). As a result, during mitosis multiple proteins are phosphorylated, 
causing a reorganization of the nuclear envelope, the spindle apparatus, the 
chromosomes, and the regulation of transcription factors. 
Recent studies brought to light additional mitotic kinases. These include members 
of the Polo family, the Aurora family and the NIMA (never mitosis A) family, as 
well as kinases implicated in mitotic checkpoints, mitotic exit and cytokinesis (Nigg 
2001). 
When cells enter mitosis, transcription of the eukaryotic genome, which is highly 
active in interphase, is abruptly silenced. Experiments performed already 40 years 
ago showed that in vivo incorporation of radioactive precursors into nuclear RNA 
declines in early to mid-prophase and resumes in late telophase (Prescott and 
Bender 1962; Konrad 1963; Terasima and Tolmach 1963). The precise degree 
of mitotic transcription repression remains uncertain, with some studies detecting 
mitotic RNA synthesis at 16 to 24% of the interphase levels (Konrad 1963; King 
and Barnhisel 1967). Indeed, mitotic repression of transcription has been observed 
in vivo for genes transcribed by all three nuclear RNA polymerases (Prescott and 
Bender 1962; Fink and Turnock 1977). Approximately 75 to 80% of RNA synthesis in 
cycling cells is due to RNA Pol I activity (Reeder and Roeder 1972; Love and Minton 
1985; Zawel and Reinberg 1995), but it is not clear to what degree transcription by 
each of the three nuclear polymerases is repressed during mitosis. 
Mitotic repression has been associated to a number of regulatory mechanisms (Hartl 
et al. 1993; Martinez-Balbas et al. 1995; Gottesfeld and Forbes 1997), including 
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condensation of interphase chromatin into mitotic chromosomes (Fink and Turnock 
1977), dissociation of transcription factors or RNA polymerases from the chromatin 
template (Martinez-Balbas et al. 1995; Parsons and Spencer 1997), and premature 
termination of transcription observed for very large genes in Drosophila (Shermoen 
and OʼFarrell 1991). 
Chromatin condensation naturally limits the accessibility of the DNA template 
to transcription factors and RNA polymerase, and is mediated by the DNA 
topoisomerase II (Hirano and Mitchison 1991) and the phosphorylation of the linker 
histone H1 and the core histone H3 (Bradbury et al. 1974). Moreover, genetic and 
biochemical studies have uncovered a multisubunit complex, named condensin, 
required for mitotic chromosome structure and condensation (Hirano and Mitchison 
1994; Swedlow and Hirano 2003; Watrin and Legagneux 2003).
Besides chromatin condensation, a key role in mitotic inactivation of transcription 
is played by phosphorylation of basal transcription factors and of RNA Pol II 
(Gottesfeld et al. 1994; Leresche et al. 1996; Segil et al. 1996; Akoulitchev and 
Reinberg 1998; Long et al. 1998).
In fact, mitotic repression of transcription by RNA Pol II can be reproduced in vitro 
with asynchronous cell extracts treated with the master mitotic kinase cdc2/cyclin B. 
This effect is reversed by specific inhibition of this kinase, indicating that repression 
of transcription is due to protein phosphorylation (Gottesfeld et al. 1994; Martinez-
Balbas et al. 1995).
Potential targets for this repression are the general transcription factors, the RNA 
Pol II itself and also activator proteins that bind enhancer or upstream elements.
Earlier studies showed that both TBP and some TAF components of the TFIID 
complex are phosphorylated in mitosis (Segil et al. 1996). This modification selectively 
inhibits activator-dependent transcription, but not activator-independent basal 
transcription in vitro (Segil et al. 1996), indicating that the mitotic phosphorylation 
of TFIID subunits does not affect TFIID promoter binding activity itself. Also TFIIH 
is inactivated in mitosis (Akoulitchev and Reinberg 1998; Long et al. 1998). The 
Cdk7 subunit of the CAK complex of TFIIH is phosphorylated by cdc2/cyclin B and 
this modification impairs CTD-kinase activity and therefore transcription activities 
of TFIIH (Akoulitchev and Reinberg 1998).
Thus, for an activated promoter, targets of repression are TFIID and TFIIH, while for 
a basal promoter, TFIIH is the major target for mitotic inactivation of transcription.
The CTD domain of RNA Pol II is also phosphorylated by cdc2/cyclinB, and this 
results in the inhibition of transcription in a reconstituted transcription system 
containing the basal transcription factors and polymerase (Cisek and Corden 
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1989; Zhang and Corden 1991; Leresche et al. 1996; Patturajan et al. 1998). 
CTD phosphorylation may also affect other protein-protein interactions within the 
initiation complex. Thus, mitotic phosphorylation of the CTD may be an additional 
mechanism for general repression of Pol II transcription.
More recently, chromatin immunoprecipitation assays showed that the general 
transcription factors TFIID and TFIIB could remain associated with active gene 
promoters during mitosis, while RNA Pol II is displaced from the condensed mitotic 
chromosomes (Christova and Oelgeschlager 2002). Furthermore, the dynamics/
distribution of TBP in living human cells showed that a small fraction of TBP-TAFs 
complexes stably associate with the condensed chromosomes during mitosis 
(Chen et al. 2002). 
These results prompted the idea that the presence of promoter bound factors could 
mark genes for rapid transcriptional activation as cells exit from mitosis (Michelotti 
et al. 1997; Chen et al. 2002; Christova and Oelgeschlager 2002).
During mitosis, not only the basal Pol II machinery is altered, but also specific Pol 
II transcription factors have been reported to be phosphorylated. For example, 
Oct-1, a transcription factor used by a subset of genes transcribed by Pol II and 
Pol III, is hyperphosphorylated as cells enter mitosis and dephosphorylated as 
cells exit mitosis (Segil et al. 1996). Phosphorylation of Oct-1 negatively regulates 
its DNA binding activity (Segil et al. 1991). Another member of the POU family of 
homeodomain proteins, GHF-1, is also subject to mitotic phosphorylation, and this 
event inhibits the DNA-binding activity of GHF-1 (Caelles et al. 1995). The general 
Pol II factor Sp1 and the oncoproteins Myb and Myc are also hyperphosphorylated 
at mitosis and exhibit reduced binding activity in mitotic cell extracts (Luscher 
and Eisenman 1992; Martinez-Balbas et al. 1995). In addition to DNA-binding 
transcription factors, also two components of the human SWI-SNF complex, 
involved in transcriptional activation through opening chromatin structure, are 
phosphorylated at mitosis and are excluded from mitotic chromosomes, contributing 
to mitotic repression (Sidorova et al. 1995; Muchardt et al. 1996). 
Thus, phosphorylation of transcription factors seems to play a major and widespread 
role in regulating transcription during mitosis.
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10. Protein transport to the nucleus
10.1. The nuclear pore complex (NPC)
In the cells of eukaryotic organisms, the nucleus is separated from the cytoplasm 
by a nuclear envelope: this consists of two bilayer membranes (the inner nuclear 
membrane and the outer nuclear membrane), the nuclear pore complexes (NPCs) 
and the nuclear lamina. 
The NPCs are embedded in the nuclear envelope and provide spatial connection 
between nucleus and cytoplasm. The pore complexes are large proteinaceous 
structures with an estimated molecular mass of 60 MDa in S. cerevisiae and 125 
MDa in vertebrates, ca 40 times bigger than a ribosome (Reichelt et al. 1990; Rout 
and Blobel 1993). The number of NPCs present in the nuclear envelope is usually 
proportional to the metabolic activity of the cell.
NPCs have a highly conserved architecture with an octagonal symmetry. Elements 
characteristic of this structure include spokes, rings, a central channel, cytoplasmic 
fibrils and a nuclear basket (Garcia-Bustos et al. 1991; Forbes 1992). More than 
100 types of proteins, termed nucleoporines, compose the pore complexe (Davis 
1995).
In correspondence to the NPCs, the inner and outer membranes are fused, so that 
the pore complexes create an aqueous channel through which proteins and RNA are 
transported. Molecules with a molecular mass below 40-50 kDa can pass through 
the pore by passive diffusion. Transport of bigger molecules requires energy and is 
mediated by signals present in the cargo molecule. The largest known substrates 
for active transport are roughly 25–50 MDa. The diameter of the NPC channel 
can reach a maximum of approximately 25 nm, but the diffusion channel is 9 nm, 
indicating that the NPC recognizes and reacts to specific transport substrates by 
undergoing a considerable conformational change. 
Active transport of proteins into the nucleus is a rapid, specific and evolutionary 
conserved process. Studies made with in vitro transport systems suggested 
that transport is accomplished in two stages: (i) binding of the substrate to the 
cytoplasmic surface of the NPC and (ii) transport through the pore to the other side 
of the nuclear envelope (Fig. 7). To this purpose, the substrate needs a nuclear 
localization signal (NLS) to be recognized by the nuclear pore receptors. This 
process is energy-independent, contrary to the translocation through the pore, 
which is energy-dependent (Schlenstedt 1996). Proteins containing an NLS are 
recognized and carried to the pore by the �-importin family of nuclear transport 
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receptors (Ohno et al. 1998), also known as karyopherins, kaps or NLS receptors 
(NR). The importins direct the nuclear import and export of the cargo in association 
with the small GTPase Ran. Although Ran is found in both the nucleus and the 
cytoplasm, its effectors are asymmetrically distributed within the cell. In fact, The 
Ran GTPase activating protein (RanGAP) is localized to the cytoplasm and the Ran 
GTP exchange factor (RanGEF) is localized to the nucleus. As a result, nuclear 
Ran is in the GTP-bound stage, whereas cytoplasmic Ran is GDP-bound, thus 
ensuring the unidirectionality of the transport (Gorlich and Laskey 1995; Gorlich et 
al. 1995; Moore 1998).
10.2. The nuclear localization signal (NLS)
The classical NLS can be of two types: (i) short sequences of 4-8 amino acids 
positively charged, like the prototype NLS from the SV40 large antigen T (Kalderon 
et al. 1984a; Kalderon et al. 1984b; Lanford and Butel 1984); (ii) bipartite sequences, 
consisting of two clusters of basic residues separated by a spacing region of ca 10 
amino acids (like the bipartite signal of the nucleoplasmin) (Makkerh et al. 1996).
Figure 7. Generalised model of function for import factors (importins) and export factors (exportins). 
For details see main text. (after Gorlich 1998).
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Comparison of different NLS show that there are some general requirements for 
their functionality, rather than a unique consensus sequence (Garcia-Bustos et al. 
1991). NLS are usually short sequences of not more than 8-10 amino acids, with a 
high proportion of positively charged amino acids (lysines and arginines) and often 
they contain prolines. A protein can have more than one NLS, with no preferential 
localization and they are not eliminated after entering into the nucleus. Hence, 
as soon as the nuclear membrane is reassembled after being dissolved during 
mitosis, nuclear proteins can rapidly shuttle back to the nucleoplasm.
Most of the imported proteins studied so far contain at least two signals. When 
more NLS are presents in the protein, there could be one strong signal associated 
to a secondary weaker signal, or many weak signals that act cooperatively in 
promoting nuclear import. Yet, it is still difficult to predict the strength based on 
their sequence. 
Studies on the intracellular transport of the heterogeneous ribonucleoproteins 
(hnRNP) family, and in particular on hnRNP A1, revealed a new type of nuclear 
targeting signal called M9, composed of a domain of 39 amino acids (Pollard et al. 
1996). M9 does not contain basic residues, whereas is rich in aromatic residues and 
glycines; as expected from the different nature of the characteristic amino acids, 
the nuclear receptor recognizing M9 is not the importin. Instead, this receptor is 
called transportin and is a protein of 90 kDa with 24% homology with Importinβ. M9 
is active also as nuclear export signal. Thus, in contrast with the classical NLS, M9 
drives the bidirectional transport through the nuclear pores. The discovery of a new 
type of signal, responsible for a way of import independent from the classical one, 
demonstrates the existence of at least two receptor mediated import ways.
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II. RESULTS
1. Localization studies of NC2
NC2 accomplishes its function as a transcription cofactor in the nucleus. None 
of the previous studies reports the subcellular distribution of NC2α and NC2β. 
To investigate this aspect, indirect immunofluorescence (IF) experiments were 
performed in HeLa adherent cells. 
1.1. Subcellular distribution of NC2
1.1.1. Localization of NC2α 
Exponentially growing cells were fixed, incubated with the antibody (ab.) against this 
protein (rat 4G7 monoclonal antibody, Mab) and analyzed by confocal microscopy. 
Immunofluorescence staining shows that NC2α is confined to the nucleoplasm 
(Fig. 8a). A closer look shows that in some cells the staining is also associated to 
the nucleoli. Since the signal of the endogenous protein was weak, HeLa cells were 
also transfected with vectors containing NC2α alone or fused to the His- or flag 
tags (Fig. 8b). The overexpressed protein was detected with the NC2α monoclonal 
antibody (Mab) and the high intensity of the signal allowed clear distinction of 
the overexpressed protein from the endogenous one. Flag-NC2α was detected 
also with a flag specific ab (M2), which showed exactly the same distribution. The 
overexpressed NC2α localizes in the nuclei and, surprisingly, strongly accumulates 
in the nucleoli. The flag-NC2α construct shows also additional distribution patterns, 
with a strong signal observed around the inner part of the nuclear membrane and 
also in the cytoplasm. Since this construct is the most highly expressed, probably 
due to a consensus Kozak sequence at the start site, the different distribution is 
most likely an artefact. Transfection experiments using 293 cells yielded equivalent 
results.
To confirm that the big nuclear spots observed in transfected cells correspond to 
the nucleoli, colocalization studies using NC2α and a nucleolar specific protein 
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Figure 8. Localization of NC2. (A) Immunofluorescence analysis of NC2α in HeLa cells. Endog-
enous NC2α is visualized by secondary ab to rat IgG conjugated to biotin and streptavidin Alexa-
488-conjugated (green). NC2α localizes in the nucleoplasm and, in some cells, is found also in 
the nucleoli. (B) HeLa cells were transfected with three different constructs: NC2α, His-NC2α and 
Flag-NC2α. Cell transfected with NC2α were stained as in A, whereas His-NC2α and Flag-NC2α 
constructs were incubated with antibody against NC2α and secondary antibody conjugated to the 
fluorescent dye Cy3 (red). Over expression of NC2α leads to accumulation of the protein in the 
nucleoli. (C) HeLa cells were transfected with the Ig-NC2β construct and visualized directly with 
a FITC-conjugated ab directed against the Ig (green). The Flag-NC2β  was visualized with an ab 
against the flag and a secondary FITC anti-mouse (green). NC2β accumulates mostly in the nucleo-
plasm, but a small fraction is found in the cytoplasm. 
36Results
(NO38) were performed. This experiment clearly shows that NC2α and NO38 
immunostainings colocalize in the nucleoli (Fig. 9a), confirming that NC2α indeed 
accumulates in the nucleoli in transfected cells.
1.1.2. The nucleolar localization of the endogenous NC2α is restricted to the 
G1 phase
Since cells were taken from an asynchronous population, we asked whether the 
ones showing the nucleolar staining corresponded to a specific stage of the cell 
cycle. During the M phase of the cell cycle nucleoli are disassembled, therefore we 
overlayFlag-NC2α NO38
G1
Endogenous NC2α
S
Figure 9. NC2α colocalizes with a nucleolar protein. (A) HeLa cells were transfected with Flag-
NC2α and stained with ab against NC2α and the nucleolar specific protein NO38. The overlay of 
the staining clearly shows the colocalization of the two proteins. (B) HeLa cells were blocked in the 
G1 and S phases of the cell cycle and analyzed by immunofluorescence as described in Fig. 8a. 
Endogenous NC2α is observed in the nucleoli only during the G1 phase, while it is excluded during 
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concentrated on the Interphase, and in particular on the G1 and S phases.
To obtain a homogeneous population of cells undergoing these phases, HeLa cells 
were treated with specific cell cycle inhibitors. In particular, G1 block was obtained 
exposing exponentially growing cells to mimosine for 17 h, whereas S blocked 
cells were obtained treating them with a double thymidine block. The synchronized 
cells were fixed, immunostained and finally analysed with the confocal microscope. 
NC2α is never observed in the nucleoli of S blocked cells (Fig 9b). On the contrary, 
the late G1 population shows both situations, with some cells where NC2α was 
excluded from the nucleoli and cells where it was clearly detectable. Hence, this 
experiment indicates that the nucleolar localization of NC2α is restricted to the G1 
phase. 
1.1.3. Localization of NC2β
Since the polyclonal rabbit antibody normally used for western blot is not suitable 
for immunofluorescence, it was not possible to look at the localization of the 
endogenous NC2β subunit. Therefore, HeLa cells were transfected with the tag 
fused proteins Ig-NC2β or flag-NC2β and later stained with antibody recognizing 
the Ig (i.e. any secondary ab against the heavy chain of the human IgG) and the 
flag tag. The exogenous NC2β protein is strongly detected in the nucleus (Fig. 
8c). Opposed to what is observed for NC2α, the overexpressed NC2β is always 
excluded from the nucleoli and shows a weak signal in the cytoplasm. Moreover, 
the two tags do not seem to influence the localization of the protein, because both 
fusion constructs give the same localization.
Thus, both NC2 subunits show a largely overlapping distribution, in the nucleoplasm, 
but they exhibit also specific patterns: NC2α can be found in the nucleoli, whereas 
NC2β is present in low concentrations in the cytoplasm.
1.2. Import and dimerisation of NC2
1.2.1. Both NC2α and NC2β contain an NLS
The localization studies of NC2α and NC2β show that both subunits concentrate 
in the nucleus. This observation strongly suggests the presence of a nuclear 
localization signal (NLS) in both of them. 
Indeed, the analysis of the amino acid sequences identified a putative, positively 
charged motif in each protein (Fig. 2b). NC2α contains a potential bipartite NLS in 
the N-terminus (4-KKKKYNARFPPARIKKI-20), composed of two clusters of basic 
38Results
amino acids, mostly lysines, separated by a short linker. NC2β has only one cluster 
of basic amino acids, containing two lysines and two arginines (100-KRRK-103). 
The two putative sequences were tested using NC2 constructs potentially deficient 
for nuclear import. 
The localization of His-NC2α, containing a small 6His N-terminal tag, was compared 
with that of Ig-NC2α, which has a big fusion of ca. 30kD at the N-terminus that could 
impair the close putative bipartite NLS. Cells transfected with the corresponding 
plasmids were stained with the NC2α ab and analyzed by confocal microscope. 
NC2β Ig-NC2βx:∆83Ig-NC2βy:∆112Ig-NC2β: FL
NC2α His-NC2α Ig-NC2α
A
B
Figure 10. Both NC2 subunits contain a nuclear localization signal (NLS). (A) HeLa cells were 
transfected with two different NC2α constructs, Ig-NC2α and His-NC2α. The fusion of the big Ig- 
tag, adjacent to the putative NLS, impairs transport to the nucleus. (B) Transfection of HeLa cells 
with successive deletion mutations of NC2β. Only full length NC2β (Ig-NC2β:FL) and deletion con-
struct containing the first 112 aa (Ig-NC2β:D112) accumulates in the nucleoplasm. In contrast, the 
short deletion version (Ig-NC2β:D83) is retained in the cytoplasm, indicating the presence of a NLS 
between aa 84 and 112.
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As expected, His-NC2α localizes in the nucleus and accumulates into the nucleoli. 
In contrast, the big Ig-NC2α fusion protein is totally excluded from the nucleus 
(Fig. 10a). This can be explained if we assume that in the Ig-NC2α fusion the NLS 
is not functional any more, and the large size prevents the construct to enter the 
nucleus by diffusion. Probably, the NLS is masked by the steric hindrance of the 
large proximal Ig fusion. As a consequence, the NLS would not be exposed on the 
surface of the protein, precluding its recognition by the nuclear import machinery. 
The localization of the Ig-NC2β construct, normally imported into the nucleus, was 
compared with that of two successive deletion mutants, the Ig-NC2βy (amino acids 
1-112), still containing the potential NLS sequence (which is located between 99-
103), and the Ig-NC2βx deletion (amino acids 1-83) lacking the putative nuclear 
import signal. HeLa cells were transfected, stained with an ab. directed against 
the Ig tag and the distribution of the proteins was observed in the microscope. As 
expected, both Ig- NC2β and Ig-NC2βy accumulate in the nucleus. In contrast, the 
Ig-NC2βx deletion mutant is completely excluded from the nucleus (Fig. 10b). This 
result demonstrates that the sequence comprised between amino acids 84 and 
112 contains a nuclear targeting sequence, which is necessary and sufficient for 
nuclear transport of NC2β. In this region, the only motif having the requirements for 
a nuclear targeting sequence is the cluster of positively charged aminoacids 100-
KRRK-103, which therefore may be regarded as the most likely NLS candidate.
1.2.2. Is NC2 transported into the nucleus as a dimer or as single subunits?
The discovery of NC2 constructs deficient in nuclear import offered us a powerful 
tool to investigate the modality of transport of NC2 into the nucleus. One could 
think of two different scenarios: (i) NC2α and NC2β dimerize in the cytoplasm 
immediately after translation and then they are imported in the nucleus as a dimer; 
(ii) they enter the nucleus as single subunits, thanks to specific NLS, and they 
dimerize only in the nucleus (Fig. 11a).
To address this question, double transfection experiments were performed 
combining a construct normally localizing into the nucleus with a construct of the 
Figure 11 (previous page). Import and dimerization of NC2. (A) Two models for the dimerization of 
NC2 subunits are showed: (i) NC2α and the partner NC2β dimerize after entering into the nucleus 
independently; or (ii) they enter into the nucleus as a dimer. (B) HeLa cells were double transfected 
with one subunit lacking the nuclear import functionality (see Fig. 19 and text for details) and the 
other subunit as wild type. Both subunits are retained in the cytoplasm whenever one lacks the 
ability to enter the nucleus, supporting model (i). (C) In the nucleus, NC2β controls the localization 
of both subunits (as represented in the scheme). Cotransfection of HeLa cells with His-NC2α and 
Ig-NC2β abolishes the normal nucleolar concentration of NC2α, suggesting that NC2α is present in 
the nucleoli only when in excess as single subunit compared to NC2β.
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other subunit lacking the import function. Surprisingly, both subunits were retained 
in the cytoplasm independently of whether NC2β or NC2α lacked a functional NLS 
(Fig. 11b). Moreover when His-NC2α is cotransfected with Ig-NC2β, NC2α does 
not localize in the nucleoli any longer, but stays in the nucleoplasm together with 
NC2β (Fig. 11c). 
1.3. Characterization of the NLS
1.3.1. NC2α has a bipartite NLS
In order to investigate the role of the hypothetical bipartite NLS of NC2α, 
mutants were generated in both putative NLS motives of the His-NC2α vector (4-
KKKKYNARFPPARIKKI-20). In the first cluster of basic amino acids, either only 
lysines 4-5 (K4A/K5A) or the whole positive stretch of lysines (K4A/K5A/K6A/K7A) 
were converted into alanine. In the second NLS motif, the two lysines (K18A/K19A) 
were converted into alanine and, in a second cloning procedure, also the arginine 
was mutated into alanine (R16A/K18A/K19A). As control, the vectors His-NC2α, for 
nuclear transport, and Ig-NC2α, for deficiency in nuclear import, were also included. 
Interestingly, all mutations affected the import: none of the mutants localized into 
the nucleus as exclusively as the wild-type protein, although the cytoplasmic 
localization is never as strong as in the control Ig-NC2α (Fig. 12). Probably, His-
NC2α mutants can enter the nucleus also by diffusion, resulting in the observed 
spread distribution, whereas the large Ig-NC2β fusion protein can pass through the 
nuclear pore only by active transport and not by diffusion. Regarding the relative 
strength of the two NLS, mutations in the second sequence were less dramatic 
than those in the first one. All the mutations in the second NLS cause a diffuse 
distribution throughout the cell (Fig. 12). The substitution R16A/K18A/K19A caused 
Figure 22 (next page). NC2α has a bipartite N-terminal nuclear localization signal (NLS). HeLa 
cells were transfected with different His-NC2α constructs, mutated in the putative NLS, and visulal-
ized with NC2α ab and secondary ab Cy3-conjugated. Left column shows DNA stained with DAPI, 
central column the NC2α staining, the right the overlay. The His-NC2α construct (i.e. the wt control) 
was mutagenized in the two motifs of the putative N-terminal NLS (shown in the on the top of the 
panel): underlined amino acids (aa) correspond to the putative bipartite NLS; aa in bold are the 
mutated ones (their position relative to the NC2α start site is shown above the sequence). Mutants 
are named after the mutated amino acid/s: the wild type aa precedes the position number and the 
aa it was mutagenized to (e.g. K4A/K5A: lysines 4 and 5 were both mutated to alanine). Muta-
tions of either one of the motifs affect nuclear import (K4A/K5A, K4A/K5A/K6A/K7A, K18A/K19A, 
R16A/K18A/K19A). Mutant K4A/K5A/K6A/K7A (comprising the whole first motif) is the one impair-
ing more severely nuclear import. When threonine 23 was mutated to aspartate (T23D), mimicking 
its potential phosphorylation state, nucleolar localization was abolished (cfr. T23D and T23A, where 
threonine was mutated to the neutral alanine).
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a reduction in nuclear targeting no greater than that observed for the change K18A/
K19A, suggesting that R16 does not play a major role. 
More evident are the effects of mutations in the first motif. The substitution K4A/
K5A affects only marginally nuclear import, and the protein still concentrates in the 
nucleus. However, the mutant K4-7A remains mainly in the cytoplasm, with only a 
small fraction entering the nucleus, most likely by diffusion.
Thus, both N-terminal motifs are necessary for targeting NC2α to the nucleus, but 
the first signal is the strongest one. Notably all mutations impaired the ability of the 
protein to accumulate into the nucleoli. 
1.3.2. Mutation of threonine 23 in aspartate abolishes nulceolar localization
NC2α contains potential phosphorylation sites close to the bipartite NLS (3-
SKKKKYNARFPPARIKKIMQT-23). Threonine 23 (T23) is conserved in yeast and 
previous studies showed that phosphorylation at this residue is important for NC2 
transcriptional repression activity in yeast (Creton et al. 2002). We asked whether 
this observation was related to the fact that T23 is adjacent to the NLS and mutated 
this residue into alanine and aspartate, to mimic the negative charge acquired by 
phosphorylation. As expected, the His-NC2α-T23A mutant shows exactly the same 
distribution of the His-NC2α wild type, with signal associated to the nucleoplasm 
and especially to the nucleoli (Fig. 12). Interestingly, the His-NC2α-T23D mutant 
still accumulates in the nucleoplasm, but does not enter the nucleoli. 
1.3.3. NC2β has a single motif NLS
The analysis of the localization of the Ig-NC2β deletion mutants suggests the 
sequence 100-KRRK-103 to be the NLS for NC2β. To confirm this hypothesis, this 
motif was partially mutagenized and the resulting subcellular localization studied. 
In a first experiment, the two central arginines were replaced with two uncharged 
alanines (R101A/R102A). In a second, both serines adjacent to the potential NLS 
(100-KRRKASSR-107) were mutated into alanine (S105A/S106A) or aspartate 
(S105D/S106D), to mimic the negative charge acquired after serine phosphorylation. 
In this latter experiment, we made use of the interesting observation that nuclear 
import of NLS cargo proteins can indeed be impaired by phosphorylation at sites 
within or adjacent to a classic NLS sequence (Jans 1995; Hood and Silver 1999; 
Jans et al. 2000). 
All the mutations were introduced in the construct Flag-NC2β, because it is highly 
expressed in the cells and easily detectable with the anti-flag ab. As control, cells 
were transfected with non-mutated Flag-NC2β and Ig-NC2β (Fig. 13), which 
accumulate in the nucleus, and Ig-NC2βx, which is excluded from it. All mutations 
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Figure 13. Mutagenesis of part of NC2β putative nuclear localization signal (NLS) does not affect 
its subcellular localization. HeLa cells were transfected with Flag-NC2β construct mutagenized in 
the putative NLS. NC2β was visualized with ab directed against the Flag-tag and a secondary ab 
FITC-conjugated. Left column shows DNA stained with DAPI, central column the NC2β staining, the 
right the overlay. The Flag-NC2β construct represents the wt control. The putative NLS is shown as 
underlined sequence on the top of the panel. The mutagenized aa are indicated as bold letters (their 
position relative to the NC2β start site is shown above the sequence). Mutants are named after the 
mutated amino acid/s (see Figure 22 legend for explanation). The putative NLS was mutagenized in 
the two central arginines (R101A/R102A). Also the adjacent (non-NLS) serines were mutagenized 
to alanine or aspartate (S105A/S106A and S105D/S106D, respectively) mimicking the effect of 
phosphorylation. All mutations resulted in a subcellular distribution similar to the control.
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result only in a slightly larger amount of NC2β in the cytoplasm, as compared to the 
control flag-NC2β. This suggests that the two remaining lysines of the NLS are able 
to drive the interaction with the nuclear import receptor and that the two central 
arginines are not critical for the import. Moreover a negative charge at positions 
105 and 106 may affect only moderately NC2β import.
1.3.4. Only the first motif of the NC2α-NLS is important for import of the 
dimer
To assess the effect of NC2α and NC2β NLS mutations on nuclear targeting of the 
dimer, HeLa cells were transfected with both subunits, wild type or mutated (Fig. 
14). In the control experiment, the cells were transfected either with both proteins 
going into the nucleus (His-NC2α and Flag-NC2β) or with one wt subunit (His-
NC2α, Ig-NC2β) together with the construct lacking the nuclear targeting function 
(Ig-NC2α, Ig-NC2βx). As shown before, if both proteins have a functional NLS (His-
NC2α and Flag-NC2β), the dimer localizes in the nuclei. Both signals are necessary 
because if one of them is missing (Ig-NC2βx) or is not functional (Ig-NC2α), NC2 
accumulates in the cytoplasm. To test the ability of the mutants to impair nuclear 
transport of the dimer, Flag-NC2β was cotransfected together with the construct 
lacking either the first lysine stretch (K4A/K6A/K7A) or the second motif (R16A/
K18A/K19A) of the bipartite NC2α NLS. The analysis at the confocal microscope 
showed that when the second part of NC2α-NLS is missing the dimer accumulates 
in the nucleus as efficiently as the control, indicating the first NLS to be sufficient 
for correct targeting of the dimer. In fact, when the whole lysine stretch in the first 
motif is replaced by alanine, NC2 distributes all over the cell, implying that the first 
NLS motif is sufficient and also necessary for the correct transport of NC2.
Thus, if both motifs are important for the nuclear localization of the single NC2α 
subunit, only the first one is necessary for the import of the dimer.
1.3.5. Mutation of the NC2β-NLS affects import of the dimer
When HeLa cells were cotransfected with His-NC2α wt and the Flag-NC2β-R101A/
R102A mutant, part of the dimer is localized in the cytoplasm (Fig. 14). This was 
surprising, because the R101A/R102A mutation did not have a strong effect in 
nuclear import of NC2β alone, and suggests that arginines 101-102 indeed play a 
role in nuclear transport. 
To investigate the effects of serines 105-106 phosphorilation on the nuclear import of 
the dimer, both Flag-NC2β-S105A/S106A and Flag-NC2β-S105D/S106D mutants 
were cotransfected with His-NC2α wt. In both double transfection experiments 
the NC2 mutants concentrated in the nucleus indifferently from the charge of the 
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Figure 14. Both NC2α and NC2β NLSs are essential for nuclear localization of the 
NC2 dimer. HeLa cells were double transfected with His-NC2α or Flag-NC2β wt 
or mutated and stained as described before. First column shows DNA stained with 
DAPI, second column the NC2β staining, third column the NC2α staining, and the 
fourth the overlay of the two subunits. The His-NC2α construct (i.e. the wt control) 
mutagenized either in the whole first or second motif (K4A/K5A/K6A/K7A or R16A/
K18A/K19A, respectively) was cotransfected with the Flag-NC2β wt. Vice versa, 
the Flag-NC2β mutants (R101A/R102, S105A/S106A and S105D/S106D) were co-
transfected with the His-NC2α wt. Only the first motif of the bipartite NC2α NLS is 
important for import of the dimer. Mutation of the two central arginines of the NC2β 
NLS also affects localization of the dimer, although it did not seem to be important 
for transport of the single subunit.
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two serines, showing essentially the same distribution pattern as that seen in the 
control. Thus, phosphorylation at these residues may have a weak effect on the 
single subunit but not on the dimer. 
2. Post-translational modification of NC2: NC2α is specifically 
hyperphosphorylated during mitosis
2.1. NC2 is neither acetylated nor methylated
Post-translational modifications play an important role in the regulation of protein 
activity. In order to investigate whether NC2 is post-translationally modified by 
methylation and/or acetylation, recombinant NC2 was incubated with HeLa nuclear 
extracts, which contain acetyl- and methyl-transferase activities. Radioactively 
labeled Acetyl-Coenzyme A and S-Adenosylmethionine were added to the 
reaction, as donors of radioactive acetyl and methyl groups, respectively. As 
Figure 15. NC2 subunits are neither methylated nor acetylated. Recombinant NC2 (3  mg of each 
subunit) and recombinant histone proteins (3 μg) were incubated with 10 μl of HeLa nuclear ex-
tracts and [14C]-Acetyl-Coenzyme A and [14C]-S-Adenosylmethionine. After reaction, proteins were 
separated in a SDS-PAGE and visualized by autoradiography. Lanes 1-4 correspond to methylation 
assay, lanes 5-8 to acetylation assay. In contrast to histones (H2A, H2B, H3 and H4), no band cor-
responding to NC2 proteins was observed.
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Figure 16. Levels of NC2 during the cell cycle: the NC2α subunit is modified during mitosis. (A) 
Analysis by flow cytometry of the DNA content (DNA is stained with propidium iodide, PI) of HeLa 
cells synchronized in different cell cycle phases (G1, S and M, see methods), compared to an 
asynchronous population. (B) Analysis by immunoblotting of the amount of NC2α and NC2β dur-
ing the cell cycle. Whole cell extracts (WCE) were prepared from HeLa cells exponentially grow-
ing (Async) and synchronized (G1, S, M, see methods). The proteins corresponding to the same 
number of cells were separated in SDS-PAGE and immunoblotted with NC2α and NC2β antibodies. 
Immunostaining with the anti-β-actin ab was included as control for load of equal protein amounts. 
Protein levels are maintained constant through the cell cycle, but NC2α is modified in mitotic cells. 
(C) Analysis by immunoblotting of NC2α in cells synchronized in the G1 and M phases of the cell 
cycle. The membrane was immunostained with two different monoclonal antibodies against NC2α 
(4G7 and 6G8). The additional NC2α band observed in mitosis is recognized by both antibodies, 
showing that this band is indeed NC2α and not a cross reaction of the 4G7 antibody with a mitotic 
protein. (D) Immunoblot analysis of WCE prepared from different cell lines, synchronized in the G1 
and M phases of the cell cycle. HeLa and 293 are transformed cell lines, whereas F99 are skin 
primary fibroblasts. The 293 WCE were obtained resuspending the cells in lysis buffer, like for the 
other cells type, but then cells lysates were also sonicated. The proteins corresponding to the same 
number of cells were separated in SDS-PAGE. The mitotic specific NC2α band is observed in all 
the cell lines. The F99 extracts contain an extra NC2α band running between the 21.5 kD and 30 
kD marker bands, recognized by both NC2α monoclonal antibodies (data not shown). This band is 
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control, recombinant histone proteins were included, since they are known to be 
typical substrates for acetyl- and methyl-transferases. Proteins were separated 
electrophoretically and revealed by autoradiography of the gel. None of the 
radioactive bands observed in the autoradiography corresponded to NC2α or 
NC2β, indicating that these proteins were not modified (Fig. 15).
2.2. Monitoring of NC2 level throughout the cell cycle: a new isoform of NC2α 
appears during mitosis (M-NC2α)
So far there are no indications about the level of the two NC2 subunits throughout 
the cell cycle. Thus, we asked whether the amount of the proteins was maintained 
constant, or was changing depending on a specific phase of the cell cycle. To 
address this question, HeLa cells were synchronized in the G1, S and M phases 
of the cell cycle, using different inhibitory compounds (Fig. 16). The correct 
synchronization of the cells was verified by flow cytometry (FACS) analysis of 
a parallel culture (Fig. 16a). Whole cell extracts (WCE) were prepared from the 
cells, run in SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and analyzed 
in Western Blot (WB). Staining of the  β-actin was used as a control for equal load 
of total proteins amount in the different lanes. NC2α was detected with the rat 4G7 
monoclonal antibody, and NC2β with a rabbit polyclonal ab (Fig. 16b). Analysis 
of the WB indicated that NC2β did not show any variation in protein level or in 
migration in the different WCE preparations. The same was observed for NC2α 
in the G1 and S phases. Surprisingly, during the M phase, an additional slower 
mobility form of NC2α appears. To confirm that this extra band was specific and not 
the result of a cross reaction of the antibody, a new blot carrying G1 and M WCE 
was probed with two monoclonal NC2α antibodies (4G7 and 6G8; Fig. 16c). Both 
antibodies recognized the low mobility band, thus confirming that NC2α undergoes 
mitosis-specific modification. 
2.3. The new M-NC2α form is specific for the mitotic stage
To prove that M-NC2α is characteristic only for the M phase, mitotic HeLa cells were 
released from the block and allowed to enter G1 in normal medium. Furthermore, 
to test if M-NC2α was a result of a phosphorylation, the release was performed 
either in presence or absence of the phosphatase inhibitors NaF and Vanadate. 
Asynchronous and mitotic cells, and cells collected at 6h from the mitotic release, 
were used to prepare the WCE. An aliquot of each sample was used to establish 
the cell cycle stage by FACS (Fig. 17a). Unexpectedly, the flow cytometry analysis 
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revealed an acceleration in the release from the M phase in presence of phosphatase 
inhibitors. This is in line with the parallel immunoblot experiment: M-NC2α was still 
observed at 6h post-release, but if phosphatase inhibitors were present, most of 
the cells entered the G1 phase and M-NC2α was almost totally gone (Fig. 17b). 
Hence, these results confirm that the low mobility form of NC2α is characteristic of 
the mitotic phase. 
It remained to be shown whether the modification of NC2α occurs specifically in 
mitosis, or rather in late G2. To test this, HeLa cells were synchronized at late S 
phase by double thymidine block and released in normal medium for 8h to let them 
reach the G2 stage. Flow cytometry analysis of a parallel culture confirmed the 
correct synchronization of the cells in the G2 and M phases compared to the control 
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Figure 17. NC2α modification is restricted to mitosis. (A) FACS analysis of the DNA content (PI) 
of HeLa cells synchronized in M phase with nocodazole and released from the block for 6 h in the 
absence or presence of phosphatase inhibitors (ph. Inh., see methods), compared to an asynchro-
nous population. (B) Immunoblot analysis of WCE prepared from the cells populations described 
in A. The mitotic specific form disappears when the cells exit mitosis. (C) NC2α was analyzed in 
immunoblot from WCE prepared from asynchronous cells, and cells blocked in G2 and M. NC2α is 
modified only once cells enter mitosis.
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sample with asynchronous cells (data not shown). WCE from the three samples 
were fractionated by SDS-PAGE and examined by immunoblot experiments with 
NC2α and NC2β antibodies (Fig. 17c). The results showed that NC2α is modified 
in cells blocked in mitosis but not in late G2, suggesting that an enzyme specifically 
activated in mitosis is responsible for the modification.
2.4. M-NC2α is observed in different cell types
To exclude the possibility that this observation was exclusive of the cell type or of 
transformed cells in general, different types of transformed cells available in the lab 
(HeLa suspension and adherent, 293) and skin primary fibroblast (F99) were blocked 
either in G1 or in M phase. Immunoblot analysis revealed the presence of M-NC2α 
in all above cell types (Fig. 16d), indicating that this is a general phenomenon. 
Again, no difference concerning NC2β was observed (data not shown). 
Interestingly, in the F99 primary cells WCE the NC2α ab recognizes another band, 
which is smaller than the usual one and has mobility between the 21 and 31 marker 
bands. Surprisingly, also this high mobility band seems to be modified in mitosis. 
Both the NC2α monoclonal antibodies recognize this high mobility band. Since the 
epitopes of these antibodies are mapping the C-terminus of NC2α, this band is 
likely to correspond to a N-terminal deleted variant. 
2.5. M-NC2α is phosphorylated
2.5.1. In vitro dephosphorylation of the mitotic NC2α
The shift in mobility observed in WB of the mitosis-specific NC2α form is compatible 
with a modification by phosphorylation. To test this assumption, HeLa mitotic 
WCE were incubated with the λ phosphatase enzyme, resolved by SDS-PAGE 
and analyzed in WB (Fig. 18a). Interestingly, the phosphatase treatment not only 
abolished the mitotic shift, but also produced a band with higher mobility (lanes 
4 and 5) than the regular NC2α band observed in the G1 sample (lane 1). The 
change in mobility observed in lanes 4 and 5 is specifically produced by the λ 
phosphatase because treatment with the enzyme inhibitor, the vanadate, preserved 
phosphorylation throughout the incubation (compare lanes 6 with 4 and 5). 
2.5.2. In vivo phosphorylation of NC2
The previous experiment is an indirect proof that the modification responsible for 
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Figure 18. NC2α is modified by phosphorylation during mitosis. (A) Mitotic HeLa WCE were treated 
with the λ phosphatase enzyme alone or in the presence of either Manganese (Mn) or Mn and 
Vanadate, a phosphatase inhibitor. The reaction was carried out for 30 min at 30°C. The extracts 
were then separated in SDS-PAGE and immunoblotted with the NC2α antibody. As controls, un-
treated G1 extracts were included in the first lane and the blot was also probed with the β-actin 
antibody. Phosphatase treatment produces an NC2α band with mobility even higher than the nor-
mal G1-NC2α band (compare lanes 4, 5 and lane1). (B-E, C, D) In vivo labeling analysis of NC2α 
and NC2β with [32P]H3PO4 in asynchronous and M-blocked HeLa cells (see methods). (B) Flow 
cytometry analysis of the DNA content of the two cells populations. Radioactive NC2 was immuno-
precipitated with the NC2α antibody and then proteins were eluted from the antibody with two meth-
ods. (C) Autoradiography of the gel made with the peptide eluted proteins. (D) Autoradiography of 
the gel made with the SDS eluted proteins. (E) The gel corresponding to the SDS elution was also 
transferred to a nitrocellulose membrane and probed with the NC2α and NC2β antibodies. Both 
NC2 subunits are phosphorylated in vivo and NC2α undergoes mitosis specific phosphorylation. In 
the autoradiography, additional bands are visible (red mark), compared to the Western Blot.
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the change in mobility of M-NC2α is a phosphorylation. To test the possibility that 
mitosis produces a change in the overall phosphorylation status of NC2α, HeLa 
cells were metabolically labeled with [32P]H3PO4 while exponentially growing or 
during the last 5h of the nocodazole treatment (mitosis block). A parallel culture of 
non-radioactive labeled HeLa cells treated in the same way was used for the flow 
cytometry analysis of the asynchronous (Async) and the mitotic blocked (M, Fig. 
18b) cells.
The two different samples of HeLa cells metabolically labeled (Async, and M) 
were lysed in the presence of protease and phosphatases inhibitors. NC2 was 
immunoprecipitated with the NC2α 4G7 Mab and eluted first by way of a peptide 
corresponding to the epitope of the ab. and then with 2x SDS sample buffer. The 
two immunoprecipitates were separately fractionated by SDS-PAGE, blotted to NC 
membrane, and exposed for autoradiography before immunodetection of NC2α 
and NC2β. Autoradiography revealed that all NC2α and NC2β forms normally 
detected in WB are in vivo phosphorylated in interphase and especially in mitosis 
(Fig. 18c-e), confirming the data of the in vitro dephosphorylation assay. Thus, this 
is a direct proof that the modification responsible of the upper mobility shift of NC2α 
during mitosis is a phosphorylation. 
Comparison of the two autoradiographies revealed the presence of additional 
NC2α DNA overlay
Prophase
Metaphase
+
Interphase
Figure 19. Subcellular distribution of NC2α during mitosis. HeLa cells were blocked in mitosis 
with nocodazole, NC2α was stained as described before. Left column shows DNA stained with PI, 
central column the NC2α staining, the right one the overlay. In interphase the staining is confined 
into the nucleus; in prophasic cells most of NC2α is not localized in the chromosomal regions, 
while in metaphase cell showed diffusely stained cytoplasm.
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isoforms normally not recognized in WB (Fig. 18e). In particular, in the SDS elution 
there is an additional high mobility band running below the 21kD marker (asterisk in 
Fig. 18d). Additional experiments suggested that this band is an isoform of the NC2β 
subunit (see paragraph 4.1 of the results). Furthermore, an extra band (asterisk in 
Fig. 18c) running between NC2α and NC2β, which shows a change in mobility 
and is also phosphorylated during mitosis, has characteristics similar to the high 
mobility NC2α band observed in F99 cells (Fig. 16d). Presumably, this variant is 
normally not detected in immunoblot of HeLa extracts because it is very rare, while 
it becomes visible in the autoradiography due to the high intensity of the label. 
2.6. NC2α redistributes from interphase nuclei to mitotic cytoplasm
To investigate the potential consequences of this hyperphosphorylation, the mitotic 
localization of endogenous NC2α was studied. Nocodazole blocked HeLa cells 
were fixed and incubated with the antibody against NC2α. DNA was stained with 
Propidium Iodide (PI) and cells were analyzed by confocal microscope (Fig. 19). As 
described before, immunofluorescent staining of NC2α in interphase cells is confined 
to the nucleus, with a finely speckled appearance. When the mitotic characteristic 
chromosome condensation has taken place and nuclear envelope breakdown 
has occurred, the mitotic cytoplasm is brightly stained, indicating that NC2 has 
redistributed throughout the mitotic cytoplasm. However, we cannot exclude that 
a minor part is still associated with mitotic chromosomes and overlooked in our 
immunofluorescence experiment because of the intensity of the staining of NC2α 
in the mitotic cytoplasm. 
2.7. NC2α remains associated with NC2β also in its mitotically phosphorylated 
state
NC2α and NC2β form a very stable heterodimer through their histone fold domain. 
To investigate the possibility that the mitotic hyperphosphorylation of NC2α can 
affect dimer formation, NC2 was immunoprecipitated with the NC2α ab from 
asynchronous, G1 and mitotic blocked HeLa WCE. As shown in Figure 20a, NC2β 
coimmunoprecipitates with NC2α in all three extracts, indicating that mitotic NC2 
remains intact. It is unlikely that NC2β coelutes exclusively with the weak interphase-
NC2α band visible in the M lane, since the intensities of NC2β in M and G1 lanes 
are comparable. If NC2β coeluted with the weak interphase NC2α band, it would 
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not be detectable in WB, due to the very low sensitivity of the NC2β antibody. 
Notably, NC2α is depleted from all the extracts (see FT), but NC2β is not, suggesting 
that NC2β could be in excess compared to NC2α (Fig. 20a and 20c).
In a similar experiment, we checked if TBP was also coimmunoprecipitating with 
NC2α. TBP is coimmunoprecipitated with NC2 only from the mononucleosome 
fraction and never from nuclear extracts or WCE (Gilfillan et al., submitted paper). 
Preliminary data indicate that the C-terminal acidic region of NC2α could make 
additional contacts with TBP (Gilfillan, unpublished data). Therefore, since most 
of the potential phosphorylation sites of NC2α are located in the tail, we asked 
if the mitotic hyperphosphorylation strengthens the new potential TBP interaction 
domain, promoting NC2-TBP contact already in solution. 
The WB membrane of the immunoprecipitation experiment was stained also with 
the TBP antibody (Fig. 20c). TBP never coimmunoprecipitated with NC2α, even in 
the mitotic WCE, suggesting that the addition of phosphorylated sites do not have 
appreciable effects on the interaction of the two proteins in solution.
2.8. Is M-NC2α excluded from the DNA?
2.8.1. Preparation of native NC2 and M-NC2 proteins for in vitro assays
The link between hyperphosphorylation and subcellular relocation of NC2α 
prompted us to investigate if the mitotic NC2 was still able to bind the DNA in 
a complex with TBP. This information can be obtained comparing the behavior 
of M-NC2 with that of the form observed in the other cell cycle phases. Native 
NC2 protein was immunopurified from WCE prepared from HeLa cells blocked in 
mitosis and interphase cells (i.e. asynchronous cells devoid of the mitotic ones, see 
Fig. 20b).
 
These two preparations were checked in WB to confirm that both subunits had 
been immunoprecipitated. As observed before, NC2β was detected in both samples 
(Fig. 20c). 
To estimate the concentrations of NC2 in the peptide elutions and equalize them 
with the recombinant protein, I and M endogenous NC2 were titrated with increasing 
amount of recombinant protein (Fig. 20d). From the WB, the concentration of the 
endogenous NC2 was estimated to be between 5–10ng/�l. In addition, the active 
NC2 concentration was calculated in EMSA (see methods).
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Figure 20. NC2α and NC2β remain associated following mitotic phosphorylation. (A) NC2α was im-
munopurified from asynchronous, G1 and M WCE. Immunoprecipitates were fractionated by SDS-
PAGE, blotted to nitrocellulose membrane and NC2α and NC2β were detected with the specific 
antibodies. NC2β coimmunoprecipitated with NC2α in all the extracts. (B) Flow cytometry analysis 
of the DNA content (PI) of Interphase (I) and mitotic (M) blocked HeLa cells (see methods). (C) Con-
trol Western Blot of the immunoprecipitation of NC2 from I and M WCE. Proteins were eluted first 
with a peptide and then with SDS buffer. Immunoprecipitation with an isotype unrelated ab (CAD9) 
was used as a negative control. The membrane was probed with the antibodies as indicated on 
the figure. NC2α is immunoprecipitated only with the specific ab. NC2β coimmunoprecipitates with 
NC2α in both extracts. TBP does not coprecipitate with NC2, even in the M extracts. (D) Analysis by 
immunoblot of the immunopurified I and M NC2 compared to recombinant protein. The blot shows 
increasing amounts of NC2 proteins. 2, 4 and 8 μl of native NC2 were used; 10, 20, 40, 80 and 160 
ng of recombinant NC2 protein were used. From the blot, the native I and M NC2 were estimated to 
be between 5-10 ng/μl. α ab = NC2α antibody; c ab = control antibody. FT = flow through.
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2.8.2. The mitotic NC2 maintains the ability to bind to TBP-promoter 
complexes
EMSA was used to compare the binding of recombinant, G1 and M native NC2 
populations to recombinant TBP and to DNA. Since G1 constitutes part of the 
interphase, these two phases can be considered equivalent in this contest. The DNA 
used for the assay was a 35bp [32P] labeled oligonucleotide containing the TATA box 
of the Adenovirus Major Late Promoter (35-AdMLP). Protein-DNA complexes were 
resolved on non-denaturing polyacrylamide gel and visualized by autoradiography. 
The same amounts of active protein for recombinant and endogenous NC2 were 
compared for binding ability. 
G1- and M-NC2 bind equivalently to TBP-DNA (Fig. 21a), suggesting that the 
extra charges acquired by phosphorylation during mitosis do not prevent NC2 from 
making stable contacts with TBP-DNA complex. This observation is surprising, 
because of the apparent subcellular relocation of NC2α to the cytoplasm during 
mitosis. 
Interestingly, complex formation is neither increased nor reduced when the native 
protein is used instead of the recombinant one, suggesting that phosphorylations 
of native NC2 does not affect its binding to DNA. 
2.9. Complex formation in a long DNA fragment: phosphorylation reduces 
affinity for DNA
To investigate the possibility that the mitotic hyperphosphorylation affects complex 
formation depending on the DNA, the binding ability of M-NC2α versus interphasic 
and recombinant NC2 was tested. EMSA experiments were performed keeping 
TBP constant, while NC2 was added in increasing amounts using different DNA 
templates. 
In a first experiment we used a long DNA template containing as before the 
TATA AdML promoter (217 bp long). In contrast to the previous observations, 
the endogenous NC2 and M-NC2 proteins showed lower binding ability than the 
recombinant one (Fig. 21b). Compared to recombinant NC2, almost 3-times more 
native protein was necessary to bind the same fraction of DNA (140 fmol vs. 40 fmol, 
respectively; compare lanes 9 and 13 versus 5), indicating that phosphorylation 
reduces affinity.
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Figure 21. TBP-DNA binding ability of M-NC2 versus I- and reconbinant- NC2. between NC2 pro-
teins. (A) Electro mobility shift assay (EMSA) performed using a DNA oligo of 35 bp containing the 
Adenovirus Major Late Promoter (35 bp AdML). Three different NC2 preparations at increasing 
amounts (20, 60, 180 fmol) were compared for binding ability to TBP-DNA complexes: recombinant 
NC2, G1 and M endogenous NC2. All lanes contained 38 ng of hTBP and 100 fmol of DNA. M NC2 
shows the same complex formation ability of G1 and recombinant NC2. (B) EMSA with longer DNA 
fragments (217 bp) containing the Adenovirus Major Late Promoter derived from the pB2-MLP vec-
tor. Again, increasing concentrations of the three different NC2 preparations (30, 60, 120, 350 fmol) 
were compared for binding ability to TBP-DNA complexes. All lanes contain 100 fmol and 5 ng of 
yTBP (except the first line, where yTBP is absent).  Both native proteins showed lower binding abil-
ity than the recombinant. Several bands are observed corresponding to different NC2-TBP-DNA 
complexes, depending on the number of NC2-TBP bound to the fragment. (C) EMSA was per-
formed with proteins amounts described in B, but using as a template ca. 100 fmol of DNA, contain-
ing a nucleosome in the middle (see methods). Increasing amount of M NC2 (and I NC2) does not 
correspond to an augment in binding, in contrast to what observed for recombinant NC2.
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2.10. Complex formation in a nucleosome template
We also tested binding to in vitro reconstituted nucleosome-DNA, which contained 
the nucleosome in the middle of the fragment. Figure 21c shows that binding of 
recombinant protein is proportional to its amount, whereas this positive correlation 
is not observed for the endogenous proteins, whose binding ability is constant.
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Figure 22. The mitotic hyperphosphorylation of NC2 does not affect stability of NC2-TBP-DNA 
complex. (A) Kinetic analysis of NC2-TBP dissociation. EMSA was performed with 350 fmol (25 
ng) of yTBP, 10 fmol of recombinant NC2 and 20 fmol of labeled DNA oligo of 35 bp containing 
the Adenovirus Major Late Promoter (35 bp AdML). NC2, yTBP and DNA were pre-incubated for 
30 min at 28 °C. Then, an excess (5000x) of cold competitor 35 bp Ad-ML promoter oligonucle-
otide was added to the reaction and incubated at 28 °C for 15 min (lanes 2, 6, 10), 30 min (lanes 
3, 7, 11) and 60 min (lanes 4, 8, 12). As a control, samples were incubated for 16 min in absence 
of competitor DNA (lanes 5, 9, 13). After 1 h of incubation with competitor DNA, 40% of DNA is 
still bound, compared to the control, independently from the NC2 preparation. (B) EMSA was 
performed as described in panel A, but using as labeled DNA a long fragment (217 bp) derived 
from pB2-MLP vector (kindly provided by M. Timmers). After 1 h incubation with competitor DNA, 
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2.11. NC2-TBP-DNA complex is more stable in the long DNA, independently 
from the phosphorylation state
Next, we asked if the stability of the complex was affected by the mitotic 
phosphorylation. To test if NC2 phosphorylation can affect the dissociation rate and 
the stability of the complex, competition experiments with EMSA were performed. 
Recombinant and native NC2 were incubated with hot DNA and TBP for 30ʼ, and 
then an excess (5000x) of cold competitor 35bp AdML was added. After incubation 
for increasing time points, the samples were loaded on a gel. Two different labeled 
DNA templates were used: a short 35bp and a longer AdML promoter fragment. 
With the short DNA, the half-life of the complex was estimated to be around 30ʼ 
(Fig. 22a). In contrast, when the template was the long DNA fragment, ca.85% of 
the complex was still bound even after 1h (Fig. 22bb). Thus, in the long DNA the 
complex is more stable than with short DNA. Recombinant and native NC2 behaved 
identically, suggesting that phosphorylation does not influence dissociation of the 
trimeric complex. 
3. The role of phosphorylation of NC2 on complex mobilization 
3.1. NC2 mobilizes TBP on DNA
Previous work showed that recombinant NC2 and TBP protects the TATA-box of a 
HIV-1 promoter DNA from DNaseI digestion (Goppelt et al., 1996; Kim et al., 1996). 
The footprint pattern in the presence and absence of NC2 is very similar, with minor 
differences seen at the border of the protected region (Goppelt). Similar effects 
have been described in the case of the AdML-Promoter (J.Kim et al., 1996).
Yet, the role of phosphorylation was not studied in this contest. 
On the coding strand of an AdML-Promoter DNA, TBP protect a window surrounding 
the TATA box (Fig. 23a lane 1 versus 2). This window was gradually converted to an 
unprotected region upon addition of increasing amount of NC2 (lane 2 versus 8). 
The EMSA experiment, made in parallel with aliquots of the samples not digested 
with DNaseI, argues against a dissociation of TBP-NC2 from the DNA (Fig. 23a 
bottom panel). In fact, bands corresponding to the trimeric complex DNA-TBP-NC2 
are always visible. These bands increase gradually up to lane 7 and then decrease 
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(compare lane 8,9 versus 6). This could be explained supposing that when present 
in excess, NC2 complexes with itself in solution, resulting in an NC2-NC2 tetramer 
that sequesters some NC2 from binding to the DNA.
The disappearance of the protected region, and the concomitant presence of higher 
order complexes on the DNA, strongly indicates that NC2 moves TBP from the 
TATA box, but does not dissociate from the DNA. Moreover, the absence of other 
protected regions suggests that the mobilized TBP-NC2 does not have preferences 
for other sites.
To further investigate this phenomenon, a time course experiment was performed: 
TBP was first incubated with the DNA at 28°C and then the reaction was incubated 
at 4°C together with NC2 at different time points (Fig. 23b). The appearance of 
hypersensitive sites upon addition of NC2 is observed already after 30sec, indicating 
that TBP mobilization is fast.
3.2. At 4 °C NC2 confers to TBP a certain preference for binding
In a different footprint experiment, all the incubations were done at 4°C and both 
TBP and NC2 were titrated (Fig. 23c). At the lowest NC2-TBP concentrations, 
the pattern of hypersensitive sites is almost identical to the control lane. At very 
high NC2-TBP concentrations, several protection windows appeared, in a manner 
dependent on both proteins (lanes 5 versus 6, 7 and 12 versus 13,14). Thus, while 
footprints performed at room temperature show that NC2 mobilizes TBP from TATA 
box, low temperatures confer to TBP preference for certain sites. 
Figure 23 (previous page). Mobilization of TBP by NC2. DNAseI footprinting analysis of NC2 and 
TBP. (A) Increasing amounts (as indicated, in fmol) of recombinant NC2 were added to 350 fmol of 
yTBP that was preincubated for 30 min at 28 °C with approximatively 100 fmol of a 217 bp Ad-ML 
fragment, labeled by PCR using radioactively labeled primers (top panel; see methods). In paral-
lel, EMSA analysis was performed, where 25% of the reactions were loaded on native gels before 
addition of DNAseI (bottom panel). Increasing amount of NC2 correspond to disappearance of the 
protected TATA region. Although mobilized, NC2-TBP complexes are still bound to DNA, as shown 
in EMSA (bottom panel). (B) Time course of TBP mobilization from TATA. 350 fmol TBP were incu-
bated with the DNA, and then 400 fmol of NC2 were added to the reaction for increasing time points 
(30 sec and 3, 6, 15, 40 min). Mobilization of TBP by NC2 is observed already 30 sec after NC2 
addition. (C) Footprinting analysis of NC2-TBP at 4 °C. Ad-ML promoter fragment (pB2 MLP-Small) 
was preincubated with TBP (60, 140, 350 and 700 fmol) for 30 min at 28 °C, followed by addition of 
NC2 (125, 250, 500 and 1000 fmol) and subsequent incubation for 30 min on ice and DNAseI digest 
(30 mg for 30 sec). Only at high NC2-TBP concentrations, some protection windows appear.
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Figure 24. The mitotic hyperphosphorylated NC2 mobilizes TBP. (A) Footprinting analysis was per-
formed with the same conditions described in Figure 23, using increasing amount of recombinant 
and endogenous NC2 from I and M blocked cells (60, 120, 350 fmol). Both recombinant and native 
NC2 mobilize TBP on the DNA. (B) Footprinting analysis was performed reproducing the experi-
ment in Fig. 23b, but using recombinant and endogenous NC2 (250, 500, 1000 fmol). At high NC2 
concentrations, the M NC2 and the I NC2 still do not produce the protected regions observed for 
the recombinant NC2-TBP complex. 
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3.3. Recombinant and native NC2/M-NC2 behave differently in footprint 
Next, we asked if the mitotically hyperphosphorylated NC2 and phosphorylation in 
general influenced TBP mobilization by NC2.
In a footprint experiment done at room temperature, the addition of increasing 
amount of recombinant NC2 to TBP-DNA causes the disappearance of the protected 
window corresponding to TATA. Equal active protein concentrations of recombinant 
and native NC2 were compared in the same assay: at the highest concentrations, 
both recombinant and native NC2 cause the disappearance of the TBP-protected 
window (Fig. 24a). This was in contrast to the EMSA performed in parallel to the 
footprint: three times more native protein is necessary to reach the same binding 
observed for recombinant protein (Fig. 21b). Again, the two native proteins had the 
same behavior.
When the foortprint was performed at 4°C, a notable effect of phosphorylation 
became evident (Fig. 24b). As seen before in the footprint at 4°C, in the presence 
of recombinant NC2, TBP-NC2 shows a preference for certain sites and makes 
several windows on DNA. In contrast, the windows are only weakly detectable 
with the endogenous protein. Also in this case, the EMSA done in parallel to the 
footprint confirmed the different DNA binding ability of TBP-NC2 containing the 
native protein (Fig. 24b bottom panel). No significant difference was detected 
between I-NC2 and M-NC2.
4. Identification of NC2 isoforms
Post-translational modifications (PTMs) can change the protein properties by 
proteolic cleavage or by addition of a modifying group to one or more amino acids. 
In particular, PTMs can determine the protein activity state, localization, turnover, 
and interactions with other proteins. 
As shown before, there is evidence that both NC2 subunits are phosphorylated in 
vivo and in vitro, in agreement with previous studies that did not characterize in full 
detail the modification sites (Inostroza et al. 1992; Goppelt et al. 1996; Creton et 
al. 2002).
To increase our knowledge on this process, we performed two-dimensional gel 
electrophoresis (2D gel) to estimate the number of NC2 phosphorylation events. 
2D gel electrophoresis separates protein populations on the basis of (i) charge 
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and (ii) molecular weight. If a protein is phosphorylated, the resulting change in its 
charge usually produces a horizontal trail of protein spots. 
The aim was to study: 
(i) the normal in vivo phosphorylation state of NC2; (ii) the hyperphosphorylation 
characteristic of mitosis; and (iii) the phosphorylation events following cellular signals, 
since both proteins (subunits alfa and beta) contain potential phosphorylation sites 
for the protein kinase C (PKC), a kinase activated upon stimulation of the cells with 
phorbol myristate acetate (PMA). Among the potential PKC sites, NC2β contains 
two particularly interesting ones (serines 105, 106), located between the DNA 
and the TBP interaction domains. Phosphorylation at these sites could produce 
repulsion with the DNA backbone and destabilize the NC2-TBP-DNA complex in a 
signal dependent manner. 
beads
Figure 25 (continues form previous pages). Both NC2α and NC2β have several isoforms. 2D elec-
trophoresis analysis of NC2. Each gel was loaded with NC2 immunopurified from WCE of three 
different populations: asynchronous (async), asynchronous + PMA stimulation (for 30 min before 
harvesting; async+PMA), and mitotic blocked (M) Jurkat cells. As a control, the asynchronous WCE 
were also incubated with a column with bound an antibody of the same isotype than the NC2α ab 
that does not recognize any protein in the WCE (c async). Proteins were resolved using isoelectric 
focusing (pH 4-7) and 13% SDS-PAGE. The migration of molecular mass standards (kD) is indi-
cated on the right of the panel. Proteins were visualized by silver stain. NC2β spots are indicated by 
black arrows, the NC2α ones by red arrows.
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Since direct analysis of modifications requires isolation of a large amount of correctly 
processed protein, we used Jurkat cells, which could be grown in large numbers. 
Large scale preparations of Jurkat WCEs were prepared from asynchronous cells 
(stimulated or not with PMA; async-PMA and async, respecvively), and M blocked 
cells. Aliquots of these cultures were checked in flow cytometry analysis to record 
the status of the cells.
2D gels can be performed with cell lysates, but it is often advantageous to reduce 
the complexity of the mixture and increase the amount of the protein of interest 
before loading it onto the gel. Therefore, NC2 was purified from the extracts via 
immunoprecipitation with an antibody directed against the NC2α subunit (4G7). 
As a control, extracts were incubated with an isotype ab before the NC2α specific 
ab. Then, the bead coupled with the isotype and the one with the specific antibody 
were washed and NC2 was eluted with urea buffer compatible with 2D gel system. 
Small aliquots of the elutions were checked in WB to confirm that NC2 had been 
depleted from the extracts and eluted from the specific antibody but not from the 
isotype one. To control the quality of the immunoprecipitation, an aliquot of the 
proteins contained in the elutions was separated by SDS-PAGE and stained with 
silver stain. In general, the purity of the elution was not high, probably due to the 
low stringent conditions of the washes (150 mM KCl). 
The immunoprecipitations were finally analyzed by 2D gel (Fig. 25). Since the 
purity of the samples was not high, three 2D gels were run in parallel from the same 
probe, one containing 80% and the other two 10% each of the total material. While 
the first gel was used for the silver staining, the others were blotted in a PVDV 
membrane and stained with the NC2α and NC2β antibodies, in order to recognize 
the specific NC2 spots. The immunoprecipitates were resolved in the first dimension 
by isoelectric focusing in a pH range from 4 to 7, and in the second dimension by 
SDS-PAGE (T=13%, C=3%). 2D gels were made from the three specific probes: 
async, async-PMA, M elutions. In addition, we ran 2D control gels also of (i) the 
elution of the async WCE immunoprecipitated with the isotype antibody; (ii) the 
elution of the beads coupled with the antibody (light chain); (iii) recombinant NC2 
protein. Comparing the 2D silver stain with the corresponding 2D WB allowed 
distinction the NC2α and NC2β specific spots from the other proteins. 
4.1. NC2α and NC2β have different isoforms 
Both subunits showed several isoforms. NC2α resolved as one molecular mass 
species, but at least four distinct isoelectric points were recognizable, in both the 
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asynchronous and the PMA stimulated cells (Fig. 26). Moreover, an additional 
distinct isoelectric point was observed in the M cells. 
These data clearly demonstrate the presence of several forms of NC2α, and 
strongly confirm the findings of the previous experiments, pointing to the existence 
of a mitosis specific form of NC2α. 
Surprisingly, NC2β resolved as four molecular mass species and at least seven 
different isoelectric points, four of which were visible as clear big spots (n.1, 2, 3 
and 4 in Fig. 26). Presumably, the NC2β observed as a single band in a standard 
WB corresponds to the series of the three big spots n.2, 3, and 4: these are likely 
three differentially phosphorylated forms of the protein, with small isoelectric shift. 
The silver stain suggests that spot n.4 is as abundant as the three previous ones, 
with the difference in size pointing to a deletion form of NC2β. Interestingly, this 
form is not observed in normal 1D gel/WB with antibody stain, likely because, in 
comparison, the 2D gel/WB have a very high protein amount. A new potential high 
mobility NC2β form had already been observed marking NC2 with radioactivity, a 
very strong label compared to antibodies (compare with Fig. 18d). 
The other NC2β spots (n.5, 6, 7) have not been observed before, but they are 
present in each of the three preparations, arguing against an artefact. The spot n.7 
has same molecular weight but different PI than n.1, suggesting that it could be the 
corresponding phosphorylated form. The spot n.6 could correspond to a form even 
shorter than the spot n.1. Finally, the spot n.5 has a size that could correspond to 
a NC2β dimer. 
PMA stimulation does not seem to change the phosphorylation state of NC2, since 
the same pattern of spots is observed in the async and PMA gels/WBs for both NC2α 
and NC2β. This does not necessary exclude that Ser 105-106 are phosphorylated, 
since they could be modified by a constitutively active kinase instead of PKC or be 
rather unstable or underrepresented. 
Figure 26 (previous page). 2D Western Blot analysis of NC2α (upper panel) and NC2β (bottom 
panel). Three gels were run in parallel from each of the three samples (async, async+PMA and M); 
two of them were transferred to a PVDV membrane and immunostained with either NC2α or NC2β 
antibodies. The migration of molecular mass standards (kD) is indicated on the right of the panel. 
NC2α resolved as one molecular mass species, but at least four distinct isoelectric points were 
recognizable, in both the async and the async+PMA. The mitotic extract clearly shows an additional 
distinct isoelectric point. Seven different points were recognized by NC2β ab (numbered 1-7): spots 
2-4 correspond to the band normally observed in WB. 
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4.2. Mapping of the phosphorylation sites of NC2β 
The silver stain gels were further processed for the matrix-assisted laser desorption/
ionization (MALDI)-TOF analysis of the spots, to map possible protein modifications. 
A theoretical approach using a motif-finder database (Expasy) identified several 
putative phosphorylation sites in both NC2α and NC2β (Fig. 2b). The analysis 
of the peptides obtained by in silico digestion of NC2α and NC2β showed that 
none of the commonly used chemicals or proteases gives a suitable pattern of 
peptides for NC2α, since none of the digestions was able to cut the C-terminus, 
which contains most of the phosphorylation sites. On the contrary, NC2β digestion 
with Glu C resulted in a set of peptides with suitable size and covering all the 
mass position peptide sequence 1 2 3 4 5
768.2828 1-8 MASSSGND OH P P OH/P OH/P
1597.9458 11-24 LTIPRAAINKMIKE NOT PHOSPHORYLATED
1098.5902 25-34 TLPNVRVAND - - - - -
880.3903 38-45 LVVNCCTE - - - - -
945.5040 46-53 FIHLISSE NOT PHOSPHORYLATED
693.3236 57-62 ICNKSE - - - - -
802.4669 63-69 KKTISPE - - - - PP?
809.4515 70-76 HVIQALE UNMODIFIED
1059.4993 77-86 SLGFGSYISE P P P P P
1846.0803 94-109 CKTVALKRRKASSRLE - - - - -
900.4309 110-117 NLGIPEEE UNMODIFIED
914.5054 118-124 LLRQQQE + + + + -!
1289.6960 125-135 LFAKARQQQAE UNMODIFIED
588.2987 136-140 LAQQE - - - - -
3205.4450 141-171 WLQMQQAAQQAQLAAASASA
SNQAGSSQDEE
- - - - -
Table 1. Fingerprinting analysis of the NC2β isoforms. Spots 1-5 identified as NC2β in the 2D WB 
(Fig. 27, bottom panel) were cut from one gel (async + PMA), digested with Glu C and analyzed my 
mass spectrometry. All five spots were confirmed to be NC2β. Only few of the expected peptides 
were identified by MALDI-TOF. Two peptides were phosphorylated at one site. Mass is expressed 
in Dalton. Position is relative to NC2β sequence. The list reports the peptides expected after digest 
of NC2β with GluC; bold-underlined residues are the potential phosphorylation sites. Numbers 1-5 
correspond to the spots of the gel async + PMA in Figure 27, bottom panel. – = undetected peptide. 
UNMODIFIED = peptide detected without modification. P = peptide detected as phosphorylated at 
one site. OH = peptide detected as unphosphorylated.
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potential phosphorylation sites (Tab. 1). Therefore, five of the spots identified in WB 
as NC2β were cut from the gel, digested with the Glu C and analyzed by MALDI-
TOF (spots n.1-5 in Fig. 26). The experimentally determined peptide masses 
were matched against those expected from the protein sequence. Only part of the 
expected peptides was detected, and the peptide containing the serines 105-106 
was not among them. Most of the peptides were unmodified, but few were found 
carrying a phosphorylated residue (Tab. 1). The most interesting findings are that 
(i) the peptide 1-8 contains 1 phosphorylated serine (out of the three present in this 
stretch), probably serine 5, as it was also identified as potential CKII phosphorylation 
site; (ii) neither of the 2 serines of the peptide 46-53 is phosphorylated. (iii) Peptide 
63-69 might have two phosphorylated sites; (iv) the peptide 77-86 contains 1 
phosphorylated serine (out of the three present in this stretch), and serine 77 is the 
best candidate because identified as a potential phosphorylation site.
The only differences observed among the five spots are: (i) the first peptide has 
one serine that is phosphorylated in all the five spots except the n.1; (ii) the mass 
spectrum of spot 5 was identical to those of the other spots, although peptide 
Figure 27. Identification of proteins coimmunoprecipitating with NC2. (A) Computer densitometry 
analysis. The digitalized images of 2D gels made from three samples (async, async+PMA and M; 
see Fig. 25) were compared with the control gel (c Async).  The proteins coimmunoprecipitating 
exclusively with NC2 were recognized after subtracting the spots present in the control gel. These 
proteins correspond to the numbered spots in the gel, and are listed in Table 2. 
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118-124 was not identified. Beside that, no significant difference was observed 
among these five isoforms, suggesting that the observed isoform heterogeneity 
must reside in the unidentified peptides. 
5. Search for potential NC2 interactors 
Next, we wanted to determine the identity of the proteins coeluted with NC2α. A 
computer densitometry analysis was performed, in which the intensity of the spots 
present in the async, PMA, and M gels was compared to those in the control one 
(made with async extracts incubated and eluted with the isotype antibody). The 
analysis revealed 20 spots present exclusively in the NC2α IPs (Fig. 27 and Table 
2). Of those, 4 belonged to the light chain of the antibody and other two were NC2β 
isoforms (the spots 6 and 7 identified in the 2D WB). The remaining spots were 
cut and processed for the MALDI-TOF analysis. All the spots were identified, and 
the list of the corresponding proteins is reported in Table 3. None of the identified 
protein seems related to the transcription process and thus to NC2. Interestingly, 
four spots are specific for mitosis, suggesting interactors specific for the mitotic 
hyperphosphorylated form of NC2α. 
Intensity of the significant spots
Spot ID Control Mitotic PMA log
76 9.9 51.7 38.5 28.5
80 7.4 23.4 13.1 13.8
81 11.9 100.8 112.5 114.8
112 N.A. 54.8 51.9 150.3
120 N.A. 153.9 242.1 180.6
128 N.A. 70.3 85.0 68.2
132 N.A. 665.6 162.5 132.2
137 N.A. 146.7 78.4 163.5
144 N.A. 38.0 42.5 44.0
171 N.A. 32.3 42.8 48.2
177 N.A. 873.1 440.2 238.4
186 N.A. 72.9 77.1 60.9
201 N.A. 51.3 38.9 28.0
204 N.A. 35.6 29.1 25.9
210 N.A. 114.6 81.1 75.3
312 N.A. 333.1 102.9 N.A.
347 N.A. 1086.1 442.8 279.9
433 N.A. 42.6 N.A. N.A.
510 N.A. 46.6 N.A. N.A.
522 N.A. 40.9 N.A. N.A.
Table 2.
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In another experiment NC2 was immunopurified from HeLa nuclear extracts. The 
proteins coeluted with NC2 were separated on SDS-gel and analyzed by mass 
spectrometry. The conditions for the IP used in this experiment were slightly different 
from the previous one. The extracts were first incubated with beads coupled to 
an isotype antibody (HA) and next with beads coupled to the NC2α monoclonal 
antibody, but then only the beads binding the specific antibody were washed and 
eluted. Moreover, NC2 was eluted from the antibody with a peptide matching the 
epitope of the ab. Thus, this IP was eluted more specifically, but on the other hand a 
control isotype was missing. Although the preparation checked in SDS-PAGE silver 
stained looked very cleaned, the mass spectrometry analysis identified around 30 
different proteins coeluting with NC2. Only few proteins are related to transcription, 
like the TAFII68, Bcl3 and p105. An aliquot of the same NC2 preparation used for 
the MS analysis was used for checking in WB if these proteins were also recognized 
by the specific antibodies. Bcl3 and p105 were in fact confirmed, whereas TAFII68 
was not reconfirmed. However, since the control IP with the isotype antibody was 
missing, these proteins could be NC2 interactors as well as contaminants. A single 
protein was identified in both the experiments, BiP, also known as Heat-shock 70kD 
protein-5, or glucose-regulated protein, 78kD.
Further studies will be necessary.
n. spot MW Proteins
80 62 Hypothetical protein DKFZp586G0322.1 (fragment)
81 34 Ribosomal protein P0
120 35 Dermal papilla derived protein 6 (DERP6)
128 61 Chaperonin (HSP60)
144 82 Unnamed protein product (Homo sapiens)
171 30 TRAF4 associated factor 1
186 64 HSPA8 protein
210 71 BiP protein
433 64 Chain B, crystal structure of the Ku heterodimer
510 71 Nuclear factor IV
522 70 Thyroid autoantigen 70kD (Ku antigen)
Table 3. Peptide mass fingerprinting of the spots coimmunoprecipitating with NC2. The table list the 
spots identified by MALDI-TOF proteins.
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III. DISCUSSION
1. Localization of NC2
1.1. Identification of nuclear localization signals (NLS) in both NC2α and 
NC2β 
In this study we provided evidence for the presence of nuclear localization signals 
in both NC2α and NC2β. 
NC2α contains a bipartite N-terminal NLS (4-KKKKYNARFPPARIKKI-20), which 
includes two highly positively charged motifs spaced by 8 amino acids. It is 
noteworthy that the acidic residues of the second motif (R16, K18 and K19) are 
involved in DNA contacts, and also in protein dimerization. These amino acids 
are conserved in all eukaryotes, while the first acidic motif (K4-7) is conserved in 
metazoans, but not in yeast (see Fig. 3). Unexpectedly, mutation of the second 
NLS (R16A/K18A/K19A) affected NC2α import less than mutation in the first one 
(K4A/K5A/K6A/K7A). Moreover, both NC2 subunits were partially retained in the 
cytoplasm when the first was mutated, while mutations in the second NC2α NLS 
resulted in a nuclear distribution of the dimer comparable to the control. This finding 
indicates that the first motif is not only the strongest import signal for the single 
subunit, but is also necessary for the import of the dimer. In contrast, the second 
stretch participates only in the import of the single subunit. 
In general, the position of an NLS in the transported protein is important for signaling 
function (Roberts et al. 1987; Nelson and Silver 1989). For example, insertion of 
the NLS of the SV40 T antigen in the buried hydrophobic domain of the pyruvate 
kinase, produces a non-nuclear protein (Roberts et al. 1987), indicating that the 
NLS must be exposed on the surface of the protein to interact with components of 
the import machinery. Since the crystal structure of NC2 in a complex with TBP-
DNA has been resolved, it is possible to predict if the sequences encompassing 
the NLS are exposed. Interestingly, the first part of the NC2α NLS is immediately 
adjacent to the histone fold domain (HFD), which is responsible for dimerization 
of the two subunits, whereas the second motif is inside it (Kamada et al. 2001). 
Therefore, the second motif is not exposed when the two NC2 subunits dimerize, 
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explaining why it may play a role only in the transport of NC2α alone. Moreover, 
the spacer between the two motifs contains two prolines residues that introduce 
a bend immediately before the first helix of the HFD and cause the first 10 amino 
acids to stick out from the histone fold, facilitating the exposure of the NLS.
Immunofluorescence analysis of successive deletion constructs of the NC2β 
subunit located an active NLS in the sequence between amino acids 80-112. The 
putative NLS corresponds to a single stretch of positive amino acids (100-KRRK-
103). Mutation of the two central positive residues of this sequence (R101A/R102A) 
had a minor effect on import of NC2β alone, but it did retain some NC2 dimer in 
the cytoplasm. NC2β NLS is located at the end of helix4, which is involved in DNA 
binding, but not in intermolecular interactions. Thus, this sequence is likely to be 
exposed to the surface of the protein also in the dimer. 
To support our experimental results, we used a protein-sequence analysis program 
named PSORT (Nakai and Kanehisa 1992), which identifies NLS based on the 
presence of a certain number of basic amino acids (Hicks and Raikhel 1995). 
Analysis of NC2 sequences with PSORT recognized our potential nuclear import 
sequences as the only NLS in both subunits. Interestingly, the NLS identified in 
NC2 do not match any of the 91 experimentally verified NLS found in the literature 
and used to construct the PredictNLS prediction server (Cokol et al. 2000). Hence, 
the NC2 NLS could be different and thus be important for NLS identification in other 
proteins. 
The finding that both NC2 subunits carry a NLS indicates that NC2 is imported in 
the nucleus via the classical import mechanism. This is based on recognition of 
the cargo by the heterodimeric importin receptor, which consists of the importin- 
α and importin-β subunits (Gorlich 1997). Importin-α binds directly to the NLS, 
whereas Importin-β targets the import complex to nuclear pores. To investigate 
this hypothesis, we tested the ability of the importin-α receptor to recognize NC2, 
incubating the GST-importin-α bound to a column with some recombinant and 
endogenous immunopurified NC2. Interestingly, preliminary data showed that both 
subunits, from either recombinant or endogenous NC2, were pulled down (data not 
shown). Also the mitotic hyperphosphorylated form of NC2α was recognized from 
the importin-α, but it was not possible to establish if the two forms were recognized 
with the same strength. 
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Yeast NC2α contains only the C-terminal motif of the NLS, which in human cells is 
effective in the import of the single subunit but not of the dimer. Moreover, yeast NC2β 
does not have the NLS identified in human and conserved in most of metazoans, 
nor does it contain other positively charged stretch that could substitute for it. This 
suggests that yeast NC2 may enter via diffusion or has a different mechanism of 
import than metazoans, perhaps via co-transport with other nuclear proteins.
1.2. Both the NC2α and NC2β NLS overlap with DNA-binding regions
Positively charged amino acids are important not only for the binding of a cargo 
to the import machinery, but also for DNA interaction. The observation that DNA-
binding region and NLS-function overlap was initially made by LaCasse and 
Lefebvre (LaCasse and Lefebvre 1995). Later, a more extensive analysis of the 
proteins whose NLS and DNA-binding region were known, revealed that the two 
motifs overlapped for 90% of the proteins (Cokol et al. 2000). The colocalization of 
NLS and DNA binding regions might be related to the evolution of the eukaryotic 
system from the prokaryotic one. With the development of a nuclear membrane, 
which separates cytoplasm from nucleoplasm, the cells had to adopt a system 
to concentrate the nuclear proteins in this compartment. Since the DNA binding 
region is an exclusive and common motif among nuclear proteins, it is likely that 
evolution favored this motif as target of the import machinery, thus concentrating 
two functions in a single sequence. Consistent with this hypothesis, the NLS of 
NC2β and the 2nd acidic stretch of the NLS of NC2α coincide with DNA-binding 
regions. The establishment of an additional NLS in NC2α may be to promote 
efficient import of the dimer. 
1.3. NC2β contains a potential nuclear export signal (NES)
Nucleo-cytoplasmic shuttling of transcription factors is an active process that 
relies on the recognition of their nuclear localization and/or export signals (NLS 
and NESs, respectively) by proteins of the nuclear import and export machinery 
(Hood and Silver 1999). Protein export from the nucleus is often mediated by a 
Leucine-rich Nuclear Export Signal (NES). Recently, a database for NESs has been 
created, which collects experimentally validated Leucine-rich NESs (la Cour et al. 
2004). Submission of NC2 sequences to this database indicated that NC2 does not 
contain a known NES. However, a manual examination for the generally accepted 
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NES consensus L-x(2,3)-[LIVFM]-x(2,3)-L-x-[LI] (Bogerd et al. 1996), revealed a 
similar sequence in NC2β. This sequence is localized between the amino acids 
99-LKRRKASSRLENLGI-113 and matches the C-terminal part of the consensus 
sequence (LENLGI = [LIVFM]-x(2,3)-L-x-[LI]). Many of the identified Leucine-rich 
NESs deviate significantly from the generally accepted loose consensus, although 
there are some preferences. A mutational study of the NES of the PKI protein 
indicated that the leucines in the C-terminal end of the signal are more important 
for function than the N-terminal ones (Wen et al. 1995), as confirmed from the high 
conservation of the C-terminal hydrophobic residues within a set of experimentally 
characterized NESs (la Cour et al. 2003). Consistent with that, the C-terminal -
LENLGI- motif of the hypotetical NC2β NES matches the consensus NES, and 
these amino acids are conserved from C. elegans to H. sapiens. 
In contrast, the first part of the potential NC2β NES diverges from the consensus 
sequence [L-x(2,3)]: after the first lysine, NC2β contains the NLS plus two 
serines (-LKRRKASSR-), instead of 2,3 random residues. Interestingly, sequence 
alignment of different NES shows that serines, lysines and arginines are tolerated 
mainly after the first lysine, which is exactly the position of the NLS in NC2β. The 
possibility that NC2β contains its NLS inside the NES is quite intriguing. There is 
currently no functional evidence for the existence of a NES in NC2β, although the 
observation that NC2β localizes also in the cytoplasm, whereas NC2α accumulates 
exclusively in the nucleus, could support this possibility. Interestingly, the NLS is 
followed by two serines, which are potential phosphorylation sites. Many important 
regulatory proteins, including cell cycle regulators and transcription factors, contain 
a phosphorylation site within or adjacent to a classical NLS (Jans 1995; Hood and 
Silver 1999; Jans et al. 2000). Usually dephosphorylation exposes one or more NLS 
and induces nuclear import (e.g. NFAT; Zhu et al. 1998), whereas phosphorylation 
leads to the exposure of an NES resulting in nuclear export mediated by the 
exportin protein Crm1 (e.g. NFAT; Zhu et al. 1998; Zhu and McKeon 1999; Macian 
et al. 2001. FKHRL1, a Forkhead family of transcription factors; Biggs et al. 1999; 
Brunet et al., 1999; Brunet et al., 2001a). It is possible that the hypothetical NC2β 
NES is activated after phosphorylation of the serines, whose negative charge can 
neutralize the positive charges of the NLS and unmask the NES. Modification of 
one or two serines could define two forms: one competent for nuclear import (serine 
unphosphorylated) and one recognized by an export factor (serine phosphorylated). 
Moreover, the NLS coincides with a DNA binding region and is followed by the TBP 
interaction domain (aa 113-133). The two serines (105-106) reside between these 
two domains: phosphorylation of these residues could release NC2 from the TBP-
DNA complex, due to the repulsion with the negative charges of the DNA, and at 
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the same time unmask the NES, leading to export of the NC2β subunit. 
These serines are phosphorylayion sites for CKII, PKA and, more interestingly, 
PKC (see Fig. 2b). In contrast to CKII and PKA, which are constitutively active 
kinases, PKC is activated upon phorbol ester stimulation. It could be that one or two 
of these serines residues are phosphorylated in certain conditions, and promote 
dissociation and export of NC2. 
To test the hypothesis that phosphorylation at these residues can promote export 
of NC2β, the two serines were mutated into alanine, a neutral amino acid, or into 
aspartate, to mimic the negative charge acquired by phosphorylation, and the 
resulting mutants were tested in immunofluorescence. Mutants and wt protein had 
the same localization, with the protein accumulating in the nucleus in both cases, 
suggesting that an eventual phosphorylation at these residues did not affect protein 
localization. Recently, it has been shown that phosphorylation at a site adjacent to 
an NLS decreases the binding affinity of the NLS for the importin-α (Harreman et al. 
2004). Interestingly, in this paper the authors substituted a serine at the N-terminal 
of an NLS with glutamate, whose negative charge is more exposed than aspartate, 
and they did not observe a clear cytoplasmic retention of the mutant, except when 
they used a yeast strain whose importin-a is defective in the import of NLS cargoes 
(Harreman et al. 2004)). This result would suggest that phosphorylation of serines 
105-106 in NC2β could affect the functionality of the NLS or activate a potential NES, 
although we did not see a clear effect in our immunofluorescence experiments. 
Perhaps one should mutate the serines into glutamate to see an effect or use also 
in vitro assays measuring the strength of the interaction between the cargo and the 
importin-a or the exportin protein Crm1.
1.4. Import and dimerization
NC2α and NC2β exert their function of transcriptional repressor as a dimer. Both 
subunits contain a histone fold dimerisation domain similar to the histones H2A 
and H2B, through which they form the stable dimer. Hence, the discovery that both 
subunits contain an NLS was intriguing because this suggested two possible ways 
of import: (i) both subunits enter into the nucleus alone, where they finally dimerize; 
(ii) the proteins dimerize in the cytoplasm, as soon as they are translated, and only 
then they are imported into the nucleus (see Fig. 11a). 
Interestingly, we found that when both subunits are overexpressed and thus 
simultaneously present in the cytopolasm, they are both retained in the cytoplasm 
whenever one lacks a functional NLS, even though the other had the ability to 
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enter the nucleus alone. This clearly indicates that, whenever NC2α and NC2β are 
expressed at the same time, (i) they dimerize immediately in the cytoplasm and 
they are imported into the nucleus as a dimer; (ii) both NLS are essential for the 
dimer to enter the nucleus. However, these findings do not exclude that a certain 
amount of the subunits can be imported separately. 
1.5. Localization of NC2α in the nucleoli: site of storage in conditions where 
NC2α is more abundant or mechanism to regulate NC2 transcriptional 
repression activity?
Endogenous NC2α localizes in the nucleoplasm and, in most cells, is excluded from 
the nucleoli. However, when HeLa cells were transfected with NC2α constructs, 
the overexpressed protein strongly accumulated in the nucleoli. This phenomenon 
is independent from the tag fused to the N-terminal of NC2α, and is prevented 
when cells are co-transfected with the partner NC2β, indicating that as a dimer, 
NC2 never localizes in the nucleoli. These results suggest that the exogenous 
NC2α accumulates in the nucleoli when in high concentrations compared to the 
endogenous protein and to the partner NC2β. Interestingly in specific circumstances 
the endogenous NC2α is also observed in the nucleoli. In particular, monitoring of 
NC2α in different phases of the cell cycle showed that during the late G1 phase 
some of the cells have stained nucleoli. Several observations indicate that NC2 
is not involved in repression of Pol I genes (White et al. 1994; Geisberg et al. 
2001) and therefore exclude that the accumulation of NC2α in the nucleoli could 
be directly related to Pol I transcriptional repression. Curiously, a comprehensive 
characterization of proteins composing the nucleoli, did not detect NC2α (Andersen 
et al. 2002), likely because the proportion of cells having nucleolar NC2α is 
underrepresented in a population of asynchronous cells. 
The nucleolus is a plurifunctional structure and its major functions are rRNA 
transcription and processing, and ribosome assembly (Pederson 1998). In the last 
years it became evident that nucleoli have also additional functions, i.e. being storage 
place for several proteins, whose activity is regulated by shuttling between the place 
where they accomplish their function and the nucleoli (Visintin et al. 1999). Likely, 
also NC2α accumulation in the nucleoli is related to a regulation mechanism. We 
observed this phenomenon during the G1 phase, when transcription is supposed 
to be most active, suggesting that NC2 repression activity is weakened or relieved 
by sequestrating part of the NC2α subunit into the nucleoli. 
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Consistent with the above model, mutation of threonine 23 (T23) into aspartate, 
a negatively charged amino acid mimicking the phosphorylation state, abolished 
nucleolar localization, whereas mutation into alanine, a neutral residue, had no 
effect. T23 is conserved in yeast and phosphorylation at this residue is crucial 
for transcriptional repression activity of yeast NC2 in exponentially growing cells 
(Creton et al. 2002). Phosphorylation at this residue can be one of the mechanisms 
to regulate the level of NC2 repression, controlling the shuttling of NC2α between 
the storage site (nucleoli) and the nucleoplasm. 
Several studies raised the possibility that NC2α and NC2β also have separate 
functions. In yeast, Collart and colleagues demonstrated that NC2α and NC2β are 
not always associated in a tight complex, depending on growth conditions (Creton 
et al. 2002). Interestingly, the NC2 subunits show different tissue distributions 
(Mermelstein et al. 1996) and NC2α plays an essential function in developing of 
mouse embryos, independent of NC2β (Iratni et al. 2002). Very recently it has been 
shown that NC2α, but also the complex, associates with BTAF1, another general 
repressor of Pol II transcription (Klejman et al. 2004). If NC2α could have a function 
independently from the dimer, it could be related to its nucleolar localization. 
NC2α has a bipartite NLS, with the second motif playing only a minor role in the 
subunit nuclear localization and no role in the import of the dimer. Notably, mutation 
of either the first or the second motif abolished nucleoli localization. Interestingly, 
NC2α accumulates in the nucleoli only when in excess compared to NC2β, namely 
when is not dimerized and thus also the second motif of the NC2α NLS is exposed. 
The consensus sequence for the nucleolar localization signal (NoLS) has not been 
defined yet, rather suggesting that the nucleolar targeting is mediated by the variety 
of molecular interactions, i.e. the specific nature of the nucleolar interaction partner 
(Scheer and Hock 1999). The NoLS associated with most viral proteins is usually 
no longer than 20 amino acids residues and possesses at least nine basic residues, 
including one continuous stretch of four basic amino acids or two stretches of three 
basic amino acids (Rowland and Yoo 2003). A NLS is usually embedded within 
the NoLS peptide sequence (Kubota et al. 1999). A comparison with known NoLS 
(Thebault et al. 2000) revealed that the NC2α N-terminus contains a stretch of 
basic residues similar to that found in proteins that preferentially localize in the 
nucleolus. Thus, our data suggest that NC2α contains a NoLS.
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1.6. BiP: a good candidate NC2α-interactor localizes in the nucleoli
Biochemical studies identified several potential NC2-binding proteins. In two 
independent experiments, HeLa nuclear extracts and whole cell extracts 
were depleted with the NC2α specific antibody and all additional proteins 
coimmunopurified with NC2 were analyzed by MS. The protein sets obtained from 
the two independent experiments, performed with slightly different IP conditions, 
were compared. The proteins found in the first analysis were not confirmed in the 
second one, except for one, the heat shock 70kD protein 5 (glucose-regulated 
protein, 78kD, GRP78 or BiP). BiP belongs to the HSP70 family and is involved 
in the folding and assembly of proteins in the endoplasmic reticulum (Steel et al. 
2004). However, a large proteomics analysis of the nucleolus, identified BiP also 
has a component of the nucleolus together with other unexpected proteins 
(Andersen et al. 2002). These observations are quite exciting because one 
could hypothesize that BiP is the chaperon protein that anchors NC2α in the 
nucleoli or assists nucleo-cytoplasmic shuffling.
 
1.7. Ig-NC2α and Ig-NC2βx behave as dominant negative constructs
The fusion of a tag of ca 30kD, the Ig-tag, to both NC2 subunits blocks entry of the 
proteins into the nucleus by simple diffusion. Thus, when the functionality of the 
NLS is impaired, both proteins are retained in the cytoplasm. This is seen with the 
Ig-NC2α construct, were the N-terminal tag probably masks the NLS, The Ig-NC2βx 
deletion mutant is probably retained because of the large size and the absence of 
the NLS. These observations have important implications. Both NC2 subunits are 
essential for viability in yeast (Xie et al. 2000) and NC2α-KO mouse embryos are 
not viable (Iratni et al. 2002). This makes it difficult to study the effect of absence 
or decreased level of NC2 in metazoan systems. In yeast, the problem has been 
solved by substituting the endogenous NC2 with the human counterpart (Kim et al. 
1997; Xie et al. 2000). The Ig-NC2α and Ig-NC2βx constructs could offer a solution 
to that problem. In fact, when one of the Ig-fusion proteins is overexpressed in 
the cell, most of the endogenous partner would be sequestered in the cytoplasm 
from the exogenous protein, affecting the normal NC2 balance. Thus, these fusion 
proteins deficient in nuclear translocation could behave like a dominant negative 
and could represent a powerful tool for studying effects on transcription consequent 
to altered NC2 levels, with respect to both subunits.
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2. The mitotic phosphorylation
During mitosis, chromatin is stripped of proteins, in order to allow efficient 
chromosome condensation (Martinez-Balbas et al. 1995; Parsons and Spencer 
1997).
Concurrently, transcription by all three RNA polymerases is inhibited (Prescott and 
Bender 1962; Fink and Turnock 1977).
Several findings suggest that phosphorylation plays a major role in regulating this 
process. Mitosis specific phosphorylation has been reported to interfere with the 
DNA binding activity of some transcription factors, and to exclude from mitotic 
chromosomes two components of the human SWI-SNF chromatin remodeling 
complex (Segil et al. 1991; Luscher and Eisenman 1992; Martinez et al. 1995; 
Sidorova et al. 1995; Muchardt et al. 1996; Segil et al. 1996). 
At the same time, phosphorylation of the CTD and of the cdk7 subunit of TFIIH 
repress basal transcription by RNA Pol II (Cisek and Corden 1989; Zhang and 
Corden 1991; Leresche et al. 1996; Akoulitchev and Reinberg 1998; Long et 
al. 1998; Patturajan et al. 1998). Also TFIID components TBP and TAFs are 
phosphorylated in mitosis, and this event correlates with the inactivation of the 
activator-depenent transcription in vitro (Segil et al. 1996). Although TBP alone 
can support basal transcription activity in vitro, activator-dependent transcription 
requires the presence of TAFs (Burley and Roeder 1996). Thus, TAFs, but not TBP 
are the relevant targets for the inactivation of Pol II, (Segil et al. 1996). Similarly, 
phosphorylation of TBP, as a component of TFIIIB, is not responsible for Pol III 
transcriptional inhibition (Gottesfeld et al. 1994; White et al. 1995). Hence, there is 
no evidence for the functional significance of TBP phosphorylation during mitosis. 
In this study, we provided evidence for the presence of mitosis specific 
phosphorylation of NC2α, one of the two subunits composing NC2. This is in line 
with an earlier report on mitotic phosphoproteins in Xenopus, which listed XNC2α as 
one of the proteins specifically phosphorylated in mitosis (Stukenberg et al. 1997). 
This observation relied on in vitro translation and modification by mitotic extracts 
that produced a mobility shift comparable to the one we observed in hNC2α. 
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2.1. The hyperphosphorylated NC2 does not dissociate from the condensed 
mitotic chromatin
Previous reports showed that the pattern of DnaseI-hypersensitive sites, which 
are located primarily in promoter or enhancer regions, appear to be preserved 
in mitotic chromosomes (Kuo et al. 1982; Kerem et al. 1984). The persistence 
of transcription factor footprints during mitosis varies from promoter to promoter 
(Hershkovitz and Riggs 1995; Martinez-Balbas et al. 1995; Wells et al. 1996; 
Christova and Oelgeschlager 2002). In yeast, highly condensed transcriptionally 
silent heterochromatin is permissive to general transcription factor binding (Sekinger 
and Gross 2001). Thus, many lines of evidence support the notion that chromatin 
structure, and therefore some promoter proteins, are retained on the chromosomes 
during mitosis. Indeed, several transcription factors are maintained on metaphase 
chromosomes, including the Serum Response Factor, the GAGA factor and AP-2 
(Raff et al. 1994; Martinez-Balbas et al. 1995).
Segil et al. (1996) showed that, following nuclear envelope breakdown, 10-20% 
of the TFIID population remains tightly associated with the condensed mitotic 
chromosomes. Recently, chromatin immunoprecipitation assays confirmed that 
TFIID and TFIIB can remain associated with active gene promoters during mitosis, 
while RNA Pol II is displaced from the condensed mitotic chromosomes (Christova 
and Oelgeschlager 2002). Consistently, the dynamics/distribution of TBP in living 
human cells showed that a small fraction of TBP-TAF complexes stably associate 
with the condensed chromosomes during mitosis (Chen et al. 2002).
Our immunofluorescence studies showed a massive relocation of NC2α during 
mitosis, from the interphase nuclei to the cytoplasm. As mentioned before, TBP 
itself and some of the TAFs are phosphorylated in mitosis, but nevertheless they 
still associate with the condensed mitotic DNA. It is impossible to exclude that 
a small fraction of NC2α is maintained on condensed chromosomes. Indeed, a 
previous report showed that NC2 is maintained on some promoters during mitosis 
(Christova and Oelgeschlager 2002). In line with this finding, we also saw that M-
NC2α maintains the ability to dimerize with the partner NC2β and bind TBP-DNA 
complexes. Interestingly, this activity was not impaired when nucleosome DNA was 
used as a template, suggesting that M-NC2-TBP-can bind also to nucleosome 
templates. 
In conclusion, NC2, like its partner TBP, is phosphorylated in mitosis, and this 
modification does not preclude its ability to bind to the DNA. 
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2.2. Hypothetical functions of mitotic phosphorylation 
Previous studies suggested that phosphorylation of NC2 by CKII blocks its non-
specific interaction with DNA. Most of the potential phosphorylation sites of NC2α 
are located in the C-terminus. The C-terminus of NC2α was missing in the NC2-
TBP-DNA crystal structure (Kamada et al., 2001). This region contains two acidic 
regions spaced by a proline rich domain (see Fig. 2a and 2b). Interestingly, most 
of the potential CKII phosphorylation sites reside in the first acidic domain. By 
looking at the crystal structure one may hypothesize that the C-terminus bends 
towards TBP and the acidic region enters in contact with an identified positively 
charged surface of TBP (Fig. 28). The electrostatic interaction between opposite 
charges would strengthen the trimeric complex, with TBP-NC2 resembling a ring-
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NC2β-
CTD
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amino
acids
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Figure 50. A model for positioning of NC2α C-terminus. (A) Schematic representation of the C-
terminus of NC2α is given. Representative residues are indicated: FDFL = FDFL domain; RK = 
basic region; ST + DE = acidic region containing most of the potential phosphorylation sites. (B) 
Three-dimensional representation of the NC2-TBP-DNA complex.  The strand of DNA is in gray; 
TBP in green (red corresponds to the basic residues); NC2β in light blue; NC2α dark blue. Oval-
blue shapes correspond to the acidic terminal domain of NC2α. Two possible positioning of the tail 
are shown, contacting either the basic surface of TBP or the DNA. 
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like structure around the DNA. Support for this model comes from the recent 
observations that the first acidic region of the NC2α C-terminal contains an additional 
potential TBP interaction domain (Gilfillan, unpublished data; Klejman et al. 2004). 
Deletion-mutants showed that the first acidic stretch is involved in stabilizing the 
complex, especially in the absence of the NC2β C-terminus. Interestingly, this 
region contains many of the potential phosphorylation sites. The mitotic specific 
NC2 hyperphosphorylation can therefore participate in making the interaction more 
stable.
Alternatively, the C-terminus phosphorylation could impair interaction with other 
proteins, like activators or in general factors that relieve NC2 repression activity, 
so that during mitosis part of NC2 remains stably associated with TBP-DNA. Very 
recently, it has been published that NC2α tail interacts with BTAF1, enhancing its 
binding to TBP (Klejman et al. 2004), although NC2 phosphorylation by CKII was 
not required for this function. 
3. Effect of normal NC2 phosphorylation
Previous studies showed that phosphorylated NC2α does not bind to the DNA. 
(Goppelt et al. 1996). Our results on binding ability to long and nucleosome 
template DNA imply that recombinant unmodified NC2 and native phosphorylated 
NC2 behave differently in complex formation: the native NC2-TBP-DNA complex 
has a lower DNA binding capacity. This suggests that the polymerization of TBP-
NC2 is inhibited by electrostatic repulsion.
4. Both NC2α and NC2β have several isoforms 
Separation of NC2 native proteins in 2D gels clearly showed for the first time that both 
NC2α and NC2β have many unexpected isoforms. Five distinct spots corresponding 
to NC2α were identified, among which only one is the mitotic-specific form. The 2D 
pattern is compatible with differentially phosphorylated modifications.
Seven different spots were identified as NC2β, four of which were particularly 
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abundant (spots 1 to 4 in Fig. 26).
The NC2β band normally seen in WB is split in three spots that likely differ for the 
phosphorylation status (spot n.2, 3, 4). Moreover a new previously unidentified band 
of NC2β with lower molecular weight was also found (spot n.1). Size differences 
point to a deletion form of NC2β. Interestingly, the silver stain suggested that this 
form was as abundant as the others, although normally it is not recognized by the 
antibody. This protein became visible also when NC2 was marked with radioactivity. 
A possible explanation could be that our NC2β antibody does recognize this shorter 
form, as proven by the clear signal given in the 2D WB, but of course in a less 
efficient way than the whole protein. 
4.1. The high mobility NC2β form is likely a deleted protein
The high mobility NC2β form could be a C-terminal deletion protein, rather than 
the unmodified version of the usual NC2β form. First, mass spectrometry analysis 
of the 2D NC2β spots identified most of the peptides within the amino acids 1-135 
and no difference at all among the 4 major spots, suggesting that the mobility 
difference could be explained in the C-terminal unidentified part of the protein. 
Second, this form coimmunoprecipitates with NC2α. Since the first 80 amino acids 
of the histone fold domain are essential for protein-protein interaction, the short 
NC2β must contain them. 
This protein was observed in all the three extracts, arguing against an artefact, but 
one can not exclude that it comes from protein degradation. 
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V. MATERIALS AND METHODS
1. Materials
1.1. Chemicals and biochemicals
Acetic Acid        Roth
Acrylamide/Bisacrylamide 30% (Rotiphorese Gel 30)  Roth
Acrylamide solution 30% (Rotiphorese Gel A)   Roth
Agarose        Gibco
Ammonium persulfate (APS)     Merck, Roth
Ammonium sulphate      Merck
Ampicillin (Ap)       Roth
Aprotinin       Sigma
Bacto Agar       Difco
Bacto Trypton       Difco
Bacto Yeast Extract      Difco
Benzamidin       Sigma
Bisacrylamide solution 2%     Roth
Boric acid        Roth
5-Bromo-4-Chloro-3-indolyl-phosphate (BCIP)   Peqlab
Bromophenol Blue      Sigma
BSA (10 mg/ml) (bovine serum albumin)    New England Biolabs
Calciumchloride      Merck
Calciumhydronenphosphate     Merck
Calciumhydroxide      Merck
CHAPS        Sigma
Chloroform        Merck
Coomassie brilliant blue R-250     Sigma
Dimethylsulfoxide      Sigma
Dithiothreitol (DTT)      Roth
DMEM medium       Gibco
dNTPs        Roche
Ethanol (EtOH)       Nardini
Ethanolamine       Sigma
Ethidium bromide      Sigma
Ethylendiamintetraacetate disodium salt (EDTA)   Merck
Fetal calf serum (FCS)      Gibco
Fish gelatine       Sigma
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Glucose       Merck
Glycerol       Roth
Glycine        Roth
Hepes        Biomol
Histogel mounting medium     Linaris
Isoamyl alcohol       Merck
Isopropanol       Merck
Leupeptin       Roche
Magnesiumchloride      Merck
β-Mercaptoethanol      Sigma
Methanol       Merck, Roth
Milk powder       Heirler Cenovis GmbH
Mimosine       Sigma
Nitro-blue-tetrazolium (NBT)     Peqlab
Nocodazole       Sigma
Okdaic acid       Sigma
Paraformaldehyde      Merck
Penicillin-Streptomycin      Invitrogen
Phenol/chloroform       Roth
Phenylmethylsulfonfluoride (PMSF)    Biomol, Roth
Phorbolmyristylester (PMA)     Roche, Sigma
Ponceau S       Sigma
Propidium iodide      Sigma
Protein G-Sepharose      Amersham
RPMI 1640-Medium      Gibco
Sodium azide       Sigma
Sodium borate       Roth
Sodium carbonate      Merck
Sodium chloride     Monopolio di Stato (Saline di Favignana)
Sodiumdodecylsulphate (SDS)     Merck, Roth
Sodium fluoride       Sigma
Sodium hydroxid      Merck
Sodium-hort-vanadate      Sigma
Sucrose       Sigma
Tetramethylethylendiamin (TEMED)    Sigma
Thymidine       Sigma
Trishydroxidmethyl-aminomethan (Tris)    Sigma
Triton X-100       Sigma
Trypsin-EDTA solution      Gibco
Urea        Roth
Xylene cyanole       Fluka
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1.2. Additional material
Disposable plastic material     Greiner, Nunc, TPP, Falcon
ECL Western Blot Kit      NEN
Film X-OMAT, BioMax      Kodak
Gel Drying Kit       Promega
GFX Gel Band Purification Kit     Amersham
IEF-Gel strips (IPG)      Amersham
Nitrocellulose membrane (0.45 μm mesh)   BioRad
Nucleobond AX Plasmid DNA Kit    Macherey & Nagel
PVDF-Membrane Hydrobond-P     Amersham
Siliconized Plastic tubes     Sorenson 
Silver Staining Kit      PlusOne, Amersham
Sterilfilter (0.22/0.45 μm)     Roth
Concentrator (MWCO 10 kD)     Vivaspin 2, Vivascience
Whatman 3MM Paper      Whatman
1.3. Instruments
2D-Gel electrophoresis system   IPGphor / Ettan Dalt, Amersham 
Acrylamid gel electrophoresis   Amersham / Hoefer SE280, SE600, SE660 
Agarose gel electrophoresis   BioRad
Autoradiography cassette    Amersham, Kodak
Developing machine    Hyperprocessor, Amersham
Electroblot-Apparatus (semi-dry)   BioRad
Gel drier     GD2000, Hoefer
Homogenizer      Douncer, Wheaton
Incubator     WJ311, Forma Scientific
      Unequip, Unitherm
      B6200, Heraeus
Instant Imager      Packard
Confocal light microscope   TCS SP2 and TCS, Leica
Light microscope    Axiovert 25, Zeiss
MALDI-TOF/TOF-MS    Proteomics Analyzer 4700, Applied Biosystems
PCR-Thermocycler    GeneAmp 2400, Applied
pH-Meter     Calimatic 760, Knick
Photometer     GeneQuant Pro, Amersham 
Rotoren     JA10, JA25-50, SW41, SW28, Beckman
Ultra-centrifuge     L7, L8-M von Beckman
UV-Illuminator     Bachofer (254 nm, 366 nm)
Centrifuges     Avanti, Beckman
      Multifuge 3 L-R, Heraeus
      Zentrifuge 5417, 5415R, Eppendorf
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1.4. Enzymes 
Enzyme      Company 
Klenow fragment     Fermentas
Pfu DNA polymerase     Promega
Restriction enzymes     New England Biolabs or Fermentas
RNase A      Roche 
T4 DNA ligase       New England Biolabs or Fermentas
T4 polynucleotide kinase    New England Biolabs 
Taq polymerase      Fermentas
1.5. General buffers 
2x Acetylation buffer:
100 mM Tris-HCl (pH 8.0 RT), 10 mM EDTA (pH 8.0), 300 mM NaCl, 1% NP40 (v/
v). Add freshly 1 mM DTT, protease inhibitors (0.2 mM PMSF, 1 mM Benzamidine) 
and deacetylation inhibitor (Butirrate 0.1 mM).
Annealing buffer for oligonucleotides used in EMSA:
10 mM Tris-HCl (pH 7.3 RT), 200 mM NaCl, 1 mM MgCl2.
AP-buffer (Alcaline Phosphatase reaction):
100 mM Tris-HCl (pH 8.8 RT), 100 mM NaCl, 5 mM MgCl2..
Bacterial lysis buffer:
500 mM NaCl, 10% glycerol, 20 mM Tris-HCl pH 7.3, 5 mM β-Mercaptoethanol, 
0.1% IGEPAL CA-630 (NP-40).
Add fresh protease inhibitors to final concentration: 2 μg/ml Leupeptin, 1 μg/ml 
Pepstatin A, 20 μg/ml Benzamidine and 1 mM Phenylmethylsulfonyl fluoride.
BCx-buffer: 
20 mM Tris-HCl (pH 7.3 RT), 0.2 mM EDTA, 20% (v/v) Glycerine, x mM Kcl.
5x Cell colture lysis buffer:
125 mM Tris-HCl (pH 7.8 RT), 10 mM EDTA, 50% (v/v) glycerine, 5% (v/v) Triton-X, 
10 mM DTT. Filter sterilize through a 0.45-μm nitrocellulose filter (Millipore). Store 
in aliquots at -20 °C. Dilute with PBS to a 2x working solution. 
Add fresh protease inhibitors (200 mM PMSF, 100 mM Benzamidine, 2 μg/ml 
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Leupeptin, 2 μg/ml Aprotinin, 0.2 μg/ml Pepstatin A) and phosphatase inhibitors (1 
mM NaF, 100 mM Vanadate).
HB-buffer (Hypotonic Buffer):
For 1 l buffer use 10 ml 1 M Tris-HCl (pH 6.8 RT), 1.5 ml 1 M MgCl2, 3.34 ml 3 M 
KCl.
2x HBS (Hepes-buffered saline):
280 mM NaCl, 50 mM Hepes, 1.5 mM Na2HPO4. Adjust to pH 7.05 with 0.5 N NaOH 
at RT. Filter sterilize through a 0.45-μm nitrocellulose filter (Millipore). Store in 
aliquots at -20 °C. 
High Salt Buffer (1.6 M):
For 1 l buffer use 20 ml 1 M Tris-HCl (pH 6.8 RT), 250 ml Glycerin, 533 ml 3M KCl, 
1.5 ml 1M MgCl2, 0.4 ml 0.5 M EDTA.
Low Salt Buffer (0.02 M):
For 1 l buffer use 20 ml 1 M Tris-HCl (pH 6.8 RT), 250 ml Glycerin, 6.67 ml 3M KCl, 
1.5 ml 1M MgCl2, 0.4 ml 0.5 M EDTA.
20 x PBS: 
160 g NaCl, 4 g KCl, 36 g Na2HPO4 · 2 H2O, 4.8 g KH2PO4, pH 7.4, add dH2O to 1 l.
Transfer buffer:
3 g Tris base, 14.4 g glycine, in 800 ml dH2O. Add 200 ml MeOH before use.
10 x TBE: 
1 M Tris, 1 M boric acid, 20 mM EDTA (pH 8.0 RT).
10 x TBS: 
24.2 g Tris base, 80 g NaCl, 2 g KCl. Adjust pH to 7.6 with HCl concentrated, add 
dH2O to 1 l.
1 x TBST: 
1 x TBS, 0.05% (v/v) Tween 20.
10 x TGE:
30 g Tris base, 186 g glycine, 20 ml 0.5 M EDTA in 1 l dH2O.
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10 x TGS: 
250 mM Tris, 1.92 M Glycin, 1% (w/v) SDS.
TE:
10 mM Tris-HCl (pH 8.0 RT), 1 mM EDTA (pH 8.0).
Sample Buffer:
1 g glucose in 1 l PBS.
Staining / Distaining buffer:
To 500 ml H2O add 400 ml MeOH and 100 ml glacial acetic acid. For staining, add 
2.5 g Coomassie Brillant Blue R250 for 1000 ml of distain solution.
1.6. Antibodies (ab)
1.6.1. Primary antibodies
β-Actin sc-1616 (I-16)  Goat polyclonal   SantaCruz Biotechnology
NC2α 4G7   Rat monoclonal   E. Kremmer, Munich
NC2α 6G8   Rat monoclonal   E. Kremmer, Munich
NC2β     Rabbit polyclonal  M. Meisterernst
TBP sc-273   Rabbit polyclonal  SantaCruz Biotechnology
Flag M2 F3165   Mouse monoclonal  Sigma
1.6.2. Secondary antibodies
Sheep anti-Maus IgG H+L (515-095-062) FITC-conjugated  Jackson
Sheep anti-Mouse IgG (H+L) (515-095-063) FITC-conjugated  Jackson
Goat anti-Human IgG (H+L) (109-095-107) FITC- conjugated  Jackson
Mouse anti-Rabbit IgG (H+L) (211-095-109) FITC- conjugated  Jackson
Mouse anti-Rat IgG (H+L) (212-066-102) Biotin-SP-conjugated   Jackson
Alexa488-SP-conjugated          Molecular Probes
Cy3- SP-conjugated  Jackson
Goat anti-Rat IgG + IgM (112-166-068)  Cy3-conjugated   Jackson
Goat anti-Rat IgG H+L (S3831)   AP-conjugated   Promega
Goat anti-Rat IgG H+L (112-035-068)  HRP-conjugated  Jackson
Donkey anti-Goat IgG (sc-2022)   AP-conjugated   SantaCruz
Goat anti-Mouse IgG H+L (S3721)  AP-conjugated   Promega
Goat anti-Rabbit IgG Fc (S3731)  AP-conjugated   Promega
Goat anti- Rabbit IgG H+L (W4011)  HRP-conjugated  Promega
Goat anti- Mouse IgG H+L (W4021)  HRP-conjugated  Promega
Donkey anti- Goat IgG H+L (705-035-147) HRP-conjugated  Dianova 
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1.7. List of plasmids 
Plasmid  Description  Backbone  Origin
pcDNA3     pcDNA3  Invitrogen
pGS49  His-NC2α  Rc/CMV  M. Meisterernst
pGS46  His-NC2β  Rc/CMV  M. Meisterernst
pGS67  Ig-NC2α  CDM7   M. Meisterernst
pGS68  Ig-NC2β  Rc/CMV  M. Meisterernst
Ig-NC2βy  Rc/CMV  M. Meisterernst
PGS163  Ig-NC2βx  Rc/CMV  M. Meisterernst
pSO5  His-NC2α-His-NC2β pET11d.1  Gilfillan et al., 2003
pB2-MLP  AdML promoter     M. Timmers
2. Methods
2.1. Cloning and related techniques 
2.1.1. Cloning of NC2 constructs 
pEP2 (pcDNA3-Flag)
pEP2 was constructed by two fragment ligation of an HindIII, KpnI fragment derived 
from annealing of two oligos, and a HindIII, KpnI cut vector derived from pcDNA3. 
The sequences of the oligos are:
   HindIII Kozak  Flag-tag    NdeI KpnI
flag.for: 5ʼ-AGCTTACCATGGACTACAAAGACGATGACGACAAGGGTCATATGGGTAC-3ʼ
fleg.rev: 5ʼ-CCATATGACCCTTGTCGTCATCGTCTTTGTAGTCCATGGTA-3ʼ
pEP3 (Flag-hNC2α in Rc/CMV)
pEP3 was constructed by two fragment ligation of an NdeI fragment derived from 
pEP2 and a NdeI fragment derived from the vector pGS49
pEP4 (Flag-hNC2β in Rc/CMV)
pEP4 was pEP3 was constructed by two fragment ligation of an NdeI fragment 
derived from pEP2 and a NdeI fragment derived from the vector pGS46.
2.1.2. Point mutants generation 
The point mutants in the NLS sequences were introduced following the instructions 
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of the QuikChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA).
pGS49 was used as template for construction of the following plasmids: pEP31 
pEP33, pEP35 and pEP36.
pEP4 was used as template for construction of the following plasmids: pEP13, 
pEP11 and pEP30.
PEP 31 was used as template for construction of the pEP32 plasmid.
PEP 33 was used as template for construction of the pEP34 plasmid. 
The sequences of the oligos used for the mutagenesis are listed below.
Plasmid: pEP31 (His-hNC2α(K4A/K5A) in Rc/CMV)
Primers:  aK4/5A.for
5ʼ-GGCAGCCATATGCCCTCCGCGGCGAAAAAGTACAATGCCCGG-3ʼ
  aK4/5A.rev
  5ʼ-CCGGGCATTGTACTTTTTCGCCGCGGAGGGCATATGGCTGCC-3ʼ
Plasmid: pEP32 (His-hNC2α(K4A/K5A/K6A/K7A) in Rc/CMV)
Primers:  a.K6/7Apost.for
  5ʼ-CATATGCCCTCCGCGGCGGCAGCGTACAATGCCCGGTTCCC-3ʼ
  a.K6/7Apost.rev
  5ʼ-GGGAACCGGGCATTGTACGCTGCCGCCGCGGAGGGCATATG-3ʼ
Plasmid: pEP33 (His-hNC2α(K18A/K19A) in Rc/CMV)
Primers:  aK18/19.for
  5ʼ-GTTCCCGCCGGCGCGGATCGCGGCGATCATGCAGCAGGACG-3ʼ
aK18/19.rev
  5ʼ-CGTCCGTCTGCATGATCGCCGCGATCCGCGCCGGCGGGAAC-3ʼ
Plasmid: pEP34 (His-hNC2α(R16A/K18A/K19A) in Rc/CMV)
Primers:  a.R16Apost.for
5ʼ-GGTTCCCGCCGGCGGCGATCGCGGCGATCATG-3ʼ
a.R16Apost.rev
5ʼ-CATGATCGCCGCGATCGCCGCCGGCGGGAACC-3ʼ
Plasmid: pEP36 (His-hNC2α(T23A) in Rc/CMV)
Primers:  a.T23A.for
5ʼ-GAAGATCATGCAGGCGGACGAAGAGATTGG-3ʼ
a.T23A.rev
5ʼ-CCAATCTCTTCGTCCGCCTGCATGATCTTC-3ʼ
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Plasmid: pEP35 (His-hNC2α(T23D) in Rc/CMV)
Primers:  a.T23D.for
5ʼ-CAAGAAGATCATGCAGGACGACGAAGAGATTGGG-3ʼ
a.T23D.rev
5ʼ-CCCAATCTCTTCGTCGTCCTGCATGATCTTCTTG-3ʼ
Plasmid: pEP13 (Flag-hNC2β(R101A/R102A) in Rc/CMV)
Primers:  b.RR101-102A.for
  5ʼ-ACAGTAGCATTAAAAGCAGCAAAGGCCAGTTCTCGTTTGG-3ʼ
  b.RR101-102A.rev
  5ʼ-CCAAACGAGAACTGGCCTTTGCTGCTTTTAATGCTACTGT-3ʼ
Plasmid: pEP11 (Flag-hNC2β(S105A/S106A) in Rc/CMV)
Primers: b.S105/106A.for
  5ʼ-AGAAGAAAGGCCGCTGCTCGTTTGGAAAACCTTGGC-3ʼ
  b.S105/106A.rev
  3ʼ-GCCAAGGTTTTCCAAACGAGCAGCGGCCTTTCTTCT-3ʼ
Plasmid: pEP30 (Flag-hNC2β(S105D/S106D) in Rc/CMV)
Primers:  b.S105/106D.for
5ʼ-AGAAGAAAGGCCGATGATCGTTTGGAAAACCTTGGC-3ʼ
b.S105/106D.rev
5’-GCCAAGGTTTTCCAAACGATCATCGGCCTTTCTTCT-3ʼ
All of the above PCRs were performed with PfuTurbo DNA polymerase (Promega, 
Madison, WI), using deoxyribonucleosidetri-phosphate mix (final concentration 250 
mM) and reaction buffers, supplied by the manufacturers.
PCR conditions:
Reagent Volume
10x enzyme buffer 5 μl
125ng of oligonucleotide primer #1
125ng of oligonucleotide primer #2
dNTPs (each dNTP is 25 mM) 1 μl
DNA 10 ng
ddH2O to a final volume of 50 μl
PfuTurbo DNA polymerase (3u/μl) 1 μl
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PCR cycles:
Step T time
1 95 °C Pause
2 95 °C 30s
3 55 °C 60s
4 68 °C 13m 30s
5 68 °C 10m
6 4 °C ∞
The steps 2-4 were repeated 16x.
Each amplification reaction was digested with 1 μl of the DpnI restriction enzyme 
(10U/μl, New England Biolab) for 2-3 h at 37 °C, 5 μl of the digest were used for 
transformation. All mutations were checked by sequencing. 
2.1.3. Restriction digests 
Restriction digests were typically done for 2 h at 37 °C with 2 units restriction 
endonuclease per μg DNA in the appropriate buffer as recommended by the 
manufacturer (New England Biolabs, Beverly, MA, or Fermentas). 
2.1.4. Ligation of DNA 
Ligation was done with T4 DNA ligase in buffer supplied by the manufacturer (New 
England Biolabs, Beverly, MA) in a final volume of 20 μl over night at 16 °C. 
2.1.5. Agarose gel electrophoresis 
Agarose (electrophoresis grade, GibcoBRL, Grand Island, NY) was dissolved in 
1xTBE buffer to the desired concentration (0.8 to 2% depending on the size of 
DNA fragments) by boiling in a microwave oven, and after cooling down, ethidium 
bromide was added to a final concentration of 0.5 µg/ml and the agarose solution 
poured in a gel chamber. The DNA sample was mixed 1:6 with 6xDNA sample buffer 
(30% glycerol, 0.25% Bromphenol Blue, 0.25% Xylene Cyanole in TBE buffer). The 
gels were run in 1xTBE buffer and visualized on a UV transilluminator.
2.1.6. Preparation of competent E. coli 
50 ml LB medium were inoculated with 0.5 ml overnight culture of E. coli DH5α or 
MC1061 and grown to A600 of 0.5. The bacteria were then centrifuged in a 50 ml 
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conical tube (Falcon, Becton Dickinson Labware, Franklin Lakes, NJ) at 3000 rpm 
(5 min at 4 °C) resuspended in 25 ml cold sterile 0.1 M CaCl2 and stored on ice for 
30 min. After a second spin as above, the bacteria were resuspended in 1 ml cold 
0.1 M CaCl2 and frozen in 15% sterile glycerol at -80 °C, in aliquots. 
2.1.7. Transformation and growth of transformed bacteria
50 μl competent bacterial cells were mixed with 0.1-500 ng of plasmid DNA or 
10 μl ligation and incubated on ice for 30 min. The cells were then heat shocked 
by placing in a 42 °C thermoblock for 45 s and then let on ice fore 2 min. 1 ml LB 
medium was then added to the transformation mix and the tubes were placed in a 
37 °C shaker for 1h. Afterwards, 200 μl of bacterial cells were spread onto LB agar 
plates containing either 100 μg/ml ampicillin or 12.5 μg/ml tetracycline and 6.5 μg/
ml ampicillin (for the CDM7 vectors) and grown overnight at 37 °C. Single colonies 
were used to inoculate either 4 ml LB for the 200 ml LB cultures, grown overnight 
at 37 °C, shaking at 200 rpm, and used the day after for either the mini or the maxi 
preps of plasmid DNA.
2.1.8.“Mini” and “maxi” plasmid preparation 
Maxi preps were done using kits Nucleobond AX (Macherey & Nagel) according to 
the manufacturerʼs instructions. Mini preps were done according to Clewell et al. 
(1970). 
2.2. Tissues culture and related techniques 
2.2.1. Cell lines 
HeLa Human epithelial cell line originating from a cervical carcinoma. Adherent cells.
HeLA S3 Derived from HeLa. Cells have been adapted to grow in suspension culture
Jurkat Human T lymphoblastoid cell line
293T Adenovirus 5-transformed human embryonic kidney cell line. 
F99 Human skin primary fibroblast
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2.2.2. Culture conditions 
The cell lines used in this study were grown in the following media: 
HeLa, 293T, F99 - Dulbeccoʼs modified Eagle medium (DMEM plus 4500 mg/ml 
glucose, L-Glutamine, without Pyruvate. Gibco Invitrogen, Cat. No.11971-025) 
supplemented with 10% heat-inactivated (56 °C for 30 min in a water bath) foetal 
bovine (calf) serum (FBS=FCS, Gibco Invitrogen, Cat. No.10270-106), 100 units/ml 
penicillin G and 100 μg/ml streptomycin sulfate (Gibco Invitrogen, Cat. No.15140-
122). 
Jurkat and HeLA S3 - RPMI 1640 medium (plus L-Glutamine, Gibco Invitrogen, 
Cat. No.21875-034), supplemented with 10% heat-inactivated FBS and 100 U/ml 
penicillin G, 100 µg/ml streptomycin sulfate. 
The adherent cell lines, used in this study were usually grown in 10-cm or 15-
cm tissue culture dishes in a tissue culture incubator with 5% CO2 atmosphere at 
37 °C. Subculturing of the adherent cells was done by trypsinization with 0.25% 
trypsin, 0.2% EDTA (Gibco Invitrogen, Cat. No.25050-014) every second day. Cells 
were usually kept in culture for no more than 20 passages. 
Suspension cell lines were grown in 25, 75 or 175 cm2 tissue culture flasks. 
Subculturing of suspension cells was done by diluting with fresh medium. Cells 
were kept at concentration between 0.2-1x106 cells/ml.
Freezing of cells was done in 90% FCS and 10% (v/v) dimethyl-sulfoxide (DMSO) 
in a freezing box at -80°C. The frozen aliquots were stored in a liquid nitrogen tank 
or at -80°C. 
Thawing of the cells was done by submerging the frozen vial in a 37 °C water bath. 
The cells were then washed with medium by centrifugation at 1200 rpm for 3 min 
and resuspended in pre-warmed medium before transferring them to culture plates 
or flasks. 
2.2.3. Cell syncronization
Unless specified, adherent HeLa cells were used in the following synchronization 
protocols. Cells were maintained exponentially growing, splitting them regularly 
every second day. To increase the efficiency of synchronization, cells were always 
plated the day before to obtain dishes ca. 60% confluent when exposed to the 
specific inhibitors.
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2.2.3.1. Mitotic block
At mitosis (M) most vertebrate cells round-up. In many cell lines, especially those 
of epithelial origin, which grow in monolayer, attachment to the substrate also 
becomes much loser. This causes some mitotic cells to detach spontaneously. 
The mitotic arrest can be induced chemically using nocodazole, an inhibitor of 
microtubule polymerization. An almost pure population of M-blocked cells can 
be obtained combining the nocodazole block to mechanical shaking. Cells were 
treated with 600 ng/ml nocodazole (Sigma) for 16 h before harvesting. 
2.2.3.2. Mitotic block and release into G1
Cells were exposed to 50 ng/ml nocodazole for 17 h, the mitotic cells were collected 
by gentle pipetting, and washed in DMEM at 37 °C, resuspended in DMEM/10% 
FCS, replated and cultured for an additional 6 h. The mitotic cells obtained from 
four 15 cm plates were plated onto one 10 cm plate.
2.2.3.3. Late G1 block
L-mimosine is a plant aminoacid that provokes synchronization of cells just before 
the start of the S phase. HeLa cells were arrested in late G1 exposing them to 
400 μM mimosine (Sigma) for 20 h before harvesting.
2.2.3.4. S and G2 block
Any inhibitor of DNA synthesis arrests replicating cells. The most used are inhibitors 
of the synthesis of deoxyribonucleotide triphosphates, as thymidine at high 
concentrations. A double-arrest accumulates more than 90% of the population. 
HeLa cells were exposed to 2 mM thymidine for 17 h, rinsed twice, released in 
growth medium for 9 h and then blocked again with 2 mM thymidine for 15 h. At 
this point cells are synchronized at late G1. To obtain a G2 population, cells were 
washed and let grow in normal medium for 8 h.
2.2.4. Metabolic labeling of mitotic and asynchronous cells
At 13 h after the addition of nocodazole, the mitotic detached cells of four 15 
cm plates were collected, washed twice and cultured in a well of a 6-wells plate 
with 7 ml of H3PO4-free medium (Dulbeccoʼs Modified Eagle Medium, with high 
glucose and L-Glutamine, without Sodium Phosphate and Sodium Pyruvate Gibco 
Invitrogen, Cat. No. 11971-025), supplemented with 20 mM Hepes buffer, penicillin-
streptomycin, 10% Fetal Bovine Serum (FBS) Dialyzed (H3PO4-free. Gibco, Cat.
No. 26400-036), and 600 ng/ml nocodazole. After 2 h cells were centrifugated and 
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resuspended in 2 ml of the same medium supplemented with [32P]H3PO4 (0.5 mCi 
/ 1 ml of medium) (NEN Life Science Products, Perkin Elmer, Cat. No. NEX053). 
Cells were labeled for 5 h before harvesting. 
The sample of exponentially growing cells was exposed to H3PO4-free medium 
containing 600 ng/ml nocodazole and 10% FBS (H3PO4-free) for 2 h, and then 5 h 
more with [32P]H3PO4. One 12 cm plate was used for the exponentially cells and the 
plate was covered with 2.5 ml medium (0.5 mCi / 1 ml of medium).
In order to preserve protein phosphorylations, the cell lysis buffer (see below) 
contained in addition 1μM okadaic acid. 
2.2.5. Calcium phosphate transfection 
Transfection was performed according to the protocol described in Chen and 
Okayama (1988). 
The day before transfection, 293T or HeLa cells were seeded in 6-well plates at 30% 
confluency. 20 μg of total DNA (the concentration in each transfection experiment 
was kept constant by adding vector plasmid DNA) were added to 500 μl of 250 mM 
CaCl2, and then the tubes were vortexed. 500 μl of 2xHBS were added dropwise 
while gently vortexing, and the solution was incubated 20 min at RT. The calcium 
phosphate-DNA solution (160 μl / well) was added dropwise onto the cell culture 
plate while swirling. The plates were incubated overnight in a 5% CO2-humidified 
incubator at 37 °C to allow for a calcium phosphate-DNA complex to gradually 
form. The cells were then washed three times in PBS, and incubated in complete 
medium in a 5% CO2 humidified incubator at 37 °C.
2.2.6. Polyfect transfection 
Transfection of HeLa cells with PolyFect transfection reagent (Quiagen, Hilden) 
was conducted following the manufacturer. For each well of a 6-well plate, 1.5 μg of 
DNA dissolved in TE buffer was diluted in 100 μl OPTIMEM 1 (with Glutamax, Gibco 
Invitrogen, Cat. No. 51985-026) before adding 12 μl of PolyFect transfection reagent 
was added. Note that this reagent is toxic for the cells, and the day after transfection 
dead cells were observed in the supernatant, also in the control (cell transfected 
with dH2O). Therefore cells were always fixed for the immunofluorescence 16 to 24 
h after transfection.
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2.3. FACS (Flow cytometry analysis)
For flow cytometry analysis, adherent HeLa or Jurkat cells were washed twice with 
ice-cold PBS (HeLa cells after resuspension with Trypsin/EDTA). Then, cells were 
counted and adjusted to a concentration of ca. 1x106 cells/ml. Between 200-1000 
μl of cells centrifuged (1200 rpm, 5 min), supernatant was removed and cells were 
resuspended by vortex in the remaining fluid. Cells were fixed adding 1 ml of ice-
cold of 70% EtOH drop by drop while vortexing. Then, cells were allowed to fix 
overnight at 4 °C. For the flow cytometry analysis, cells were resuspended again 
by vortexing, centrifuged 5 min at high speed (3000 rpm) and the staining solution 
was added to the cells resuspended in the residual (after removing) ethanol. The 
volume of the staining solution (50 μg/ml propidium iodide, 100 U/ml RnaseA, 2 
mM EDTA in PBS) varied according to the quantity of cells, in order to obtain a 
constant concentration (1x106 cells/ml). Cells were incubated for at least 30 min at 
RT and readily analyzed in a FACSCalibur flow cytometer (Becton Dickinson). 
2.4. Immunofluorescence 
Unless stated, sample preparation was done at room temperature. Antibodies and 
dilutions are described below. HeLa cells plated on glass coverslips (11 mm) and 
transfected as described above were washed once with PBS and fixed with 3.7% 
PFA/PBS for 10 min (see below for solution preparation). Then, they were washed 
twice with PBS and incubated 15 min in 1 mg/ml NaBH4/PBS. After washing again 
twice with PBS, permeabilisation was performed with 1% Triton X-100/PBS for 15 
min and then washed twice with PBS. Blocking was done with 0.2% fish gelatin 
(Sigma) for 20 min. A humid chamber was prepared containing one layer of thick 
paper moisten with water and a stripe of parafilm. Drops (50-100 μl) of primary 
ab dilution were pipetted over the parafilm. Each coverslip was then transferred 
over a single drop, with cells facing the ab, and incubated 45-60 min at 37 °C. 
Afterwards, coverslips were transferred again to a 6-well plate and washed three 
times with PBS, for at least 30 min. Incubation with the secondary ab conjugated to 
the fluorescent dye was carried out as above, but for 30 min and in the dark, due to 
the fotosensibility of the fluorescent dye. If the secondary ab was biotin conjugated, 
a third incubation was performed (after 3x PBS washes for 30min) identical to the 
second one, with streptavidine dye-conjugated, followed by three PBS washing. 
Last, DNA stain was performed. To get red staining cells were preincubated with 10 
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μg/ml RNase/PBS for 20 min at 37 °C and then with 100 μg/ml propidium-iodide for 
10 min. To obtain a blue stain, cells were incubated with 1 μg/ml DAPI/PBS for 10 
min. After a final wash (3x with PBS followed by dH20) the coverslips were mounted 
on a precleaned microscope slide in histogel mounting medium (Linaris, Wertheim-
Bettingen, Germany). In alternative, coverslips were mounted with 10% glycerol/
PBS and then sealed using nail polish. When possible, cells were observed at the 
microscope within one day. Slides were stored at 4 °C for two to three weeks, after 
which the quality diminished.
Target NC2α NC2α NC2α Ig Flag NO38
Proteins NC2α NC2α
Ig-NC2α, 
His-NC2α 
(wt and 
mutants)
Ig-NC2β, 
Ig-NC2βy, 
Ig-NC2βx
Flag-
NC2β 
(wt and 
mutants)
NO38
Primary ab 4G7 4G7 4G7 -- M2 NO38
Dilution 1:10 1:10 1:10 1:400 1:200
Secondary ab
Biotin 
anti-rat
Biotin 
anti-rat
Cy3 
anti-rat
FITC anti-
h IgG
FITC anti-
mouse
Texas 
red anti 
Guinea 
Pig
Dilution 1:300 1:300 1:400 1:100 1:100 1:200
Streptavidine
(optional)
Cy3-
streptavidine
Alexa 488 -- -- -- --
Dilution 1:400 1:400
Color Red Green Red Green Green Red
Fixation solution:
37% paraformaldehyde (10x PFA): 
1.85 g PFA, 3.5 ml dH2O, 10 μl 10 M KOH.
Mix together in a 50 ml Falcon tube. Boil water in a glass beaker in the microwave 
and put tube in it with cap loose, swirling frequently to mix, for no longer than 5 min, 
until the PFA goes into solution. Store at -20 °C.
2.4.1. Confocal microscopy 
In conventional fluorescence microscopy, fluorescent light emitted by a sample 
comes from molecules above and below the plane of focus, thus the observer sees 
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a blurred images caused by the superposition of fluorescent images from molecules 
and many depths in the cell. The blurring effect makes it difficult to determine the 
actual tree dimensional molecular arrangement. Confocal scanning microscopy 
produces much sharper images by reducing the image-degrading effects of out-
of-focus light. Exciting light from a focused laser beam illuminates only a single 
small part of a sample for an instant and then rapidly moves to different spots in 
the same focal plane. The emitted fluorescent light passes through a pinhole that 
rejects out of focus light, thereby producing a sharp image. Because light in focus 
with the image is collected by the pinhole, the scanned area is an optical section 
through the specimen. The intensity of light from these in-focus areas is recorded 
by a photomultiplier tube, and the image is stored in a computer.
Microscopy was done with two confocal microscopes: 
1) confocal microscope Leica TCS (Leica, Bensheim) equipped with an Ar-Kr 
laser (488 nm and 568 nm) exciting both FITC (green) and Cy3/PI (red). When 
double transfection experiments were performed, cells were stained with only one 
dye at the time, to avoid cross-talk. In fact, the emission of the FITC can excite red, 
resulting in a false positive Cy3 signal.
2) confocal laser-scanning-microscope Leica TCS SP2 (Leica, Bensheim) 
equipped with four lasers: (1) diode laser (405 nm) exciting DAPI; (2) Ar laser 
(three lines: 458 nm, 488 nm and 514 nm), exciting both FITC (green) and Cy3/PI 
(red); (3) He-Ne laser green (543 nm), exciting Cy3, and (4) He-Ne lase red (633) 
exciting Cy5. 
When cells were double transfected, so that they were stained simultaneously with 
both dyes (FITC-Cy3) a sequential scan was performed, using lasers 1 and 2 one 
after the other, to avoid cross-talk. Images were acquired with a 63x objective, 
using the built-in software from Leica.
2.5. Protein purification
2.5.1. Expression and purification of recombinant proteins 
We used the pET11d expression vector (Novagen) where the proteins to be 
purified harbor a 6x-histidine tag at their N-termini (T7 system from Novagen). 
E. coli BL21(DE3) pLys S (Novagen) were transfomed with the pET11d vector 
and selected on LB/ampicillin/chloramphenicol plates. The cells were harvested 
by centrifugation for 5 minutes at 5000 g and the pellet resuspended in 20 ml 
lysis buffer (500 mM NaCl, 10% glycerol, 20 mM Tris-HCl pH 7.3, 5 mM β-
Mercaptoethanol, 0.1% IGEPAL CA-630 (NP-40), 2 μg/ml Leupeptin, 1 μg/ml 
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Pepstatin A, 20 μg/ml Benzamidine and 1 mM Phenylmethylsulfonyl fluoride). All 
remaining steps were performed at 4 °C with pre-chilled buffers. Samples were 
sonicated on ice (Branson digital sonifier): amplitude 20%, for 3 minutes; on 0.2 
sec, off 0.8 sec (i.e. total elapsed time 15 minutes) and spun for 30 minutes at 
39,000 g. The pellet was discarded and imidazole added to the supernatant to 
a final concentration of 5 mM before loading onto a pre-equilibrated Ni2+-column 
(0.8 ml, Amersham). The column was washed with BC400 (20 mM Tris (pH 7.3 
at 25 °C), 20% glycerol, 1 mM PMSF, 5 mM DTT, 1 mM EDTA pH 8.0, 400 mM 
KCl) including 10 mM imidazole. The recombinant proteins were eluted with 
100 mM imidazole in BC400 and then loaded onto a 0.5 ml Heparin Sepharose 
column (Amersham) and washed with 30 ml BC200 (as BC400, except 200 mM 
KCl). The recombinant protein was then eluted with BC600 (as BC400, except 
600 mM KCl) and the protein total concentration measured and adjusted to at 
least 500 ng/μl with BSA (Roche Diagnostics GmbH). Hepes-KOH (pH 7.9 at 
25 °C) was added to a final concentration of 50 mM, and aliquots were frozen in 
liquid nitrogen and stored at -80°C. The human TBP-pet11d vector is originally 
from the lab of B Roeder and the human NC2 pet11d exists both as two single 
subunit-vectors, or a bicistronic co-expression vector. NC2 truncation mutants 
were constructed using PCR primers harboring a stop codon at the desired 
place, and the sequences of the final vectors were confirmed by sequencing. 
2.5.2. Preparation of whole cell extracts, WCE 
Cells were collected, washed once with ice-cold PBS, resuspended in ca. 1ml ice-
cold PBS and transferred in a 1.5 or 2 ml eppendorf. Cells were centrifuged 4 min 
at 4000 rpm at 4 °C, the supernatant was removed carefully and the cell pellet 
was gently resuspended in PBS at a final concentration of 2.3x107 cells/ml. An 
equal volume of 2x cell culture lysis buffer, supplemented with fresh protease and 
phosphatase inhibitors, was added. After gentle vortexing, cells were kept in ice 
for 15 min, frozen in a dry ice-ethanol bath and thawed in a water bath at 37 °C. 
The cell debris was spun down at high speed (13200 rpm, 10 min at 4°C) and the 
supernatant was collected. Protein concentration was determined by the Bradford 
assay. The total protein extract was stored at -80°C. For western blot analysis, 3-5 
µl of extracts were used.
Interphase and mitotic HeLa WCE
For the big prep of mitotic and interphase HeLa WCE used to immunopurify native 
NC2, 240x 15 cm plates were collected in three different experiments. Each time, 
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60x plates were used for preparing mitotic (M) cells and 20x for the interphase 
(I). This gave approximately the same amount of M and I cells, corresponding 
to 3-4x107 cells for each sample in each experiment. M cells were prepared as 
described above. At the moment of harvesting, plates were shacked and only the 
detached cells were collected. 
Interphase cells were obtained discarding the mitotic cells by shaking off and 
collecting only the attached ones.
Jurkat WCE for 2D gel analysis
For the big prep of Jurkat WCE used for the 2D analysis, three spinner cultures were 
grown in RPMI Medium (Gibco). These cultures were: (i) asynchronous cells, (ii) 
asynchronous cells stimulated 30 min with PMA (0.05 μM), and (iii) mitotic blocked 
cells. During culturing, cell density was kept between 3-6x106 cells/ml. For each 
population, 3.9-4.0x1010 cells (6.5 l) were harvested, and then centrifuged at 500 g 
for 25 min with a G3 rotor. Cell lysate was prepared as described above.
2.5.3. HeLa Nuclear Extracts
All the steps were performed at 4°C and with ice-cold solutions.
HeLA suspension cells were washed with PBS, centrifuged for 10 min at 2500 
rpm, and washed in HB-buffer. After centrifugation, cells were resuspended in a 
volume of HB-buffer corresponding to 4x the initial packed cell volume. Cells were 
incubated in ice for 10 min and then the swollen cells were dounce homogenized 
15x with the pistle B. The cells membrane debris was separated from the nuclei by 
centrifugation for 15 min at 3900 rpm. Nuclei were resuspended with low salt buffer 
(0.02 M KCl) in 1/2x of the volume corresponding to the nuclei pellet and then the 
same amount of high salt buffer (1.6 M KCl) was added drop by drop in 30 min. 
The nuclear extracts were centrifuged for 30 min at 14000 rpm, the supernatant 
collected, snap frozen in liquid nitrogen and stored at -80°C.
2.5.4 Measurement of protein concentration 
Total protein concentration was determined using the Bradford assay (Bio-Rad 
protein assay) by detecting absorbance at 595 nm. A standard curve was made using 
serial dilution of BSA (100-250-500-750-1000   μg/ml) and protein concentration of 
the sample was calculated according to the standard curve.
2.5.5. Coupling of antibody to the beads
All centrifugation steps were done at 2000 rpm for 2 min. 1-2 mg of rat monoclonal 
antibody (hybridoma supernatant, ca. 50 μg/ml) were incubated with 1 ml of wet 
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Protein G-Sepharose (Amersham) over night in gentle rocking in the cold room. 
Beads were washed three times with PBS and three times with 0.2 M sodium 
borate (pH 9). After resuspension in 10 ml (10 volumes) of 0.2 M sodium borate 
(pH 9.0), 52 mg of dimethyl pimelidate (DMP) were added. Beads were incubated 
for 30 minutes at room temperature with gentle mixing. The reaction was stopped 
by washing the beads twice with 0.2 M ethanolamine (pH 8.0), followed by 2 h 
incubation with the same solution in gentle rocking at room temperature. At the 
end, beads were washed twice with PBS and resuspended in PBS containing 
0.02% Sodium Azide, and stored at 4° C. 
2.5.6. Mapping of the epitope recognized by the NC2α 4G7 antibody
Both NC2α monoclonal ab (4G7, 6G8) recognize a sequence in the C-terminus 
of the protein, but it was not known which amino acids correspond to the epitope. 
Knowledge of this sequence allows elution of the NC2 bound to the antibody by 
mean of a synthetic peptide mapping this epitope instead of using SDS buffer or 
pH elution (which lead to protein denaturation). Protein eluted with the peptide can 
therefore be readily used for in vitro assay. Three partially overlapping peptides 
(20-21 aa long) were tested:
159: 159-PPQASHAPSAHFQSPPTPFLP-178
171: 171-SPPTPFLPFASTLPLPPAPP-190
186: 86-PPAPPGPSAPDEEDEEDYDS-205
The peptides were eluted in 40 mM Hepes 7.6 to a final concentration of 3.5 
mg/ml. The peptides were spotted in nitrocellulose membrane at three different 
concentrations (10, 100, 1000 ng). As a control, an unrelated peptide was also 
spotted. Then, the membrane was immunoblotted for both ab. The 159 peptide 
was weakly recognized by the 4G7 ab and strongly by the 6G8 ab. The opposite 
was observed for the 171 peptide, while neither ab recognized the 186 peptide. 
The ability of 159 and 171 to elute some recombinant NC2 bound to protein G 
ab was tested. Only the 171 peptide eluted 90% of the protein, while 159 did not. 
Thus, 171 was used for all peptide elutions, with the following conditions: 
1-1.5 mg/ml peptide in BC100 or 150 / 0.1% NP40. Beads were eluted twice, each 
time with one column volume, rotating for 30 min at RT.
2.5.7. Immunoprecipitation
All steps were performed at 4°C and all buffers were supplemented with fresh 
DTT (1mM), protease inhibitors (200 mM PMSF, 100 mM Benzamidine, 2 μg/ml 
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Leupeptin, 2 μg/ml Aprotinin, 0.2 μg/ml Pepstatin A) and phosphatase inhibitors (1 
mM NaF, 100 mM Vanadate). Each step was separated by a centrifugation at 2500 
rpm for 2 min. To deplete NC2α, 1ml of NE or WCE were incubated with either 
200 μl or 150 μl of ab-coupled beads, respectively. To reduce unspecific binding, 
the extracts were precleared incubating them with Protein G-Sepharose coupled 
with an antibody of the same isotype of NC2α for two hours in gentle rocking 
(IgG1, CAD9, kindly provided by E. Kremmer). Extracts were then incubated with 
Protein G-Sepharose coupled with the specific NC2α ab for at least 2 h, rotating 
at 4 °C. Beads were washed 5x with BC500/0.1% NP40, followed by 3x washes 
with BC150/0.1% NP40. Proteins were eluted twice from the ab either with 2x SDS 
buffer (1 min, 95 °C), or with the peptide corresponding to the epitope (see above), 
each time with one column volume. 
2.6. Protein analysis
2.6.1. Sodium dodecylsulphate polyacrylamide gel electrophoresis (SDS-
PAGE) 
15% separating gel was cast using 30% (w/v) Acrylamide (GelA), 2% (w/v) 
Bisacrylamid (GelB) (Roth). For electrophoresis, protein samples were mixed 
1:6 with 6xloading buffer, heat denatured for 2 min at 95 °C and loaded onto the 
gel. Proteins were separated by applying a current of 20 mA until the dye front 
had reached the end of the gel. Unstained marker proteins (Bio-Rad) were run in 
parallel. Following electrophoresis, proteins were stained with Coomassie Brilliant 
Blue G250, silver staining or subjected to Western blotting (see below). 
6X loading buffer:
0.35 M Tris-HCl (pH 6.8 RT)
10% (w/v) SDS
30% (v/v) Glycerol
9.3% (w/v) DTT
0.12 mg/ml Bromphenolblue
Reagents Separating gel 15% (170:1) (30ml) Stacking gel (10ml)
H2O 6 ml 6.2 ml
GelA 20 ml 1.7 ml
GelB 1.3 ml 0.7 ml
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1.5 M Tris-HCl
(pH 8.8 RT)
7.5 ml
1 M Tris-HCl
(pH 6.8 RT)
1.25 ml
10% (w/v) SDS 0.3 ml 0.1 ml
10% (w/v) APS 100 μl 50 μl
TEMED 30 μl 25 μl
SDS-PAGE Protein-Standards for low molecular weight proteins (Bio-Rad)
Proteins MW (kD)
Phosphorylase B 97 kD
BSA 66 kD
Ovalbumin 45 kD
Carboanhydrase 31 kD
Trypsin Inhibitor 21.5 kD
Lysozyme 14.4 kD
2.6.2. Coomassie staining of polyacrylamide gels 
For Coomassie staining of polyacrylamide gels, the gels were incubated minimum 
2 h on a slowly rocking platform with Staining solution (40% Methanol, 10% Glacial 
Acetic acid, 0.25% Coomassie Brilliant Blue R-250). To visualize the proteins the 
gels were incubated overnight in destaining solution (50% Methanol, 10% Glacial 
Acetic acid). For drying the gels were soaked in dH2O, placed between cellophane 
film and dried at RT. 
2.6.3. Silver staining of polyacrylamide gels 
Silver stained of the gel was performed with the PlusOne-kit (Amersham) according 
to the manufacture instruction. The gels were fixed in 2.5% acetic acid, 2.5% 
methanol, rinsed 2x with dH2O and shaken in dH2O for 2 h to overnight. Sensitization 
was with 0.02% sodium thiosulphate for 2 min, followed by rinsing 2x30 sec with 
dH2O. The gels were then incubated 30 min in 0.1% AgNO3, rinsed 2x30 sec with 
dH2O and developed with 0.01% formaldehyde, 2% sodium carbonate. When a 
sufficient degree of staining was reached the developing solution was poured out 
and the process was stopped with several changes of 1% acetic acid. 
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2.6.4. Western blotting (immunoblotting) 
Proteins separated by SDS-PAGE were transferred to a nitrocellulose membrane 
(Bio-Rad) using semi-dry blot transfer (Bio-Rad or Amersham). 
For protein transfer, the gel was sandwiched between gel-sized Whatmann 3MM 
papers soaked in transfer buffer (20% methanol in 1xTris/glycine buffer) and run 
for 45 min at 15V. 
After transfer, nitrocellulose filters were incubated for 1 h in a Blocking solution 
(TBS containing 6% dried milk) in order toreduce the unspecific background. The 
membrane was incubated for 1 h in appropriate dilution of the primary antibodies, 
directed against the protein of interest. The membrane was washed 3 times for at 
least 10 min in TBST and incubated for an additional 45 min with the appropriate 
secondary antibody conjugated to horseradish peroxidase or alkaline phosphatase. 
After 3 washes in PBST, antigen-antibody complexes were detected using the 
enhanced chemiluminescence detection system (NEN, Boston, MA or Amersham 
Biosciences), according to the manufacturerʼs instructions and exposed on Biomax-
MR film (Eastman Kodak, Rochester, NY). 
Primary antibody Dilution Secondary antibody Dilution
Rat monoclonal NC2α-4G7 1:10
-rat-HRP (Promega) 1:4000
-rat-AP (Promega) 1:3000
Rabbit polyclonal NC2β 1:500
-rabbit-HRP (Promega) 1:6000
-rabbit-AP (Promega) 1:3000
Rabbit TBP (Santa Cruz, 
Cat. No. sc-273)
1:1000 -rabbit-HRP (Promega) 1:6000
2.6.5. 2D Polyacrilammide gel electrophoresis
In 2D electrophoresis gels, proteins are separated according to their charge (i.e. 
their isoelectric point, pI), and on the basis of their molecular weight. First, proteins 
are run using an electric field, so that they migrate until they reach their pI (charge 
= 0); then, the immobilized pH gradient (IPG) strip is rotated 90° and the proteins 
are separated by size in a standard SDS-PAGE without stacking gel.
Native NC2 was immunopurified from three different Jurkat WCE, each made 
from 3-3.5x1010 cells (asynchronous -/+ PMA and M-blocked). As a control, the 
asynchronous WCE were also incubated with a column with bound an antibody 
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of the same isotype than the NC2α ab that does not recognize any protein in the 
WCE. Proteins eluted from this column represented the control for background.
Proteins were eluted from the antibody-coupled beads with 2 ml urea buffer (7 
M urea, 2 M thiourea, 4% CHAPS, bromophenolblue at RT). To minimize salt 
concentration, the elutions were concentrated to 20 μl with a centrifugal concentrator 
(Vivaspin 2, MWCO 10 kD; VIVASCIENCE), and then 100 μl of urea buffer were 
added. To this solution, 0.5% IPG and 1% DTT were added, samples were shaken 
at 20 °C for 30 min, and then stored at -80 °C. 
2D gels were performed with a standard protocol, according to the method of Gorg 
et al. (1988). Protein samples were applied to IPG strips, 18 cm long and with a pH 
gradient between pH 4-7. Proteins were focused using the IPGPhor Amersham). 
After isoelectric focusing, proteins in the IGP strips were separated by SDS-
PAGE (T = 13%, C = 3%) and either silver stained or blotted to PVDF membrane 
(Amersham) for immunoblot analysis.
2.6.6. Computer densitometry analysis
2D gels made from the specific samples (Asynchronous -/+ PMA and M) were 
compared with the control gel (c Async). The digitized images from these gels were 
compared to identify the proteins present exclusively in the specific samples.
2.6.7. Mass Spectrometry 
Spot identification was done by peptide mass fingerprinting. Mass spectrometry can 
identify molecules based on very accurate measurements of their mass/charge (m/
z) ratio and identify post-translational modification based on the detection of mass 
changes. Only peptides with mass comprised in a certain range (300-2500 D) can 
be identified. Thus, proteins cut out from the gels were digested either with Glu C 
(NC2β spots) or trypsin (all the others). Peptides were processed for the MALDI-
TOF analysis according to the standard method.
The 2D gels and computer densitometry analysis presented in this work were 
performed at the Toplab AG (Martinsried). Two different Mass Spectrometry 
analysis were performed, in the Toplab AG and by Gerhard Mittler (at the Mathias 
Mann laboratory, Odense, Denmark).
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2.7. Analysis of protein-DNA interaction
2.7.1. Electromobility shift assay (EMSA) 
35 bp oligonucleotides including a 4 bp 5ʼoverhang were obtained from MWG-
Biotech AG. Their concentrations were controlled using a spectrophotometer. 
Oligos were annealed in buffer (200 mM NaCl, 10 mM Tris-HCl pH 7.3, 1 
mM MgCl2) by heating to 95°C for 3 minutes and cooling gradually to room 
temperature. The annealed oligos were stored at 4 °C and labelled with 32P-
αdCTP (Amersham) by Klenow fill-in by standard procedures. The 35 bp 
sequences used were as follows (TATA-sequence underlined):
ML_up:  5ʼ-CCTGAAGGGGGGCTATAAAAGGGGGTGGGGGCGCG-3ʼ
ML_down:  5ʼ-CGCGCCCCCACCCCCCTTTTATAGCCCCCCTT-3ʼ
Labelling DNA 
The short 35 bp oligo containing the Adenovirus Major Late Promoter (35 bp 
AdMLP oligo) was labeled by filling-in of recessed 3ʼ-termini of double-stranded 
DNA, mixing:
Reagent Amount
DNA 10 pmol
Buffer Klenow 2 μl
3 dNTP-mix (3.3 mM) 2.5 μl
Water to a total volume of 15 μl
water to a total volume of 15 μl
add α-32P-dNTP (3000 Ci/mmol) 4 μl
Klenow fragment (2 u/μl) 1 μl
Incubate the mixture at 30°C for 15 minutes
add 30 μl TE
Purify the labeled fragment with MicroSpin column G-25, according to the manufacturerʼs 
instructions (Amersham)
Dilute in TE (100 fmol/μl) and keep at 4°C (up to 3 weeks).
The long DNA fragment (217 bp) containing the Adenovirus Major Late Promoter 
is derived from the pB2-MLP vector (kindly provided by M. Timmers). The DNA 
fragment was obtained by standard PCR of the SmaI fragment from the pB2-MLP 
vector. Two amplification reactions were performed, each with one of the two primers 
(forward or reverse) labeled in 5ʼ with radioactivity. In this way, the resulting DNA 
fragment was marked only in one of the two strands and used for both EMSA and 
113Materials and Methods
DNA footprint. After amplification, the desired band was separated from unspecific 
products in agarose gel. The labeling of primers at 5ʼ was done with Polynucleotide 
kinase. Sequences of the primers are:
Sma-1: 5ʼ-GGAGGCCTTCGCG-3ʼ
Sma-2: 5ʼ-GGGCAGCTGGATATC-3ʼ
Reagent Amount
primer 10 pmol
Buffer T4 Polynucleotide kinase 2 μl
Water to a total volume of 14 μl
add γ-32P-ATP (3000 Ci/mmol) 5 μl
T4 Polynucleotide kinase (10 u/μl) 1 μl
Incubate the mixture at 37°C for 30 minutes
add 30 μl TE
Purify the labeled fragment with MicroSpin column G-25, according to the manufacturerʼs 
instructions (Amersham)
Dilute in TE (100 fmol/μl) and keep at 4°C (up to 3 weeks).
The Nucleosome template DNA was kindly provided by G. Langst. Nucleosomes 
were assembled on a 248 bp rDNA fragment using purified histones, according to 
Langst and Becker (Langst and Becker 2001).
The binding reactions for EMSA were carried out in a final volume of 20 μl, with 4 
mM MgCl2, 25 mM Hepes-KOH pH 8.2, 0.4 mg/ml BSA, 5 mM DTT, 0.5 mM PMSF 
50-200 fmol labelled DNA. The final concentration of glycerol was kept between 
7-10% and the final concentration of KCl between 70-90 mM. Protein amounts 
are given in figure legends. Binding reactions were incubated 30 minutes at 27 °C 
before loading on 5% acrylamide gels (acrylamide:bisacrylamide 50:1) and run at 
120 V in TGE buffer. Band intensity was quantified using a phosphoimager (Packard 
Instantimager). When using long DNA, 0.5% TBE buffer was used instead.
The amounts of protein used for EMSA refer to the active protein concentrations. 
NC2 was kept at limiting concentration, while TBP was in excess, and DNA 
was titrated until no increase in complex formation was observed. Under these 
conditions, all NC2 proteins capable of binding participate in complex formation. 
This is defined as the active concentration of the protein, and is expressed as fmol 
of bound DNA.
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2.7.2. Footprint
The binding reactions for footprint were carried out as follow: 100 fmol of end-
labeled DNA fragment (see above) were incubated with 25 ng of yTBP (350 fmol) 
with NC2 in concentration ranging from 50-2000 fmol (3.5-140 ng recombinant 
NC2). Reactions were incubated for 30 min at 28 °C in 20 μl volume, with 20 mM 
Hepes-KOH (pH 8.2), 60-70 mM KCl, 2.5 mM Sodiumphosphate (pH 7.6), 5 mM 
MgCl2, 6-10% glycerol, 5 mM DTT, 1 mM PMSF, 0.05% NP40. 
1-10 ng DNAseI in 5 μl buffer 2 (5 mM DTT, 5 mM CaCl2, 100 ng dGdC, 50 mM KCl, 
10 mM Hepes-KOH pH 8.2 and 2.5 μg BSA) was added to the binding reaction and 
incubated for 20 to 30 sec. 
The reaction was stopped, precipitated in Phenol-chloroform and run on 7.5% 
denaturing gel with 0.7x TBA.
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LIST OF ABBREVIATIONS
ab   antibody
APS  ammonium persulphate
Ar  Argon
ATP  adenosine 5ʼ-triphosphate 
bp  base pair 
BSA  bovine serum albumin 
Cat. No. catalogue number
CoIP  co-immunoprecipitation 
dH2O  distilled water 
DNTP  deoxynucleoside triphosphate 
DMSO dimethyl sulfoxide 
DNA  deoxyribonucleic acid 
DTT  dithiothreitol 
EDTA  ethylenediamine tetraacetic acid 
EMSA  electrophoretic mobility shift assay 
FBS = FCS foetal bovine serum = foetal calf serum 
Fig.  figure 
FL  full length
g  gram 
GTP  guanosine 5ʼ-triphosphate
He  Helion
Hepes  N-(2-hydroxyethyl)piperazine-Nʼ-(2-ethanesulfonic acid) 
His  hexahistidine tag 
h  hour 
kD  kilo Dalton
l  liter 
Ig  Immunoglobulin Tag 
M  molar (mol/l) 
Mab  Monoclonal antibody
min  minute 
MW  molecular weight 
NC2  Negative Cofactor 2
Ne  Neon
OD  optical density 
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PCR  polymerase chain reaction 
PFA  paraformaldehyde 
PI  propidium iodide
RNA  ribonucleic acid 
RT  room temperature 
SDS  sodium dodecylsulphate 
SDS PAGE sodium dodecylsulphate polyacrylamide gel electrophoresis
sec  seconds
SP                 streptavidin
TBP  TATA Binding Protein
Tris  Tris(hydroxymethyl)aminomethane 
V  volt(s) 
W  watt(s) 
wt  wild–type
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